var title_f9_36_9792="Telogen effluvium";
var content_f9_36_9792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Telogen effluvium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 285px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Telogen effluvium is characterized by diffuse hair loss. Hair loss is often most noticeable in the temporal region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD, and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9792=[""].join("\n");
var outline_f9_36_9792=null;
var title_f9_36_9793="Morphea with features of lichen sclerosus";
var content_f9_36_9793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morphea with features of lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lichen sclerosus (indicated by arrows) overlying a plaque of linear morphea (hyperpigmented plaque with dermal atrophy cliff drop border).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9793=[""].join("\n");
var outline_f9_36_9793=null;
var title_f9_36_9794="Leukocytoclastic vasculitis";
var content_f9_36_9794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78697&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78697&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leucocytoclastic vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 234px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADqAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxK5X7MskMggPmScpIFYggjjevQfT/APXEgjEzSybRGEwMIuFI9iRkc9eetW0twkkeHkMCIzEAA4HHHXr2/wA4qBYYJoUWNC5L+YoEW18f3c56dPb25rBHp+g8x7JRKRC1vGmd8ahsDsPvZ64HtWol68dtaeXKYlYB5IRKBvA/2j9Pes+O2jkupJXlAkLFAGhRt3oNo4z9P/rFbmGaK7Ik5ZV2AiJF+nrjv1pOz0Ek9y5cTeZMEhEkYlGGCSK7Kc9849feorm1mhmmuHtYA0ZAUFhlsn+7jHvTo7OG2sbbKytKVJJW2wSO4Jzn2qFobgrHDhXhkOSTGJCi5yBkHOcj/PeVa+jHaxPbIkoZp4tkUCEM1wV/eMSewHbIqOyKztbPDdwW2WLOjum3OegB49AMircsDWyymBo1gZgA8sRHmcfdwSTj/PXpTltozJP5EEc2xPmzEAq47j2z7fj1paMErFtVjmSV5AnnyYYTRBRgqcHIA9DnjippYVaMstzdJEFy5MwYv/vHgkH2/man0ya0sbaO3eS4jvjJlTiOWJQQMkgc/p/hVESvAXEjKcyEKWijYlv4ckevGOoHfmos29B2GwWNs9wixNPGyAybxMmTg9cNjHfkmkcTxxQT28kl3GQQyyMBjBPqOOn+cAVO0ETQ3Mt3JNb3nREjEeGPpnr69PekO+KJlOqSSwIAuxI1TGecZPJPAH4VV7hYq3V8RGM2plVuXZ3G6Mf3R6j69Bn3qBruAqzR4UxZQRXDBmcHvxjAGf8APUyx2kYm+eWTeS5WR5lVePY+oxxUEUcS2MsrywyK3ylVRCQ3sePX/PGb0JSJ5dQKOI4raCExKWVFlzggDkAcY75GD+WKkt5b5Y98ksWybIZ4mLsOcknuR9DTdJBZ5PJsI9jMIxNJNGoQnrx3zxyePb0fqUV2uYIw5IQhpFK4yPTHU/l6570rpu2glaxW3W8c7pH58ieXsSR2bcDnsQPf/PQ2bZ1mjUWM+yOJREFl+ZyxPqOvP9PweEUWMERe4jLDerxzBouOMEY/zz7g5yGZt0cUzK7Nkqz9QepJ4x/nt0FqFjRt4/La2tvOtIzkOymQ8n1J4/Hn/wCvFOqxai8iR+UX+XES5hYA44z0GP8ADHUUQtZ209w0kcBYrsURvu5Pf9OCD9Md4pb24ISOyWUGNSXWTJWPGM44znp/nipV7ldB534mVYrZAi8FCzjaew9cH/6/TNNVrGB44NkjSxgEFGZSuMknBwfT1+lNtZnltxJbwQPOuN5TJ3n/AGiOvt+nqK0rRhLh44YlkyCCjtx1APPPT1x7+92uxbIltphGPMa2udjPgvIpZDnGPTB4P+Hor3EvAih3FfmDcsWXH3W9f8+masae1kZwkiNC6ookVpWABI6cA9f6455xPeLY25t/sUPmgFg7DlT35JP4e9K9nsU13Mx7/wAi3LiODaVIClCWUEYPBOOuf/rVJaRGayCtG88ajcpij+7+I5B6fnUrYR/ImCRxSEMEWE4U5weT6EDnH0q5eLbWsM1xG6ySFifKUZGeucE4xyOf68UN9ibGXb2ZlTZG0rESbnLLhVHpyD79+vHFF1BOow0JEPOxQi5I/vYz7H/PNa7S200cbmAmO2iIwgCBpNuASfUEg9OcdPSiHdBEs0UoyWYZUAMMZbjrj3+nPU0Xdx2ILOzljLOoih2oCS4DEcdcHv3wPz6ZbcoLdQl5M7hsncMDjPpjA/X/AA1b06Zc2Ujo1yEPKqtvuG706gevUfh640oLxrJ9olJVSEVgqhT3BHUfz+tJO7ux2sV7plkMzkhXkccKQNwz256f4/jVSOSVbmYK7xhhtAYDOc+45wOOP8RWgkDs9u8rFlXLF92WYcduvX0/+uYZ57sIJXErCR9wQMFIAODwOQOcf/qrRNEtEk1vcRCJVu45I1G8fvcjOeTinMxSPe0qea5GGUswjHc55/z29c9RLczF0jmkdpACN2WUk45J6ZrbWS4tmYtGIiqbApKglc9c424/z3qWNMow392FIieLy2+RnkRQOueCRx+FOfUJw7eTLPujUjJcADJ5AHp+vNR+fOzMkrTAsvCysM9scAYq0dLcQwmSZWMhPyE8gepOMd+mP/rt8qeqGk2Vmnntp0aWOKVFxvPls4OfUnv/APWqWARSxqCVgZ2wJHQhBx90c9frUItFUN5pWRD8m7lV+uPX2qC8iUMYXQMsC8EN1HqfbJp7iSaVy1PARuPmsCThQibW+gwT1/UflTnuLieSWSSIIqRgFWiGQPwP1P8Ak03So7O2ktpblTjPmFlc9jwMEe2OKr6jdJMGKRDe0hYv0Zz79KSTbsJ6K7KwLRFPLRiQAWP3Qx/p9KFuJXdCUSZuqqSABz0x371GJ2jQNGoWbpho+P54P5UWt43ncRxHI6bQPyq7GaaRNOs1wz3DIQMjcqAALk9MZ55pixyOWCW0rbRjcmMCmQAPcAeTFkHJEhx+fIqKS5k8oAsVH8KoOg96EugNrcf5UksiKLeTevocZ56kUVCl1Ik/mLJIVJAPzYz2or08DzKLsr/O36M55OJ0P2JIopDIzsuVB2RZ3EfjwfcVbtkaJywsY5LeJSSWOD7fX9auP9imhMd7sZw3m7hEFVRjqdvY8f5OStv9kiglM1qJftII/doAVAxg89uD9f0HkOTZ3WQRxi4njjnsY0l2l98hyQoxwCCR14zUV9HGrL9miDqXwe7KO2QOD+VLNFbJBKbeVXlwAjSRgleO2evHIPbr6GrGlSahFcbbOVZWWPcAYwDnpjk8n/PHSlfrf8wSIWkY3U9w58xRGFjigTkE+3Qcc+/bFSWywyACaJkWNfn8sKD2P3egPTg//rZEt8s8YuLQKjybmPljkY5+bP1Podp+ogZDJcCGNYz5rD968KhQv+9nn/6/PU5S9RtdDTt7a5htlWeJruAZZZHiRePUH1479QD9BUeMXH2dkkDQSSHgqFIA/Hp+n55qu87rLMbg7FQ7SqJvCHpkAHn+XHtgR3pRlj823LJGuZGVAGGc9ieffqOfXmizvcRPcS+RcTx3EaPtQqf3a5Az/If/AK/cWFLqFo2keKO2BIdoowFI5wD34xz14PPothGuyEpYSSTEj915ATzDnkZ555A6e2O1X7hJEt7mb+x2hgLbFhjkDeUOxK5PYZ/zwm7MaM06VbkoLhZl80+YoRVIPHrnPPT+vOTDdRN5UkVujySySfP+6RQcfw88cH/PYWXk/d3ErIZJhlA7RqFHPPfkjg5HTP5w2xF8WS2WeWaJS0jPGMLz1OM4HbOPbocCk3uJlSaOaJ7lbu13SogPlvs2qf7wxx+PXv3zWsgdViHkj7PJESDJ5aFR3xkc9fX9TgwRlki8p7xC4fhIdgyp/jPrjvnvzzgmpYpLWdriGYtKsalY38lDh8jByRnHv159+U3zC2FtdMtUigBCNJvYO8m3nnpjGc9fX07cSz2kE0cgRCImYiMtdKyAf3ueR0J/X3Mk10sT7Z4kufKIRUbbukHrhc5A9OvHftXu5LuO8jnUF1AOI5BtCg98dD27/wCNK73Afc+WkcW6SMKqmPfHdA7x0ycDIPQcD274MP2O3jdUQZVR0hm3MH7NyCccdB7DtxF/aE0ttBZQiNYpG8zYQucgcfNjp19qtXN7fjTpY3laEBgpfzFBbtnOM8ev/wBcUrNaDQ2PT1llVbs3EKr+889W3H9Bz3yT9SQKq3sNlBJPcS3VxEJG2R5kOSvIP8jUcl60uwLLOFi6eZNnI/AEZ6j0/WoLRDc3cDylxGrFgxcOfY8++PwGfSqUX1YzXtrrQYbWPEEsxCncZZMvkjqMYH/68mqnnXE9gYII4IkhYMm3czkYJzkcn0x2qCWFZpQZLmJoR8qqHKg4G0YXGdvvj27itCOWHTz5yKmWQKRukygxwDjr17f/AKla21wvdWKdgbWbcqzO284dEVwwOMkj2/z6VdjvhZxXG2MSQsDCpIYkqcc+gPbpx0qFYpDc2++ZYrbZucjee5+8OMevp+eabcwTR3FnEkSyGbcVddwG36fe6f5PSm0mwLst5PevbPDdRp5EHDOHjGAMlSw49OeOvU4rLOn+TOzN9muG+8+Cxx1yQSf5jr6Z5kSSdIykb2pExztuMkr6HcePz/8Ar1NqEsltct5yKLyMFf3EJO/t1zgcccfT6pe67IT1WpnPp8ayyPNGFEj/ACJHESmOoHX16/5FOktbbz3cRrHGiYG5cLL/ALoz1x78frSM0szKGjkIUkjzItwQHoPl4xx2/wDrCa6kS4feQEXOB5UG0cdTlj+p57n1q033CyKxEcFqE8yULv3j92hUtxnOfmBHTP4fWGe5iki3NEUllcKGEakHnnp+oxz/ACuzSOGkSGOOJUBDKIA4xgcs2cY56gAe3aoFRW+W3S3Xam8skQXn0AJxnA/nmi4a7IazxLcMNs8e5Nu6MBgAOh/l7/1kSedImlFxACgJc7gHPp/nt+dV4LxbdEVVjfcQ7ABSV5HCjpUVyjfabiSO0wJhhTIq4XP930P0p27hexatL7ITkoAxdjLIq+YST1PWpZT9tuJMiONJG37VcEg+397p7mqghkYPG1oFWPI5Kow56Ef4fh15nhlgjhURySfaEJLIHDnr0xjr/h+SaV7oLlgrYhHmN3seNeN7MJW56KB1+vaoLu+hmuY1ae5uBHgDdKQqnPXpn8xT7a6jYx/bLu480sNiR84XOT/nr+HNU9QtVt5XIuC6luARgtzjkAccH/PSkkr6j1JkuxsjMk0YUuWYhSzDPqSOg9fy6ZEcrJJE+2aFvmAEahuBzz9O/P8A+uukUkuX/dYj4bMp9c8Z4FT2URjAMjM6NkZUkbvY46fj/jmmkgTIDLLZlvs80RZsEhojjj0J4/z0qvLHd37GaSSFQOgHGOOg/wD11djdIYWV0VHYjYj7mC+vHrwKdFEsgkkR0SYYUYhJ3eh4wOp9O351exPJfczBYbraObz4yOcx4P3QeuaiWzlEDSFMRlgF4+99BnpWpcQfaE3zzyuVA3M0H5DP5VBBAvy+TmZwM7UQnB+lNSI9mhtpDLFFIfsiOV67xyO2CScU020ccvzriTbzGpHB55yf8/1lW1DRtJKZnZyDtUZzz6Z/Xp/Rl4LeGR1gtJTEW2o7/e/Eev8An3Kvdjasig4CSrFIuCDgZI9f1ooMztLCrlgYwFUEAcCivXy+nGUXzfmc0pWeh0X7uK7lmjsZniQEKRAyHHvn6/57rb3EqXG63gEeMg7oSS3qD+XI6dvYXZIbhbZy85ED/wAJjZSPbrwef19+acDzsJmWAvJtEe0RFuDwBjPt1/yPH5rnbyji8dwbcsPJDyHzVWMk/wC8OfTJ/X3qe6DyJiKEMiMVjlMPUdsAHIye3/6qfp9sSWUoEECbh+6YcHue2P8A9fuXyWkTTRMIwgjyxaLJV+2Mf59BjIqXJJjsRQwajImYnkZh8qwPFnPcc5x2z19/emrFcnbFfxmzAU8JCVkJPbrz1z/nmxHHJPby/NDGGbAEsTEnjKgn+HgE8Z6fjTREq2k00n79EOyJXRghxj6+vX/Hk5hW1GadZOTtK+UsmAskluWyM9zng/eA9xjp0jee6mSXzI98EbFA+NxJPTBz6YPX+hrRgsoQ0h3NOsSCRlET7UBx1Gfwz36fRYbqO3dGazR1lOHDIUAX1OD2zn88d8zzD5epFNavEY4YJ5WlVAF823AOe/fjuMc/rin2cMUl0I54LjKgtvYjLe+M+ufy/EABaO7V7ZUgBJO6EuSByAOcf/W4xnAq/b6hNMnnJAskYTYd2BhT0xkEjp9cYqHJ2CxDHD5d0+63jlYtnaYlznH3hnnPPpn+sMlt53mXBESA5jVUCgEDrjB7Feh6Y9at7mSFomW2mdVMkYaNFYdBnOc8Z47Z6HjmN5XjffcNbCRjtaN9oycdQe317/lST6jfYsNI0aSJfWt4iqgCvAIwAdoO7IGPTjOenbmsMkrGkrSbJ3yq7I1znsTg46/TqfpWkLuKEFIIjG/mbl8tlyOO+SRgE46Hrj2pNUdlkZ3dYnUbGMm372M5OOO+eP6U46A1coJJexXMMxlkSRsrFLDtBHZs4OcYJ7/WrsTzR3DwT38bqU+VTIi/h7emOvaiwjupn8loJVOwtvXZkr/vH3+n49Dmz27h2jCtIcn5mMa8+nt07enrxVaPRk8vU0HR7cxtZyxTSIhYbZFyvvj1/wAPY1RurfzfKQZmDMWkjWfBI9xj19vw5GZ7i2+RpBMpVvl3xNGrDpwcE56j8+PWnwNO826ONVtIV+fEi+Y2TjGe5OD69xx0KTtsCRUtrl41liV5PKeQCRBIAo4xjIzwB/nNPa4hVpMSl2jACI1wdo98FcnnP+ea1RAXhRYIp45ISJGAYttPXlgMdcfT+VRIbVp5VhmuT5snyD7QGK+27A9z/P1JzJ3ZVrWRFDZRyMkovYYJYV3bIw+XbpgEjAH19fwqSBJLURbbiJ5pZNwdyx2++fTqT9M+4ljmFg89uYXkjKYDeYTnJ5yMfmMdunUVH9tZQJ3nQugOzhj5fcnHTqPwx7A0tX0HZILxZdQa4MkxmZ9p3w79uRxjGOB29OfXkq2ntFsM9u6skatG0gYoQDg9xkHGCcdQMVBFcyxbZLa4cxs27dvwSMdh1Hfp/PrNb7pZS0oa5eRtq+aWAAHZQOnH064+j1QnYZbQrugW6YQWhDbpYlds5OSVDkhsHHAx05OeapXd9p7W80a5ed32+Y0eDt+vQZz29q0b8GJ3MqNIclWRiZCqgnoM9T1x7+1M+wJbiLzmaKNzlIlDDcvOee5/X6U+buJLsYtvcR27StDII2CD+Bl3e456e3T8Ku3p8wFZrcSzqpIaNcgkj2PHf2+tMm09SFMMUTRyNzGSxD8+3TgA1NZhRDcQoxhA+6fKwSfXGev+FU2nqGzsUrfTZhhJobhlbBMcMeCV75J6HvSS2Jhkk2QSpGuVBLDn265Hb/OK1EwpLySxSoo+6VyMEcLjP+fwBqkTKWV0YrID5mfKEar6bSefX8+cZpKTb3HYIzp9jCHuYXlmAONzKpDe478/1qrFcFyqyJCGILjdtJBHQj/J/kRpxMWuJH1ASzMcLuMCjkcc9sf4d+gju5JLh2kbyILfI48lAevOCeQeAf696E9QsZm+H7IJ4mUSM3zoAqkAnsfz/XpmnO5WNvLtzGAAA8T4Y/49+f8A6+L0ltCgY215HErZITZkA/XrjPYD/Aw200os44oNREoZ/mglACg++Qf8gHnoKutyVfZjhDezz25aQeaiDCmRVbA6fj/j+NRwm7LRtJO4jJy2WLZx0XgfnU7S3DxFpY4hOSIvMZ1UY9cDjGP896FHlkkRoZA+wIZ8heuCMcfyqShlzE5G97YyhmGbjzGyw4xn3P5/pUiCIKPMiWDAG1ldtzZzgYHT05xSySXccEEMt6jKpLqhlP3s8lvU9+vNZb3XnTW8Uk2Iix3kOSCOeeR9fzppNoT0ZYm8sToCs5kPOZgWB/Ifr9OfSK4uXVYYYmBZDykYdc+ufWtUahEm1I1jZcBNz5ZcDpx29az50hLS+enmlSP3gBATr1GPwxjt65Bav2F03G2kts5fypBDK7bmJyRxk5wKZ8szPKJgqldheMhR78Y4/wDr/nHDZWwnj8yNwnLlkDnd34PfHsaZNbAMptWmWM/Mm9CML65/z/jWlydbaii1dY5lhnUoi5JZSCwPbI/l7VRdxuiBfySR8xUDp9P89auRrxJGzSB3xtG3Gcex/wA/0bLsa5ZYbXYBwFClu3Jpp9xSjpoUEnZ1iRW3RrICAVGT/U0VqLaI0hSKaL5F3lQoDHv156Yor1cva5ZaJ+v9IwnFp7nRQK11IMljHBh8tuzIexx+Pb/DNBLZpZ/OlVnDvlI4i3Iz17e36VzUmq3EoO98EgD5SeeO/NSJq14jbhIxYKVBOTgEV5Kg11Oj2sXsdT9sSGK6Ri8UjyBseUSCO/c8YP1/CphMLq1uWjVFdVC7lVwF/DoOn0rjft91lOZW2tvXIJwfp/npUrahfSqUkErhvvAoee+KPZ9h+0uddYQxGERXBTZAokZmDOcnnAHTOT+vHeleJlto4o4oD5reb5ixsvy44wvTH09/SuVSfU5HcQwvEWQ/KkTYPrgDPP1p8dtq0kW428xAGEycYxjnH0/zxScdbtjTb0szr7K3FrORLG627uAnlg9Djvn0+vbiq8pRL+ZYwbiOI4MRjJYjP3fl9O/rXMx2GrhFeOF12/OCcjHvn/P61JFo+sGWNjCwywIA5/QjH51PKusjS0+kWdcdblR0sbWG1ghgHmpG0JL9MH5s+w/LPQCmC2kurQb7WZlYiRnWHO3IyOSeevT+dcmulayJ/NaAs2SSRtOfXH5/SrVxpmvoPMT7YWbIZBnI9Bx3OPQD6dKXJBbNE+/1izZSIG2lluIIDGx2hhbYZ8epz/n8DiK5ljj3SW9vGISu0hgof6dfX8iec1ixvr0TIrQ3CmIllMkWdp556H3qq9/qMMryTQlXfO7dABuz68Z/z9aajd7oltrdM6O2hlzHGiwBdm8qsgOOeBz346D+mKbbIZpZLeUszyMQWYoOOo7/AOcevNYEGty26OUWMcbdhUADPoPf6Y6Voab4lmglUhthAwGESsw+mRwffr79w3CXQOaL0OjfTprXfiVjImI3Csr47Y9QPYeuP96aWBoXZ7kgFcDyRtBbPPt+o7dD0GDa6yj7FmvAUkO5gY1UKc98D/P40g1tWmkYXuzc+Cdg37e53Hpxjg5H5YrLkkae7sbNnOLNyjxQ7PmKzSbTyxyQp6g9/wCvekmvrZIhI9wvksSVjyFUn1xtPHX+XqDnXOtCWWY2m2XcmI2ldWdfXkAE8En9aS0mtzFEjXis+QxG/YTnv14PbHanyPdoWmxoW/iaWxkcLGZ4ZVJVDLtG4jA9zyORkdMUkt3G5lV4IY9q7swjJIxwSSMn1/X3NAahFatcQoIipyCwnU4weF7gjjrU8OrQM000Vw4dvl2jAyTjI+7g9KTh2RStpdiQuPLEMaNLJkHAnYk9+AAD/n3qae4YiVWkkeVjs2lnUspzjIxgduvfH4U21Vor3c0kcG1A5KlGGeeOF9z9PwqaHU4by8hd0iuJthaT5tu3GckEYGOh9epPenyvsDt3HErbySqE+QR4VndsRkcccc9+vpz3qV0t1s4JEvIQeXY5ck8DjaBwec89umetU4DIwQCMpF5m9gHYrjnp69+mfxIqYSzJM73Em0uWQksx+X/dz7/144JVhMav2eaNUt0t3Zn/AHgUt06bgvb36nn8KfFcMryo8iRZYRgPbMxx6g9+g7/TPaB1hZovJVDGqgBowwIOOAf17f4VcjdrkrDOfJLNuZ2R2B4HUk/hnI7fUNghRbSNLGixM6BC2GQ5bp0z6H6fyJiaxcC2aKMrCGLPmMoSx/H/AD6dgyS4MsMnmnFwrmPKRtvbBxnr07+4+pynkiW4eF2MpTiNDE3zZHJOT1/z04parQNNyF2HmzPb2wkWTcrPMhAbHIyc4PAHp+hNTmeCNbg3cSM0ajy9kO4A9hye3PT/APXHqEstyFPlCKJRlonQYJ/PJyPp+PWoIRI4JuFCws2BLIowT9B36fl27sVhm+9uXHnQPHwSkgCkM3pkn0H6AegqqsM0dwq3MfnNvyxeQfKM56g/5/I1ceQyrvhRHVW2hyo247cfiP8AJ4YHktVnW78t05CrH5Y7n888YqkxcvUbNY+b5qROrvuO3CKO/OORx/niliintl+dSfLGNi7d5GepJ+n+e1i2WVdKt0itkimJLMzupXHsO1NM8zqqyTyne24EsigkHvnngZ/l9TmewJDUEUbIkqYhK5kDspIOfUevuO9Vo7XJkSCBAJWBU+YOAMkcdBVsq0rXM9zJxt2xHenPPPHr2Hr2HanWgFxdIITcJ5a796OMnnPT2+vuTwCFew7FGeSeUSQSiYMpCnDArnp/n/63KQ2JL/LKqRBAXDvnPt09c9M1ekA8sKjXKktueVm2j03cjkf5HJxUKBY4TdXF5ExVgEO5mIIPsOP8/hSb2QrBbxJKhSOVvNVt+3zWwe+cdfXp9fej+zGCllMpkeTojscjGOmP/r/ypyBm+0NLdhGJULtb8eT/AJ9feoohKblSJYwFjB3h2UEdP8/y7Ua9BbEMDRF5CIXyRtUu7An8QP8AP8pFMC3EkbIWRFAwu884I5zz+FT/ANpK5gtZLuWEOdzbckKfx49/WqJQPMyh5nL4wwVhtHT8vzo16gElg7yxssvlgrleS2fb2/z71X8u4iieMoWfdt3YGc46HOMEdKfPE0GfIg3FsAOyMOnoc4PPf/8AXUZ+dUN1KsgUYKKpXj6nn26f4VS1FaxCbK43B9kuN+3cqDnB5ziim/u4yh8lxF1IU/MOODjNFd+FxcaCal18v+CjnnTUn/w56EvhJIpyhhQqxyApY4z68f5/DNaUfhJVYOIUwgAAZmHP5f5569/Q47EbkKDIPOOnYf49KtCyIOFVvQngD6f59K+UljZ9GfVeygjz228KfLgAbxx8pYZA56dulOfwpJszExXDbtsmQQcdRjHHbB/Ppn0aOw24ODjHbHr2+uKLeBpFY+WgG7ofmDA9+O3rWbxkujFywR5/ZeHSsGZYYC3+11U455/DIP6dhr2uhQ4y0SFs4U56jnv+X+eR2K2HRmVWcnGWI5+vvUkdkFycjA9CB/nk1nLEylpcfuLY5GPQbNWH7mGIjv3J9R6/59wZV8P2oX5YUB+nf1/+v/kdd9mVgBtOQeR0IP8An+VSNAAuBgd+owT/AJx/kVk60u4/aJdDjH8PQs5JjUKcHCgAkjn8v89eTE/h23aQsFH+7tAz2wf8+g9q7Yw7ic4PvnHb1/z/AFpotgD0BycEM2P84/rTVeXcXOuxxR8OKzchNqseqcfTPf8AzjoMMl8NW+SrwQsoPI2Dpx/+rGfyzXbm1TLA56c5PHHTjGP8/gGeS2C2MEHGc9+O/ToTT+sTXULp9DgrvwfZSqd0cb7uGUx/gP19s9vph3Pw10+4i5iSKTnmPgHnpx3/AE/U16pJaD5tgXae68DHp/n+vKSw5JyAQOuRkn9PbtzVxxlSK0kJ04T+JXPE734ZBZD5MkqhV4+7hu/X1xj/ACazLn4eXS3BZZXWF3IGUXK5PGcHGPXHH6V7ybfe4O0lmXrgg/5/zmmG0GGU/dweQM/56+nrW6zKqupH1Og/sng0/wAO76KQFLk7DnkDnH1HH/16ik8G6tBbSWsM1s8MjLKVaNS+4A4IbqBgngEA9+mR7xLZKEZVUN7EcD/Z+n+eajaz2iPzCRtAxj0I9/8AH/GrWZ1ET/Z9B9Dw6w8C/aVYS3EqyJkMDgYP1596bqvw91G3YCzlE6hMkOMEHJ6Y68Y/lXuC6fsmVhw4XHThh6H/AB7fztG1Qg8qhYDnHTPPIz04o/tKpe6HLA0LWsfN9v4Vu5dytLHG/XaxHX354HfPTv0wafc6Bq+nGGeJfMSNtwaJu+fTHB9P/riveLnSI49RS6OQmSHTPXjr/nH9ak/suF4/lD4x9cnv+f8AnA4Ov9py3sZvLqTWh89Rz6nEWYx3L+WR97cdoPQ0h8QXJgMNyuQ53EklWPXqfTk8V7nfeGI5pskMHQ4AJ2gEf/WrNuPClvd7Q8MbYOPnOc5J/wAT+X56xzCnLdGTy5/ZkeS2HiCOO2lSQy+Z0Qhj/ngH/PStKLXbeaZQ11J5TR4ZZVYqpweMZ56D8+9dhe+A4WTm0iz9z7pyfcY6c1lXvw9WOTHkypJ02guMH0Of8/StViqEjJ4Ksno0zIlv9ILxFXTYeoRHLAj6n0/z3MMbRupm3lXZhsHl5G3IBye3br/hia98DvCBseTd6bW6Y65IrIuPDN7CT5RO4chSCM8c89sVrGVN7SM5YestbFiS9ZVconmsRgOqHcp5AH+f0qe4eJQiTOTEyjcGiAVjnsOh+v8AWsR7TU4NqyRs6g+ZtI64I9evpVhxrN2xVbM4kOFDqMgZ4GfX3/GteVdzG0tuVmrKolZ2jjC7Tu3vBhjgemfwz/k1POYBXktow5bCh0UZA9279f8A6/SiPw/rdwWd5Io1KYyD2H0/n/8AWrXsvAMsy4uLmdx1CLtUZ9uT/wDWrOVWnH4pGsMNVltH7zNfV7Pax8tImIwCUViB7Y6HOev88Yr3mqWPlwhJnlkTJAZFx+Pr+dd9pXw707jdaeYc53SHdx+f6f8A6x0dp4MsIwu20gUAhf8AVKB9en6/5PLLG0YvS50LL6n2mkeH2+rmMBFjb72QY1AOM9On+fyq3b6rOQZPLvXfcOfLyGHJwePYn8PaveYNAghT93EBFyBwBgducfzH+FTNo6AbioxnIHP459ecH/OazeZQ6RKWXW1c/wADwSfXbmRFWe1u9qjC7i3A9MYx3P5/gYotathCkckV2qqdxy3y/TGP8+/b39dGiLn5QoHAxz7/AOTUcmhIybSvm5ICgjp9Pfp/niksxp7OP4g8uf8AP+B88jUoHXYX8tCRwHOR7n1/D/8AWR3VsWJZjNIuPm3lc/h9MflXvE/hGxkDM9pA/OcbRjA7dPTr/nGLf+ANKkO/7Eu3ceikDntwc+v9PWto5jSe6Mnl9RbSTPJHui8hHmO0gA27W3DHP/1sUtqTGSrysVZPkPzEpkdscev5/l1upeArdJClukqN6I7HP4Ef5/Q4l74L1XT2xHcMu4dGzyPwrpjiKctE7HNPDVobq5kteMh2kb2Qglic5Oep9fpTxfO+RKuyMt1RT19P8/8A1qpXMF/bDEseVHPA7gdT+dQW8vmMVyCDzyCR0/nW6SeqOZycXZ6FtnzOhQK5JxuYdOe/P+f1oqKxVklijlVl3OMcHP50V9Xw/l8sXTnKKWj6t/octWbT/wCGPrQQq54C5J5OB2HUD/PWrKKGYLt6cqFGfw/yKWFflwQoyckYA+pzn/PWrMYw5PGewIwK/JG7n17YkELKQSTt64yD61JHZq7g4UgAAYwCPQZ6/wD6/wA7EK4Rdq46fgfSrRUEDGcHGOn5UrnPKTuVPIUscouMYwBgdqkWMBsDOSOcf1/KrCr/AHlOc49P8inhSBuwCPQn+tO3YjmZUCjBXP1x0HFIYVZTu55xgcA1PhgyyKMjByT2PpUgUlDt27u/b8OlKwc1jP8AsxJOFyTjH+enrThGyHAJxnnt/SrpQZJGcjjB4oAGMEsAMZ+vtUu41PuUmiMhIz8uOuT/APr70ySHqSTwMg5ye1XSvUqMZ6n/AApWj3N8uGZeozzSt2KUzO8khWOOB/L/ACaVoFPLAAEHo2M81f2E7goywHQ8VEzKCPMJQMecHHPYfX2qrMFMzpYAuSu1WXqRnIHuP8/rUZAjRzLxwckHbt/zn/PfQdQRuYgZIPeqrAAE4KkjPPQYzSN4yutSmYgFyULcDBAyDnnGc1CdoBBGEwDyOMdsD/6/+NXjCGK5XMZYZA5zzyAKqupMh3E+hDErxnAFVuaxYkag7Tgntjbnj1/lQVDPvwMnB3Fe/Tn9aiOPkIGcAgE5APtmpC+G3AHcRkfL16Zz7+1JFuI9rZWRMgDJ27ckEY78/Wo7eH5NrKNwJJbGB36fp09KeJCUc8RjjjbkE88Ef55pUGAwBKkkZB447Hj/AD/Ohu5FmlZkU8G0kIArqBgBen4/UVEbdWco6KSeeQvQ+h/X/PF4Hbu3gE8DhAB7gjsOn504IArOWG0jrgcdeTz6UuaxN2kZ/wBljcEcF85xgHIHoM571C+nrsOFJ65JABrXRSy7pVT5eASelLLGdnJw3UL2Bx3NPnaBVHc5y50tZISHVSp6Y5wOe/41l3OjRBUZcgjOV/l/n3+hrryi7SHG4DnHAAxxUMiAkqCWHQD0Oa0jVkjRS7nnd/4bVyxVE29cDgfl37fT8cVSstHjhnHnRAxg8qU+XHrknA/l+XHotzagk5HzLgZJ6Ec89s/59jnT2DM2VIJzk+vYf06V0xxUrWbKUIy6Gfa6apCtgPHH0cn7p64P6+n9a2LHT4lGQkajqfwyP5VWgilhYCPgDuOp6cf/AFvatWzvoV+WZXU/3lOQfw7f5+tZTqN7CnFpe6XIbIHg4z6g96tC3VRt4GO3PTqBVmxEdxDmGZJAOqg8j8KnCDaPmIGRyR/KsThlUd7MzhbiPhV4zjGenX/GmGBuECjjB6/5961jtxhic9tx4xSCNWwFUvnkdTn6f57UaoSqPqZLQ8FtuWJBOFJ7+/0qLycg5QYBywxntWzLAUZd6ALnOTk9Of8AP9aqzQYcKH3Enr26f/XpXsaKpczWgJkCZPXlc8j/AOvxTZ4f3XJzxyOc4x+taywkJgJ1+YkgnJqO5icqQYw6k8hl5PHvScrO41O5zkllG4aT5h6+2R+Xp/Ksm704S7gVIDfMS3p0z3xz2/yO0kVFLbggyM7mGB+X5Vz2q52ukAK4JHHU++P8/wBK2p1Ghr39Dxz4h31jpbpY2e2W8xuYbTiL0JOcE+mOn1rz+K2YN5m/J77RyPoK7D4kaWsUwuEBLE/M25jn3ya5S3nkeEI7YRmAJJIFfTYa3s00eHjIyVbln8h9srvPGXcFiwOcnOc5xRSxKftcYUMy+YAuEJzzRX6bwV/Aq+q/I8rE2urn2NFAOn8OM4H8qkjjzgtwCRjH8uaVEypwQue5AP1qdUCMSB3yc9Pxr8FbsfXNiwxlXUYGPfsKnGQCSVBxnNNU7Rwu47cDp0p6DucfTg8/SqTuZO48/dwN+SOPpS4w/H0zTdhAG0gt6Dp7Un8PBOPzo5kTygQBuwSOeR0qRTnAViAQOp6UwEKAflyO+4f5HNOAwSAW5HT0polrQlBXHUe2T2NRkBRw2FPcnv6U7HyjoT+QPHpUAYMV6gg8jp19KGJIRsEk5BzweenvTcnYBuOepqVkBHGAoHPWmMAhYDrnv3PFTY0TGs5BPI49M9PaoyAfTIPrn+dE2QCRgkds9Pfio94Z9uNyYySvUj15qWy1HQRiScpyBknBPX+dVnXJYHdnA2qM5zn+VWCcAZDEnHBUg9eR6dxTWbKnofVieP8AGhGi00IJBtU8sCDweTg8flVG4ZhMMA5x3Pfrzn39asTfMSoUl+g+Xj/P0qJkIXcfujOVK9uv4dqZ0U0luVVBy+1MdD0z9Sf/AK3+FJEW/dsBtxjIzjj+gqfarZIUsWHTHAppUSD5VX5SGJI9zn/Ip3NrgsY8wEqC2MdOoxx0qVFVj86lSOjcc59/r+dRlt2QpGBj+HHPbj86jxy3mn90OQccdDwfak9SWm9y/EpLNvEmc7s5zjt+FIgH3dhA6rkDJPqOc+vamBzsjZG3ZP1/I/rUm4Ftqk7uoBIwQB245qephJMmU54yc8jI6j/GmNIm/HbPTIx9f8+tV/PII5CkHk+v4dqRpgIw2055CkjjI6k8GqtcXs2Nk2ldyMM5yOcn6/z7VWlZ9/Ppg4/p6Gkab5SOMjnqPT0qMSBQQvBPVu//AOqnY6IxEkI3eWG5Unvjjv29u309ygiLOVJwoJAPGKlx6ORnJyGX07VYtVVBjBPrn/OKG7DbsiBLfdKVAzvJz79P55p0thETkrw2Oh6fh/jVwIfMChjk5Awckf5/xq2OFLDA5zweam73MZVGtjBl04qQpPI43ZyRz60kVtcp925mTjrvOPSumjiUAlvmzz0PFMaDcRz0YZ45/CmpSsT9YvozANxqIRG88Pt+6CnT/PWo3vtULBVlRMcEhO3+T/IV0DW24nC855wT6moXslPy7eAcHvmq5rajVWm90jB/tLUtuBOp2nkGPH0/nToNW1BcgxI7ceuemfX8fzrTms2/dqw5PPpxVMWrkn5RgnjBGQMdf5/5GafNc0TpPohV167DANaISRubBOBVhdYhaIu1rMjqMnAyP07ZqAxeWpby2L9B8oI+uag2kqvOCeSuOnuB/WobuJ06b2RL9qWaVZJdiLjd/k/5/rVS9Rcbs8kZGDz054H4f5OKlFujESOVA4zHksSMeg78VRumJDs7EE5xxg46jpj1/wAcd6iHKr+6ebfEG1WaJwAeQcex79P8/wBPJ7GQKXTCk443DOPpXrvjljNE53KY1Ug8kbeOPx4xz0ryG3UPLJkFsnPfP4V9NgX+6szx8zX7yLRraTKgngSTdGAwyyKQSc9Ov+f0oqnZyH7VFsyMFcKUJzziiv0/gumnRq69V+R4leW1j7NV26LkqOrYwD9akUfOeT04zgfnUaOq5JwOeM85PpUgCqqgj72OOnOfWvwbqfUMlU/MAvr1IpyvsyASD6g/zquSFA45AwMAHn8KkJUuSVAyMcelULlJmkIHr0PPb1pItzYbnd9c4/z6VFnlsk9M4yOfrTyuGBB4HOcdBSvcGrEoVS2fvZxwPwpyk7sjr16/nUIO9W2sRnnGOpoz8hAUD8ck5pohpj8kqwBzzg8nB4puUJBH3sHJB6/pmgnJCEtk9jUMjEHCna33SMc/X2ouNRuSBw4VVbBxljn2okYK5HUZ6k4qtJuRAm7jHQHkmmyPsdt7DeOV/wAf8/4Ur3LUOo+STa25+Sei+tNbc7feIA5PXB71BkZw2OhIJB46dP8AP+FRkF1P3c46E9OPala5so2JpMRrluMcYz1H1P0FQSPuyxyGYEAhPyGKsGFmgJIIz09v8+vXmqkoIlC7+DyOuen8v500VGwrFmyQPlAJHbJH489ajlTAw6KQCctktgj0NI8j4CsuVBOH7Ed+abD5jv5cYcO3HA+bHfAJ6/5+rNEraleXcEYKDjsVPH+e3p7UwMwOXDDHAVRz1q4tp+7DZGOz4z7fn0qKe1XYShUkctgbs+/14zQmjRTi9CvI5JCuOC2SSOMfzp4KqFJJCgg5J6ZGM/0qNgRIR5eCBg7hnJ9P/wBVA2mPZcBNknHzAHPP/wBb07UNGjWmhfjVUJCgY+6D0Hsfeom4QEsWPp1OfqBj8P8A69RKJFKujyKxwMEAjr2FSRSoqBlYKOB+9AOM5xx60rGDXUgkDI46EZIU9h7f571BdXUUSbXkQpuxkHsOo/8A1f4Gm6teR2tq8jzF1I2IuRktjuAP8+lcpeS6hd5dPMSMLubam5lIA+YYOfx/wrelT5tWdFOnzavY25NShU4DZAP1BPpyMDH9fepIbmIyHy3HGSOclvz6/wCfpXmOpRyYjMPmMN+3gMyFj1I44J6Yx6+9N87UNB1O5gmha3lgxvhZShGMY649fTpXd9TUlpLU2cYrQ9etZmd23P65J+YH+taMDhwuSuB3Y8DjucVxmg6uNRt1kRXQkZdWH4cfjXVWEgZSFIxnjDdT/nNedUhyuz3OatTtqahyGXrt6bfTp+dWoVBfdllJHU545qrDlScjbn5l7D6/r7VejBBC8MGHy5zz2zWJwT2JcEMVIBbv/n0pWQIyKV+XHUjGBzzj0p6A71EbGQZy2Pl5z6/5FKzBZGRW2k8MCOPzHWtEmc1wVEffvwyAYDe56Z4JpnkDcNvUjKhj8yjHXNIzeWrFxuBOM5OAPYUze0i5G5o9oO08Mf8ADn+VU2uokpboY8KtEu9SuQQDgkN7+tUJokC4O1sEcBODx1yf5f5F57krIVzyRt+YbiPoe3viqLtuOFRtwAzjJ7elQzendEE0SfMxUg9gG496pSqM53BSTgjscdver7gFAGJbPA259P8APeqEq5UcH5sn6D0oSOiDIZWGNpIx/M+n/wCusu/Kxxs0meQV57f5/wA+tXZ5CN+35WbAyemSOgPb/PtWJqt3thdtq5UY55J756/p/kbU43djZKyPPvHN0BbuWxvxxtBO05/z/wDqxXmtgSJtwUkjkcH+ldR451Eyy7WJJfBPUE8foPp/9esDS418lyJWVzwpVSecdPQZ6fjX02HhyU9TwcdNTrJLoW7Yzz3lurpglwFzGQFH1/KipbeW4R0MMjSRRkZYlhtGf6f4/Wiv0PhCtKnRqKLitVu7dPRnk4lNtWPrcMOCWc45H9e/+elM3gjITnPU49aiLLtJ3qGP+zjvxQigYJAJA+6B0r8PaZ9WkkWFbdEB03cnHX6VKoDKuCCe+e9RDKEBge2dp5HPHFSZCHg4PTGO/wD+qp13EyQjEa8dOjYGPoO3/wCqg5Vgc4554piEFc7U3Pndgjqe545PFPH8RPGR7Zzn/wCtT2JYKzbTg4YHHTvTpFGV3Havb2P0702HbGuAwIH6UHhNyMzHB/iH50WsT1GklAMZyOoLdOaVZCuChJ6nav0qJi0jkAcAdDyOfQU3jIRQG4AI5wR9KCuXuNmdjjaCAOQQMZ+tRq+5EQjaOQT1z9f8/wCNSTNnBiJK9OvJ/Gm7h5Kli24cAd+f1o8jSOxCOPlXnJxjJGAen+P86dhN2V3NwNxOccjvnp+dTHCyZSRiwAO7BB6c/SlhjB52jDE4Yk8n3z9KfqPnLasyRjJ5x069uP8APvWdIULkjaA2Vw3P1/kKuuWSNQRtBTn5uW9f51nuqEMTkA9CQQMemDTfmZ0rXKbqrOQynj0BA5GR9asxIURXbjDcDOAD7n8qjmyICZlHJyB26dD6/wCfwcj+XEEaNRkjODj5vp270ndo627odcFkV8f6zGDvJ2n6ZH41Tuw8eGLhJVIwQAeeuR69jmpjNIqjeSwAIxxtI75Oc4HtWRO3mSKSW6nA27V6dQM/56elNJjpQ1LUr+aTJHtyAANy8flTrY7o+SRjhSuOPy+vb1qozBJCY2PlYAbJyCM9R6n161aQlyQrZOACRjnHb9etNqy0NmtLD1D7xlmJTkZO4MfTA71NJj5t4jAZRuC4bH+929agysi7TtUgDDIcYPP5D2P8+KeHVkePewBOSd+C3QfT+eaGjNoxr67MOoWckWxGUsNxxkg8HnquPXtyapzwRywXLLb5RlBMrck5bkbupB9fQcdcVLrcQSeV4lK+ZHkElCM856nHUA/5zWPLG10jfu3lnOFLkhs4HIXgc/TtwK6qa0TOuMU0mit4iQG3mtme8n8varKmAkZAOAcEDcBtwDzgnGa5DxFiTVbplXlm6HJPQcknqD/n1re1ASCXylxITID5bIwDdscHk+uf/wBXP35aO5dmjjQq+4K8WQOeFwc5Ax39+vf08MuXYOQueF78Wd8pJHlsm0FgQCM9h6/59q9e0uRHKOGDDOQ27sf6V4dZRSXF8Fj42nIIj2k59APyr2jTGCxRMwJVlXPP4fX/AD3rjzGKTTIqK8DqYGzjd87k5y/QAH3/AJVat5NihmPl9fmxnNZ1vIPLAOwnrvySWOenapkkUAFTIM+jYHfj2ry72Z5M4X0Lcjsq8xkg5bI6g89fTt0polACw5IZsHaOMH8etQsPlLlBtAyxTPPPWk8w8jJZSRuWTO4//WoUtSOVBcFpJTuYKB8u5RlenrUROCwLbwABuxtAP4f1odsuoQhFB+7yQPpTM7U+VQAMBflJX2wD/TvVF20EkfCFQWBHOQOKryPuH3COMBh9P/rUsso38Z+XqRk/jyaoP+7B3IOemTt7f56UI1jEsvcYAx90DgkZ/r/nmqL3AyQ52nPACD5uOfX/AD+dIzbju5yeWyDkn/HrWfLIWAEiqc8464/zitIxuzSMUhtzKyZRAQSQNo9+v8sVxXijUxGjKX2Zyduf5fl/nBxvapdxwxP5mNw4ODn8sf17V5D4w1YXEpiiK49VyMD0r08HQ55XZnia0aUGzB1Kc3l+xjGUBwOTg/nV+2LfZ441UeYR02k8c9cD26f/AKqq2McG1QWJd2AA5OfetHY5uiisg2ghTuIycdief8/SvbbS0PntZNze7IbVJjdqyhwGkVslGySD0Hr+v1oq9p4u1uI1ypCsGYPkDrywPaivvuD8RTpUaqnJLVbvyOPERu0fTysxAO4Y3cgdT+vAqfkqPlYj7vPXOfeqkUKrlhIehGcY7/qasbi7c7DnjoK/EHHsfWyaLUbj+Fg4PdT/AJyKdNKSjAYBx7Dj86rJlQjy/dPCkgHj606QttJAyFI993fr26/kKEjO2pbidRkZ+YD5s9vwpy9z0HY4xjn0pI1RgdrOXzknHT1/nTg2GH4jBP50rGbeoKN4Oc4ByOwNJIGX5txyxAJzxn05pM4Cqh3Y5z/Wkdh5mAxHGASScc//AFvwpWBbjGO1WUbRxuIB61E7sHUbh82GPLYAoeQneSCy5DEHPXpn1pDkKOcMOCwYj/8AX9KRoh2RligUFSMLzkUwsm7c2cnBPXOT6UeXujHVlGOx+fn9KBjcNrLuAznkAD8O9FitCWMKWyycgcFeNo6VYCrDluCoXqDnp29O5qrBdRozDMm7Py5747kngDjiop7gyFZHDOo5wATg+ufz9qtIz5XJ+RO824SN5hfKjg59eOPwP6+9QKRGoKbDg/O5Gec8D2PtTBgllZC67Rudh90emaSULsXzMsFXO1QMDjgeme5pGiVtBtwXZFLQpnlsuCflx6HpUC3GYvLKhWAHIH+c02Vl2YZSjn5y4xnbjpiqLshzuRiqYIGAuc9ARVct9DeENBbt3iVo0X524IIxz1/P8apOoADzDiTglh1z6Z/z1p814wEqjDE8Eep6gZ7VmyObyUxFsBsqwKkfzq4wbOqEWi7auzXLskQaMNxnGRj8DxWiIeNoIVhgqDznnn/9X/16p2kOwBAq7ehLAc89KtRkMDu6qcEBB/OnKxM32Jll/eHpGv3uSCV+h5OfbjrUUrEnhz2+XgkfXil3fIXC+W/QfKOvXnjn/wCvUbMVQn5sNzuDZz2z/n/61T1JSCZI54Cjn5j/AAkrxwTjBH41iqskDcsFIyCqqqn0HP8APFa0hbcGZs7eQp6//XNNYZIEiKQp4PBJ9ecen+e9Uro0jLl06GEVBEgUIC5wzDGWwPU8nn/6/Sue1XSTIJfs8eZWwMd19e3t0ru0+zpKSsAJzj5s8DHHb0o84SkDacA/Lxn2/wA/5xrCrKDujRVbdDhNE8PMjie8T5VwQj8H6cdv5frXdWJMTKQA/AAUqcfj6+lMjgd2Dbu55ySMfX/P8zV6KLygq4AznLZ79u3HSorVnVd5EVKiasaFnJtcO6qcjG3cevt+OauCTHJxGc4Xg5/HrVJMhPkLEDnB+vap/MAyVDYHUAEn/wDVXK1c4J6u5ZDYboWIyeBz9enT2qKR/mIbB2+vBNU3mDOUUZYfxg4Kn0+lRtkbsEkZHXvwemT65/wppCUO5cUjKgEgY+7nIHtSyfKxG0luM4GMfUH2qmr7Svy5YDHI/X6/59aJHOzcGw54A5xj/P8An1eonHUWcDIbK5J9KzpWMbKVA+cYJBOOnPPT/OferVw7NkkfNgEgKeP5/n/Wsu5nCDfKWHPBPP8An/OO9awjc0g2kMlm2cNtweuDgA/j0/z7Vi6nfKqMHZQ33QOvGe/t2/TrUOrauiRDYwyWzjnp/X3xXnXiHXXjULEQCSSQrE/0/T3OfQehh8K5smpXUFdlnxT4kKoUidQxHIBb5jzz6flXCW6NczvLcOq4yzPITjOD6AnnH+NSrvvJUeVlDMcgsTgVeeS2hUKLdUZ2ADkk54xnp65/z19unTVKNoo8GvWdd3exE0ySQRrGy+XnkBSCM5/+v+H6NCAMyK4cMwwFUg/4CjMW1mCCTGAMZGO3f+dMgZvMjR0CZGSSD+eeuD7VaRk3tc0opmtrqJ4YniGQqNlj36e4xn/PFFO0u3DzRebO7ksoCRoXxz7fT/8AXRX6BwbKKo1eZdV+Rx4lXasfUKyAbMgNvI6kHPHFSK2VG7ocnLYAz/XFZ0c4KuR2yFJA6n9fT8f0nimbaqKRuI2ls9f8fX8/w/EGj61wZeByrOrMM5AIHWlTJYIWBCjc3zd+OMVXjmClXG1gPljUYBz9O1TGbA4KEHJ3bsYPfgfypGbTRbVgvIIZz8uA3AHGR600vueQ5A42gA53dOarR7WAAZmHKnkcjNSeYsoDbz8uRkHnj04pEWsS5JOfMHU5GPu/Qf56e1NY5IxgIR8uTjAA5JPr7VEZM5AC7F98gc9T/hRLIQHK4Izkhj8z0rXKQOyg7gMhc+25uwx2IoBMrZkc5P31z8oyen61DIWwXTk9Bg/KPc/5/nTGlL7ApZ19M8n8+f8AP5OxSV0WVkmSQblQRHGOuV5OSe2On60ruGKhSWXP3QDlz9fzqu8oRSF5XpnB+b1x6j+X50jysCEKld3O3JG3Pb2GaVrDURxVnbYz42tlzgYHPT3+n9ajkVt4AGAwO3I49Tx+HT/9dRI3yooCoGzhcHrnqc89f89KcZkIXccjOckcnpzk9qLMtJoTCxREJCjk42kjBP8AtE+gOcVG0wwyAM8YO7aBgMf7x9ufr1qUuh+ZlyerZGAeOnHQf59aoSzAMAxILAYIXOeueewq0rlxV9x8zFWy2373APHOOv074/xqlMyAjB2rjOGwceufrTZplSLLFVHHzADn2z+H+NZd1qaKhOPu/MRt4PHH+f8AEZ0jBvY3joPu3VVZvmUg8LtAwCeOe3Oar6fehpW8xR5jHAOCPw/T/PBrldX17A2MF384AJ69Pz6f/qwA7RNXxtJTJxn7pHB5H+f/ANddn1aXLdle2itLno0chKfMBgkcDHY9PbqKmXKYdshfugHA9sf5/l05u01yFlYHAyOWCn8+fx/rWjHqEMpREZSM5yq8H/OK5JUpLSxmaxYfKAVIUZPbHPBz+dROfmOGzkg5zwMHrxzjj/PetHcbk+Vsrnoep59u3TtTGnZi5XhcgfeyOTUcr2BE6jLMoYNuAznjIPf+XNOC9g/GSGAPB71DFOpZVypxkgFunPX8fX9KmaXcMsSWPXIxk+3+f/rDTG5MjMIBAAABx948H0xx05/nUyWrEYxlQDu6n2yf8+v0pInC4Ea+WQOoUDH+ef8A6/WpUO7JDEnBHBIx1xn2/wA/WWRKbRLGkZyoHzE5IJ6D14qcoAAFUAqOucjjv7VWL+vDDHOSce2e4pryHkM4WMgZJOPpn+f51PmZO7JfNClmKKFXJ4JIH4VOsqb2+cnk8/N19qznl2qQ7cjqQcn+f9P/AK8byhFwN5kGMKQcnpnoev8An2o5LlONzS3/ADMpY89889e4PagtGpXcAGxjpk+n51liXcSzEkE8ZJ3Y9v8AP+NPhddpJXbn+ELgnFPluJxsi55mBk7vMznPY+h61WnuCSGYsDt5B47c/wAxVEXQdGZjuJAYK6YK/n/X/wCtWfe6hGqkKSzLwxORjjrnn3/LNaxpNvQWxZu74KA2MMOhzn6/Wua1rVUjTIIIC5AzzjPBz2/z9RnaxrsUUZ3yfJyMknt6DGP89K4G/wBWn1Odk8xolbhn+dicn06+n5V6eHwd3dmVXFRpqxd1vXyZ2SJmZi2GySQB756fT/6+cOOKFszzuZpHwCTu+U+npn9KspYRiLawYSIPukN8x9/8elWIZESFDJs2FhvxvOMdv5fn9K9SKUVaKPIqVHUd2Pa4hhiUWtsoVFG4ncSD1GQen+frVSGUXG0SqpzyGdGBPft1xSy3cTwsQyv8wBDK2SPX2P8AkURwSSBpYgkUCrjcQ2DyeD7f5+jtZGLZJHOkdsYzBbO8nzGQDOB1xxwP8/WnOUS0mWW2XJ+VHwxIz7E/SqOZGlO2fZt5L4bI/X/PPvVmN22JHGNyDk5BJHGRx6/5x2p2FfoPs4I1mSWKcgK4XfGMYPoRnNFVbbdFeRLAjSu5XLFc55z6+vf9e9FfoPB38Grr1X5HHiFFtXR75baujYEjheSev5cf4/jzWnBfBkBAO05Dcjn6nt/nr1rxSPxVbBdxmYdAEywHTnoPXt2/LM8PjKIFSDl+hbcx3d8c8D6+nv0/J5YCT2R9a8TSls0e2fagisobBPQ54+g9e3+eror0F8bwTzkZ+8fr6f59q8Xm8bp5vGI485VCGwOPzxj/ACKcfHvBVGO0/wAe0gv7Hn/P0xjP+zqhKrU31PaRegj7ysBkjI5x3xz0/n/J66gEkQKxQZwpBxnHUCvHo/Hi+aucjIPJUnPXGOev+fQVei8dRrlfP4yRgKBuX6g/X/OTUPA1F0HzU31PVzehhlmUsuT94njt9e/P/wCqmS3qlQpbnBIIJ+Ydu3cf1rzUeOLdmy0gYDOMEKM8c/gP8O3L5vHFsY5FeUptbDEsoI5/z9cflksFU7BzQ7nojX4FvluMfeHcfQVD9tDBydoIPLKDjr6dv8fpXmcvjOCST93MhwvG2ZSRznP5+nTr71Sk8ZO/+reIeo8wHoOgHTHTr9O4FarA1Gtg9rTXU9Uk1BVPzMPM4HPYc5wPp3pBqS8bWQkDOPQHnPpnp/k8+Wp4pkn4llRv4dyzr+pPB7dyP6W7XxCF+femclgBKCfU9vU/j16ZNKWClbUpVoHogvo1QN8oB5wy/e+v+f8ACj7bCcEvkYyR1xzz+uf8jjhI9fjjJy5ZMcAsAw98dsjP09ulNbXoiWHmouflyHP8j/npU/U32L9rB7M7qW7UD/WA4/g7njrnOT/k/WjNqaOuVJYAYOxsZOO+OnH+e1cRfeIIDEd9wjMQAcseB6A446HNYN74rjd32v5gPPyls8D/ADz/AE5reGCk9WiJYiEd2d3easoVsOGHGAC2fXgfX09vrXGeIdfWLIT5p3GAoLHn2HeuYu/EFzcssUKHceAXJ5x7dD/+v1rK8qVm8zLM/HzEHj2/n/np6FLBqGrOGtj+kB897dXUjSZK5PRcnPH+Gf1qdr+/t8oSGIwMqCePT35/HtVpVNuBB/CIwd4BySefoCc/p+cbwpvhhWFxOxJDjPP0A9eeO38+rQ4faTve4q69eRnAi6cn73oPX6VoWviu4h2JJExjBztUc+2OfTnr7+hrLeARSSGID5TtZHALL07n8f8APSeC2uI0lb7O21gVPylgQMH1xjgcdKmUINao0jiaq2Z0v/CegRkMsodjy3lnkex7H8/6VdtPGIuGfY/HoV7A+5/z+ZHLQ2sZBlbynkiGWjePk5zyOCOo9QenGMiqF5pap++GFLHcAAAAOvqT07exrH6vS22No46ot9fwPVbbxF8uFZ8j1Cg/z9f8PrrW2sRnLv8AK78gsw5A4A+v+e2K8QgS4ifdFcKSP7xGPXqauwavqMT7UCyMvBIABHqDj/P4VjPAxex0xx8X8Sse7x6lCGVTzuw2CeDx1POfX/PIdJqSqgIePjHzA9OvHJwOP8jmvFLXxRcRtuME3zMOrKwbnp09uv8A9fOhD4zVNrssqkHCs+OD68fl+tcssBNPQ0WJpvc9bbUUIG1gM8AsOo9MHrz/AJwMUxrzzFZtyhuXJBP0B/8Ar9K8oXxlboqhHwoGD9PoR1/z708+NIMBTMSoYcnOcewC5HbP5elT9Qn0Q/rNNdT1Br5NxBkQA527WIzjoCOo49P606S+REJZ1xjOB836eleWDxupXEbPkjpnJ6dSMf8A1v6VJ/Gy+WQGf0IGcnjHPT1/n0o/s+b6CeLprqepPqC72bcoj68tye2f/wBef8KUmsxRthCM5we/ftwcZ/p+NeZSeJ7ubbHbwNljgKWyOw/x68fmap3eo6m800IcIE+ZmVmyOhz654/QeldEMC+pnPGRR6DqXiKKH5jIoIyM5bgdc9PT8v58lq/iuS5VktUlcAH5udoGcen+f0rnYbeeaSOZ5Q/J/wBYzEZ+gx35/L8bLwsxBLopJ5wrnoR2HbH+e1dcMNCFupyTxUpaLQq4uL25D3RaQkZVdxPfsPwq3DGttD5ghWRmIUEFmPH9On+SKsyWzy+ZuRVTHysrMwAznH/1z/8AXqS302BCftBlAQYCsrFScn079f16VtzKxy3I4rlR5jtbgOx4XLHB/wA+3tz0EMb3Al3qcxHkM5K8ZPTkf/r5z1NWPKQAmC2ChhkvhiPp9OPw9+lRPboEVnicsfuoQfl+n5/n+dSrdBDBp63Lj7kUY5x5eN2Mjr/nn8qgFrblUWC4dsnJGD82D3GfTHT2+oklsfKsm3JKAg4GG555yP8AP40yxspJ/MKKAVUNjYc8nsc8H3H+FWn1uZsVrKMJv3Mjv/eXHGe3+f6ZclvtQf6JgMAGcL656c+n5/lUU0D7UDQbuBuCZyvqfx4/wp89si28TwztkkDbtyc+/PWn8xXsNtDbxXu6CRkwBhXXnqOBzgfn/jRVVYkQnz0ZW9dp4wf8/wD6+KK+qyDGww1OanPlu/L9Tkrxu1dEUkKMd6FQFUbRg8/5602VCUVXTnrkKcCk8pTISckDGTztFPcLk4zs7LgnP49v8++fmT0LkYjdxgBgCc89P8+9W7eAOrExGUkAeYIzhf1/l781PnyYY40iVyvzAPF97jODz6Z7f/Wnjkijtd9rbyLdSlcxNGNoBHGDnjPY/wD66hyKStqZslkqT7du0qMv09/X8sH/AOtT4LRCQpCFMglsAYHtk9effofTiVpLhVZZbdVckAFUUcemR/P0P0qJiXdViVNyAYYIBjvnPPNO7YtOiLaadGz4Nu7qdyrhVwfoen4/THWlubW1yp8rggLhSnX6de/6Y9KktrmS3t4B5am4BJzvQbh9OuOPXnn0qJXa83nPlFWJBDIOcenfv/Pvmo13BvoI9hHKyBZGEgGVKkYz2xjnr/Q+9RnTbeKMNI6kYyfm4J5wAMegPXjrnvVhYLmGFZhcB0RtoVZBnA7Y5/kfT2pX80ujSBnG0l183G0nHfGe2fp9M0r+ZL1ZkPCjZCON2eN0gC46/wCfpT57aaJcRu5Cjna+QP8A6/8AnrxWvcLbCJBCPJbBUlpc9APbGOfxPp3DfmOLy/Lbe2WOJG2Y6AEY69D7Y/J8zfQTt0MjL8Fbt8qM/fPOccdKekEziPMzcg4yzEgZ/l16f/rmnvfNeXPyhsDbkgDH/wBf1/8Ar1ZtrN5FZzuIUY+QtnaT0HXj/PHenotRqVzKFv5m6PezsThQpJzzVuOzlMYkjIDcht2QT35x/n+dTW9v5MrPHK8Tx4kPDjkN17YPSorq8eeaYQlRGzbtwLHHPXJOevrnp+JL32FsWkEsIjkRQrFduwxseeev5/55BZdzy3EEfnJHDk5DbWH0OM/rTbaaUws/kuYUyqttJHvn169vWobqZXmUyIybEwAVYY/Dt29unoKlLULlqJfs4TbZiTeuwLIjMpJB9/fII9Bj1p6QMpcqERwoywj24H0zz6evviqsc3lYRJw8T5OI1I/rzznpn3q+4gmQsYvLLLwWPDccDGeOBnr/AFNJsBj6fK4ErwpERxhoucFeOCe456Ukd1PJItu7sqbsMm0Dccevrj/PWq/nLFK4IV5CcnIBXpyeT1/+t9C62lgMy+W+9CRguFXjHQjn/DjHoKdnuwuTTLKZJ2jf97L94EodxwO474z+XNMkVI5AJ4o3iA6fLnj3P+enHSkuJIg4ChWlD7gqgc57k56/4A+9RXF00imNk2hmO1RsUY98Y/zn1xS1YLQtLLaoVc2KHJOMBCTjuAOD0/zzTLiJMs4wgYghCVyeehx+PX6+9WrS6OGjNsEaNMLkrk9vTpx7n69i6eRMgmBGUjczEfL+Q5/z9SluNlS1nXayzMq5OCX6Hnp0yP06e+KmMMRtf3kmQq8Espxz0xj3x/jgYZAZGjWVHRm3Ku3gA8nGDj0/PmmzfbMhJ9jRk5wHwB6n37HmhoLkdvcIsKKgV3yNu8Y5APcZ9ev4+9Tx3FpKrRrbRgkE7wTlMg+2Mf574qWwcRuTcRhFQARhXwe4+71P59/rS3jm6nQqdjIm75WYZ4+mew/IUnq9gvoZhUtKyFQ6g85yOvqcf/X/AKStblbv9wYsKMkHvz34z6/56z3EHkKDHO0xb74MrY6dP69+nOaYu94pGkG0vlc/MQ2M+3A6/wCFVfqh3LVomyB33SDdkISSMZ9sD/8AX7CmBGwzTSeadzEFWbHTGP8AP/1xFb/uwj/vFOCMszEdOAPX8Pzqd57edmZlDMQeSTnA/IH8uvFQF2Ptbm0RZ1knJIHAYMQo6cYxzU8kschiWNhKCoABLdcdMn8P/wBXAqfY4X3kQEGQnPLZU/jnoP6nmoZT9nR4beJyyglsqwyOP06f55p2TFdmjbwvG4kjUsrEtgBsKM9vb2x/jUgt7idppTloR2IY9MZJ557fn3rMsprkyr5oEYAztYMuCDjjn17d/fpVqG789vIR5IhkEnn5j15wfb/PBVNMaZZtVv4Z3khWNVUDKlDjr054OT+vtg1m6kbmHyzcDf8AN1CkjH4fz4/wuA5xFqUGIwTtK5wQOc5J9/8APekUid2jj+7u+UlSSe2OT9eP/riiPcTG2k0lyIY5FwhI2fITuHpwR7+/9FlnWN5IIozGw4YqnOM8jnoPbj/F0ltDAWMZkM+Dt3KR0/H9O3vwaoyRx/aC0o8sY+ZxH0Pr1/w9vfRJMhkqrbEhoVkkdCMgpwc9R149P8atXEdrMFRovJXHVI/u+5BPp7d/xNfS7bMg+zyl42PClOfy9/xH9F1KKGMebFMgk4V0KDPbnPXPT37+lLra4itseP5UZXXJJwBjr04+tFRiCCQtKFfy8A7QuACfTH5/lxRXfhtmZyuVhIgZVkUsFbccZx/P2/z1q9bG3mQ+RDGCzDqCSB6c/wBKhjt4JUlyHEi4HyqcKSenX+dX2sksojNuZpFIBQR5XBzk9f5//q45NbHTFPqVnAVpDMjRqBtx5eVHtnOM/wD1u9QW6Ybhi7AcIVwDn3zUtpCLvCQsynlmDL1xnqSf0Gaj8jMZGxiWO0FQAcD0/n9PU9C9hllPtbKjxxRtsOVzt46/y5P+c1HH5ly5nniyC3zCPaAT/n/PapFgcQuHCBMDnjI/Lrz2/Xuah3RsYpsFByVXaBn19vT/ADyITLUs4gKkMoG042BQc8df07Ht+Ez3Ak8ksY9wTlgy5z/nPHbp/vVLK3aSJfNCjncGYqOPp1qOKONAH8whs4BDKO3BHGaNGIteROIUZXLLn5ikgXtz246Ae+PwqeC6mggMcdzKGkO7YzZBxj29/X8eQQlrcRLJKVLuVUD5pCMe4GM/h+HSmP5DwgJJIYwADiQ4z6cDjnueOah+aAWSedg0ouI8twIt5z0+nTB6+/HU1LIgEcjm5TeiBvvP8y4HTj/d/wD1VXaBBCHSYgSHcY/Mb5+ufc9/1+tIixtBIGTarHIwzcnj0/z6c9QTHwyCWBREZJZN2GQEnn/D+v409FEduzmea3kf5VCF8AY4HPOMZ/WoXcxyeXbebFGM/OAwJ7Efn7dfyp0M8FzPEJiEUc5w7EH9BwPTHbrjIPMBbiVSMSyKAny5IZjjpgjPfjj/ACWJiEEIHZUyGViwI544Pv29fyFieC0t58Sh9xckcMc89yOMcjkHtzjPNXUEj/1bk5ztQmHyzjjuOwweue/qQGmnoS7rUQTTIqREiFCN/wBzPHX1x39cc+2aVXZEkEzLJ5jAbRHkrjjqeh6f168yCwTczPICwXBLLz7YOSAccf5zV0QWU0cBlgxIQFJiQYU/TPI4PX/9Y5JArsqLcRbQY7dXHchP898cdPrjFL5kEj26rGIpFXduK8/U5/DBHt9aJIbYuiorxMfmIKKM56DOTn/6+eKngm8g5O3Lt8rtGhI9Od3H0/rSuirGekEjSxlY1wSMlwqlhnqOef8A9daH+jxQOy/Z4vmA2Mqljx/TJ5x7464atzGtyxP72KJAcYQLnPXnv0x+Xc4bvtDJGRDsLHJYlOCe+D0HX8fbqSu9xOw5tRs3dnYKflChdirx/wDrA/OqkzRFCHUpIwLZBUDPb9f88Ur23nR+f5ytuclQHTIAHqB6D9Onaq8csszMrTZ7A7lG44zxx6/57hpJbCNGLE9kUFyyyE42mQDOP8//AKutWUjjMcyyTYfbwTOMfhxjHv8AXv0kz5cEGzZNGqn5kbBU5+8fl5HXOOo4+uaSWKxoo3MSxKuDzn1x1/z0yKm1x9SeeeOR0jiuGjCqRgy7ATyeeAP8jp2hieSaXH2kHavJeQjcfy69/wAuuOZkt4JVEkah5N+B8xxnPrjj/Oc9acLZVChX2MCN7hn4bPHQZ/qB6E4JdBZIYMrEHV2MykKD5jDHbjAx0BHvVCS7kaTJZ3XaDtDswAxnHt6/5zVye4kmKo8YmVTtALNh+gxkcegx/kDlLmDy44RHNkAFWY4xk9/z/WmtAK9jK1o7SfMJAAEUbjg/gPep7S5uTLgwlwXPy7WznOSeP6/yqqbW4jwY2kWLdt4DE9/QZ6Z/X1NattboUeVTIGKjYQG2k9vwz2x9KUmirdyjFFL9+QnDfKoKv9eB/kc596kkiyXfLtg7flRwVxwcf5/DnBs3Mc8FztnLZIJ+bdz6nqcdueeRVNovnbf5hhKjy+CBjH154P5cChO4t9jRhSVVUk+XEiZUlWbb6fj/AF+gw2RUnlhC5EzvgFFPPOc59/8A9dV7eO2hC/aIp3PJXG7bjA46/wCeOalnbYRsgLMjd0IPsOvP5VIWswmuPKV0GHUk4OwnPQc846f57U+3jEgVxGCwU5bafX0zx0H6ZqKd283yo4ljjOWOIcnHc5z09/x7VLdsYoFSGAbOctswWORx1/z6Hin5DGmaeVzCUaQKcqxU5HPc54Oc/rVZLNoFileF3RifnXoDnsufT+nHSoPOMsRV49se8gNtBz9PwqW3iKIWDBUHOdm7jPuetVsT6kk9ssk/mFpNh65XDL6Zx0GSP0qlNbGIui+aWYAbXULxnGcd+vFWWHmTKpjVgMbisY456dfqPz6dKZ9nFs+7Y5fqqlVJ/wD14/z1IIu2lxdCr5zQDZgxt3ymDnuM/wCetMBba7RLtRirfdA6H/P61NcCWZfMMKAjORsAP3v8T+f6wboYwyzQZcnkHpn8M/l/+qrvczZYYwhYZbcq0jDkBRg/hnr1orOdsTKEBLZzwoyOeOnfp/nklddCkpptkuo0NFwx3mVd2/j5QefoPz/PpUkbGSRiSE3D+P8A+v0+taV5FGI2IjQHHYD++RWWiqeqg8DtXMtTa7iWYiEjxF5eMYLNHj6jOf8AP83Q3UYZFjjEhBBJYLjPT8agtgCpyM8/+y1dtlBvgCAR5Xp/tY/lSaNE9NCSC7QxbVhj+f5jtC8DGD+H+cdKhLxGORYk/esQFwV54/z0plsoMioQCnmZ2kcfeA/lT5kUmMlVJ3Ic49QSfzNTsJMWHKDbJNtEabVVXUgAjqD+R/KpI7VJ0j2XkMj43EO5Ug+nQ54H6+xxGzubUsWYssJ2nPTDcY/M/nUKu32d/mPVe/1/wH5Um9Bl+8srcQpMjo8m/axRiM9e2Onbr79OakUzIu2JxlmCErn6cAD9Oo/HFYtrI/2uM72yOQc9DxU9zLIi7Ud1UMuADgDrQ49CS5dSRxykNsYhVOfnzj0/P69vTga4jMEZl2sU+Vdm7IPcdf8AP6lk7MXnyx6469sD/E1SvFCl9oA/dE8URVweiuXJ7p7uBdixsd2epY4AAHU/0qp5e55JUzKVP3cEk/jn/wCvVMKBGCAAcHn8q1dGijkjl8yNH/eAfMAau1jLmv0LC3JFsjShVGzap8vuD0P049elQ/uprNwy/vnPO4Yxz255PHfvj8c5wCoJAJ2nk/U1tQogOQqghQQQOny5/nSkuUFK4y1tYjD5ICo8mSC6ZXODxnk88/j64xUqac8sbGFtrIB8rhMse44Pp/L8i1jRppcop2hiuR0xIoGPw4qsGJsDkniRe/qeal3KuQyJbpM7zSMpAyqjbgk5yAB2/wD1elSEwRR4t8uSdx8zac+x4/Tv6cEVHeD/AEeD/a3MfchcgmtG9ijW2hKooIkTkD3NDdhp3M5YizyPPIELMMKCoBPT8/8ADvjIuTWkcLqz7CHwVAmVc9uccD8unPeoERfsyvtXeGb5sc9D3qrE7Pfx72LZZScnOTx/jQNmxb2SC4ELGMI2STI2MAD6cHgf19KJi1uVSZRKSDlg5wefvdCD9f65qeWaRo5y0jkiKMDLHgYJ/nVbTbib90fOkyFPO4+1Zc2l2J72J5ZhGfO/0iMuQvzTHnjnHGfX9T35ZJe/YUKRSP8AKMsCSfqOmADkf5xUurSyHR7YmRz+8x949Nw4rHWWRpCGdjlsnJ6nHWrVmritrY0NP1FTLlzIqtnOS4GfU4HP4fhzio57uKSMkKxBJAYl88emPx4qGZipmVSQoLAAdB82P5U+1kfZafO3VT1ostyt3YbBDIMP5buqYO35mHIyeR0OMcUkt0kcQWNcsoGZNr49MDPOP88dK1bhj59vyfmGT79D/Os8ANJMGAIExUZ7DB4oTvqG7sS2k0MkcfnKXGS2RG24cZyB09Pr+tLE4KfuYJhLkFcKSTz1HI74/Hv3MEYH9mO38Ww89+lOkAW1LKAGDOAR1GOB/Ola4yO5vJJLcRoHkcNtzJHk9OmAccf5HYaNjCpbdx5h+9vBJH69/oPr3GbpyKdJicqpclSWxyeRVWf7ye+SfrjrVON7pCubN6IxIsc25YVzgKnOe3f1P6fmR2ux4v3ZOQV27QcDrnk4+ue3T0pscUY01GEabishJwMk8c1A5K3rheAWwcdxl/8AAflUpPYJaFuZWTzdkMyIB1EatgfXP/6v1qRMfYtquSpJ2B0HXPf16/rj2pZuLS3X+EjkevFZUqL9rk+Ufwjp2+T/ABP5mnFczFfQebe1+0IrzCMrnPCqOe3X/P8AKJ5bezJO5nUdDsH5Zz6Y5/yZr6GL7LC3lpuJbnaP71Ns40ZJwyKQrYGR0FU/Md7Fe5lmQNNbosYAwAEXJwe//wCr2pgYlvtNxwSu3ChcdPQ9D/8Ar7CnyIoS0YKobA5A571TkUCRcAffA/DI4p20sTfqSw7ZpsHgYDMVCg8+n+fpjNPeNAUVI2UgkgfKSBn9f8/hWk++31H86TUiRDHg/wDLIH9F/wATTsZt2FZvlWRozuLfeVV9aKmUnyrMZOGzn3+fHNFd2Ei5RdnYVnLqf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Leukocytoclastic vasculitis appearing as raised purpura. This lesion can occur with any vasculitic syndrome and in the collagen vascular diseases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marvin I Schwarz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9794=[""].join("\n");
var outline_f9_36_9794=null;
var title_f9_36_9795="Silver sulfadiazine: Pediatric drug information";
var content_f9_36_9795=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Silver sulfadiazine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10964?source=see_link\">",
"    see \"Silver sulfadiazine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?41/48/42756?source=see_link\">",
"    see \"Silver sulfadiazine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Silvadene&reg;;",
"     </li>",
"     <li>",
"      SSD&trade;;",
"     </li>",
"     <li>",
"      Thermazene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F221121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Flamazine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1049922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Topical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1049915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10964?source=see_link\">",
"      see \"Silver sulfadiazine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults: Topical: Apply once or twice daily with a sterile gloved hand; apply to a thickness of",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      16",
"     </sub>",
"     &rdquo;; burned area should be covered with cream at all times",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F221103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: 1% (25 g, 50 g, 85 g, 400 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Silvadene&reg;: 1% (20 g, 50 g, 85 g, 400 g, 1000 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SSD&trade;: 1% (25 g, 50 g, 85 g, 400 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thermazene&reg;: 1% (20 g, 25 g, 50 g, 85 g, 400 g, 1000 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1049925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical: Apply to cleansed, debrided burned areas",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1049918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Discard if cream is darkened (reacts with heavy metals resulting in release of silver)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1049924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct in the prevention and treatment of infection in second and third degree burns",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F221141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Discoloration of skin, erythema multiforme, itching, photosensitivity, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, aplastic anemia, hemolytic anemia, leukopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Interstitial nephritis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions may be related to sulfa component",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1049928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to silver sulfadiazine or any component; premature infants or neonates &lt;2 months of age since sulfas may displace bilirubin from protein binding sites and cause kernicterus",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1049914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with G-6-PD deficiency and renal impairment; sulfadiazine may accumulate in patients with impaired hepatic or renal function",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F221097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F221099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9611621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Because of the theoretical increased risk for hyperbilirubinemia and kernicterus, sulfadiazine is contraindicated for use near term, on premature infants, or on newborn infants during the first 2 months of life (refer to Sulfadiazine monograph).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1049921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes, UA, renal function test, CBC in patients with extensive burns on long-term treatment",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1049913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts upon the bacterial cell wall and cell membrane",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1049927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Significant percutaneous absorption of sulfadiazine can occur especially when applied to extensive burns",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 10 hours and is prolonged in patients with renal insufficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Within 3-11 days of continuous topical therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: &sim;50% excreted unchanged in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1049920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?41/48/42756?source=see_link\">",
"      see \"Silver sulfadiazine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only; may discolor skin",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1049929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contains methylparaben",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Kulick MI, Wong R, Okarma TB, et al, &ldquo;Prospective Study of Side Effects Associated With the Use of Silver Sulfadiazine in Severely Burned Patients,&rdquo;",
"      <i>",
"       Ann Plast Surg",
"      </i>",
"      , 1985, 14(5):407-18.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/36/9795/abstract-text/4083697 /pubmed\" id=\"4083697 \" target=\"_blank\">",
"        4083697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lockhart SP, Rushworth A, Azmy AA, et al, &ldquo;Topical Silver Sulfadiazine: Side Effects and Urinary Excretion,&rdquo;",
"      <i>",
"       Burns Incl Therm Inj",
"      </i>",
"      , 1983, 10(1):9-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/36/9795/abstract-text/6640389/pubmed\" id=\"6640389\" target=\"_blank\">",
"        6640389",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12790 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-581423BC0D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9795=[""].join("\n");
var outline_f9_36_9795=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221120\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221121\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049922\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049915\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221103\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221089\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049925\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049918\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049924\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221141\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049928\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049914\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300042\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221097\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221099\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9611621\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049921\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049913\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049927\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049920\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049929\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12790\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12790|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10964?source=related_link\">",
"      Silver sulfadiazine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?41/48/42756?source=related_link\">",
"      Silver sulfadiazine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_36_9796="Darier plantar hyperkeratosis";
var content_f9_36_9796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plantar hyperkeratosis in Darier's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9796=[""].join("\n");
var outline_f9_36_9796=null;
var title_f9_36_9797="Cefazolin: Pediatric drug information";
var content_f9_36_9797=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefazolin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"    see \"Cefazolin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/26/32163?source=see_link\">",
"    see \"Cefazolin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F16329907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cefazolin For Injection;",
"     </li>",
"     <li>",
"      Cefazolin For Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1045881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Cephalosporin (First Generation)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     PNA &le;7 days: 40 mg/kg/day divided every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     PNA &gt;7 days:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &le;2000 g: 40 mg/kg/day divided every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;2000 g: 60 mg/kg/day divided every 8 hours",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1045874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"      see \"Cefazolin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children: 25-100 mg/kg/day divided every 6-8 hours; maximum dose: 6 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild to moderately severe infections: 25-50 mg/kg/day divided every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe infections: 100 mg/kg/day divided every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bacterial endocarditis prophylaxis for dental and upper respiratory procedures in penicillin allergic patients: 50 mg/kg 30-60 minutes before procedure; maximum dose: 1 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild infections: 250-500 mg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pneumococcal pneumonia: 500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Moderate to severe infections: 500 mg to 1 g every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe, life-threatening infections (eg, endocarditis, septicemia): 1-1.5 g every 6 hours; maximum dose: 12 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     UTI: 1 g every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bacterial endocarditis prophylaxis for dental and upper respiratory procedures in penicillin allergic patients: 1 g 30-60 minutes before procedure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Perioperative prophylaxis: 1 g 30-60 minutes prior to surgery; 0.5-1 g every 8 hours for 24 hours postoperatively depending on the procedure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing interval in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants  &gt;1 month and Children: After initial loading dose is administered, modify dose based on the degree of renal impairment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     40-70 mL/minute: Administer 60% of the usual daily dose divided every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     20-40 mL/minute: Administer 25% of the usual daily dose divided every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     5-20 mL/minute: Administer 10% of the usual daily dose divided every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     35-54 mL/minute: Administer full dose &ge;every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     11-34 mL/minute: Administer 50% of usual dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;10 mL/minute: Administer 50% of usual dose every 18-24 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed iso-osmotic dextrose solution: 1 g (50 mL) [products contain sodium ~48 mg (2mEq)/g]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 500 mg, 1 g, 2 g, 10 g, 20 g, 100 g, 300 g [products contain sodium ~48 mg (2mEq)/g]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147051\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1045885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Cefazolin may be administered IVP over 3-5 minutes at a maximum concentration of 100 mg/mL or I.V. intermittent infusion over 10-60 minutes at a final concentration for I.V. administration of 20 mg/mL. In fluid-restricted patients, a concentration of 138 mg/mL has been administered IVP.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Deep I.M. injection into a large muscle mass. May dilute vial using SWI to a final concentration between 225-330 mg/mL (see package insert). Shake well before use.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F147138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      10",
"     </sub>",
"     W,LR, NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in peritoneal dialysis solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, allopurinol, alprostadil, amifostine, anidulafungin, atracurium, aztreonam, bivalirudin, calcium gluconate, cyclophosphamide, cyclosporine, dexmedetomidine, diltiazem, docetaxel, doxorubicin liposome, enalaprilat, esmolol, etoposide phosphate, famotidine, fenoldopam, fentanyl, filgrastim, fluconazole, fludarabine, foscarnet, gallium nitrate, gemcitabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), insulin (regular), labetalol, lidocaine, linezolid, magnesium sulfate, melphalan, meperidine, midazolam, milrinone, morphine, multivitamins, nicardipine, ondansetron, oxytocin, palonesetron, pancuronium, propofol, ranitidine, remifentanil, sargramostim, tacrolimus, teniposide, theophylline, thiotepa, vecuronium, vitamin B complex with C, warfarin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, caspofungin, idarubicin, pemetrexed, pentamidine, vinorelbine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Amiodarone, anakinra, cisatracurium, doxapram, hetastarch in NS, hydromorphone, pantoprazole, promethazine, vancomycin.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1045878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store intact vials at room temperature; protect from light. Reconstituted solution is stable for 24 hours at room temperature or 10 days when refrigerated; thawed solutions of the commercially available frozen cefazolin injections are stable for 48 hours at room temperature or 30 days when refrigerated",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1045884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of respiratory tract, skin and skin structure, urinary tract, biliary tract, bone and joint infections, genital infections, and septicemia due to susceptible gram-positive cocci (except enterococcus); some gram-negative bacilli including",
"     <i>",
"      E. coli",
"     </i>",
"     ,",
"     <i>",
"      Proteus",
"     </i>",
"     , and",
"     <i>",
"      Klebsiella",
"     </i>",
"     may be susceptible; perioperative prophylaxis; bacterial endocarditis prophylaxis for dental and upper respiratory procedures",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F147140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CeFAZolin may be confused with cefoTEtan, cefOXitin, cefprozil, cefTAZidime, cefTRIAXone, cephalexin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F147137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fever, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash, Stevens-Johnson syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, anorexia, diarrhea, nausea, oral candidiasis, pseudomembranous colitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Eosinophilia, leukopenia, neutropenia, thrombocytopenia, thrombocytosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain at injection site, phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased, serum creatinine increased, renal failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Abdominal pain, aplastic anemia, cholestasis, hemolytic anemia, hemorrhage, pancytopenia, prothrombin time prolonged, superinfection, toxic epidermal necrolysis, toxic nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1045888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cefazolin sodium, any component, or cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1045873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with a history of colitis, renal or hepatic impairment, poor nutritional state, patients previously stabilized on anticoagulant therapy, or in patients with a history of hypersensitivity to penicillins; modify dosage in patients with renal impairment",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1045872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prolonged use may result in superinfection; may cause pseudomembranous colitis or antibiotic-associated colitis; do not use in patients with immediate-type hypersensitivity reactions to penicillin",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: CeFAZolin may decrease the protein binding of Fosphenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: CeFAZolin may decrease the protein binding of Phenytoin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5944549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects were not observed in animal reproduction studies. Cefazolin crosses the placenta. Adverse events have not been reported in the fetus following administration of cefazolin prior to caesarean section. Cefazolin is recommended for group B streptococcus prophylaxis in pregnant patients with a nonanaphylactic penicillin allergy. It is also one of the antibiotics recommended for prophylactic use prior to cesarean delivery and may be used in certain situations prior to vaginal delivery in women at high risk for endocarditis.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Due to pregnancy-induced physiologic changes, the pharmacokinetics of cefazolin are altered. The half-life is shorter, the AUC is smaller, and the clearance and volume of distribution are increased.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1045880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal function periodically when used in combination with other nephrotoxic drugs, hepatic function tests, and CBC; prothrombin time in patients at risk; number and type of stools/day for diarrhea",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1045871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins and interfering with the final transpeptidation step of peptidoglycan synthesis resulting in cell wall death",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1045887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses the placenta; small amounts appear in breast milk; CSF penetration is poor; penetrates bone and synovial fluid well; distributes into bile",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 74% to 86%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Minimally hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates: 3-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 90-150 minutes (prolonged with renal impairment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: Within 0.5-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Within 5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 80% to 100% excreted unchanged in urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Moderately dialyzable (20% to 50%)",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1045889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sodium content of 1 g: 46 mg (2 mEq)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Pickering LK, O'Connor DM, Anderson D, et al, &ldquo;Clinical and Pharmacologic Evaluation of Cefazolin in Children,&rdquo;",
"      <i>",
"       J Infect Dis",
"      </i>",
"      1973, 128(Suppl):S407-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/36/9797/abstract-text/4744023/pubmed\" id=\"4744023\" target=\"_blank\">",
"        4744023",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robinson DC, Cookson TL, and Grisafe JA, &ldquo;Concentration Guidelines for Parenteral Antibiotics in Fluid-Restricted Patients,&rdquo;",
"      <i>",
"       Drug Intell Clin Pharm",
"      </i>",
"      , 1987, 21(12):985-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/36/9797/abstract-text/3428165/pubmed\" id=\"3428165\" target=\"_blank\">",
"        3428165",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilson W, Taubert KA, Gewitz M, et al, \"Prevention of Infective Endocarditis: Guidelines from the American Heart Association: A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 116(15):1736-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?9/36/9797/abstract-text/17446442/pubmed\" id=\"17446442\" target=\"_blank\">",
"        17446442",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13124 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-FFF4911520-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9797=[""].join("\n");
var outline_f9_36_9797=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16329907\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045881\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442202\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045874\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147067\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147051\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045885\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147138\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045878\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045884\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147140\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147137\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045888\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045873\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045872\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298985\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147060\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147063\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5944549\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045880\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045871\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045887\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045889\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13124\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13124|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=related_link\">",
"      Cefazolin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/26/32163?source=related_link\">",
"      Cefazolin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_36_9798="Malrotation due to metacarpal fracture";
var content_f9_36_9798=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F69061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F69061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malrotation due to metacarpal fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJAAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCyi/Mp2SIQTuA6ketI8b+W+1JSSOD6U8u6zKSZPL2jcGBP400zHa+95N5+7g4H5VsfPaCESGONA0jEHa3HTNOQlZWBLqh6Bhnn09qUllaMmYqxHzsq9/enRyMryq0ilf4C55zTENdpSilJd7K3Kkdsdan+cOUCRNn5ySc5qN5yEicmNwWO4BefrSlgszIIdwxu5bHXmiwXGlo3RpBbtwwDBenvSx43wrIjx5HyspzTVCmInEozwQM8+9ToYw8ex3jkHCeYBz3poQxzFtmBkkLNwdy8cHnNOY58pBJFEF5X3XPNJ5iESEXCnzPlxjpUnlbjBsjiJjG3B7+/NMkaFIkmkkRGEoxuU8VFIjpbjETQyBsDblhj+vFLHuVrgbGxKOkfQU4K6LC6s4I++HPBH+NMBXdPtTGOYiNuh24HSo9zSWuSIi5YLz3B9qd5jlygaMqASoUdBSljIqu8KDfwVJxjHpVEMY+WnVF2xORkMucDA5zUMYSWNsTPh8kK/GfpVhgDK6MSjKucJyCOwFQ4EqFY5Mnkqrrgj6UAiZI/NZC0TFvujBP6imwsY15YB85UyA5UCnpFNK6uYpN4Gdmeg6U0PKqbQAGB+YsOcelAySLfLJCmxJMjAZBgipQyBN0kbRIp+c56+hpmfNmCbEB25DRZ7UwOpjyyyIHOD6ZqkS3YnZgJGAklEqLt5Bxg0x48xKgnTYCXyv8AEO9PkkUks07eYflYdqa4VEjUMg2dBjrTRIzY0iOcI4k4YkcZHrTZECCDdGIwmGJTBz7U7yg0BCoG3fPndxQh8i73GJ1CgAhSGGccZpkiyMS8oMrhiM428c+1Md28lCY4t7/K2W6+lIryruImbeGwA68E+9SOv7xEVYSWAJ3Pk9KaQ7lfcRLOJox8pyCvT6e1SrOqrDH5TKXyOGyPaoseZFLIY2OwgYQ9c04gK0cW2WJmXchPOfeqJvYe0kYDO3mEgYdsZAOcflT2dMxq0saqDlBgc5qP7RHtO6SXaxCncOKlygI+eMeXkYYDhaQyMp5pmYKjBwAWLY/lUbL8qF49uxhkRkAn2pxiAjaMpG28huCQKVYmS4jkUFeNvynhjjvQASKWWbMcihzlCW+6aj38RnzZAcbW2jrz1pCknljAmjfeRknOAPb0qSVsu2yZlUr8pEeKLCuOSfy0mLSqXRhtB5OD1oVXLKJdhVl7ELtqIOY4FI8vzfutnnp7VI7ySGTKxuI1Db1+X8KB3I9xCltkLjcBhOpHtTiirI6eSA4Bb5m9uelIkjIU8yJCkjYATkgmo/NMYLLAQI+vzjJHr9fagQjPEYYyVmCyngdtw9amGwFnDSRvHwynJYA1GojO1Ssz5+dVwcL7c0u6Joy/mugf5So5JbPp6UB5jHVCEi/ejPKmQcE5602KWMu5E4y+AQQRmpNymRisjCROoYYwPWo8LLH5fnJIXOQCMGgZZUshVHkjXaOB/wDWpGjcxOu2Mq3O4nr64qIsd5YmLc64C+napUiDGNCsKonzZZsZH+eKhjEMbNIWWIMGXb8rcUu1k8tmQ5U/PsbnnpTnhG19qZyQ4VW+UCnFFEjbQVLDChG4Y+9IqxE0b7GJVw24gE8kU9TvJDtIwK5Ue9GPLjjJSVTjLEHNIwb523TKwbCAnt7jvSARZjviDStuJIJC9PrUnnNtdjIjlHwpblsHrT3kYnCyYUJncq45/Gm+YTFCHMW88H5c4x60i0SHc5ZX2Mqpu3kBenagBndB5cbF1JAXsPWmFgVLyIrhWwzdN/4U/bmR8xDeoDZQ8Aemf50AMBXYAYPYkHO4+lQyqI/mdJBgFSxPA9OKnby2CRrFglSVCtnP1qIlRtDRSKZGAZjzz9KQyvGQLhULMUI+bf29xUXz+U58w5XoCuMkd6sQ5a5AaUGMr95/WmiR3ifLhyGwBt6/jWRoxyyMCCHUKwG4AZ5pUc/vh8m5PmRicZ/Ch1dLmMK8QDKCQRkZ96NxaOSSSNZGTnPQU2IVm4iZkjdGJGFHIPrThGoZ4xbsHUHJLY96aZAoi3QqqN0KnOM05o1aWQPHcFkBDEnr70WAjzF9mGTIFb5NoJO01OpUzDZId6qCA6YpgkjMSDzyImztGOff6VJn9+ZI5d20YG7qOOaYDTtdWCTxEORx0p3ku7xkRRtgbduSOO3WmtAWhZcxSqx6DggUskJldP3DgEBTh/SmS0JGrJDMMMjMfkAGQMdxSySyebCvmFlcYbfxj6UiyNHA6NKyvuyuUzx3pw3STQrlZVYYJxg49PaqQmNdmG5QsB2ggNnJ/wD102UDCt5R3HDYzjaR6etOy6rK5jiO3rg9Rnj8aGVWePzIWO4BlwMbfamSyM7SZ8yGNkGHUjNN+WeGELMjEA4A4bIpWZEEoD7RnbJnqDSskbSwuJFk2fP8vUD0oEgKt9oeUib51yNpJwaTdII0wymXkOWPPsDSF3jaU7pAx5Bz3609MmSIBImLgM25uSaBsGI82QY8tkBJMTEhx6CnqI5SsYaRVJ3KJB0P+NRoyr5pB8lQ2yVfXPTFSx7G2qsgkZOeRj8qpEslOFZyZY8SjGPQ+1NxiRWKopUbTznJ9aR42kikBZCJRkBRyO/FR+U2XJjz8uBk9D61RLDyiI0iSNiFfu3rS/6qW4ABQycdNwB9aXcGS23ecwRcNzjNQAsonG8bwRszyQKBDpJHCKyzsx3YKuuCeMZ9jUrhhO6qsTKASCx9uaAzO6oxik3j+7gg59aagwk5ESAIMZZsZGaYIiQ74N5ilw3ylc4/H3qWOQNKwBkiliHVvTvTMqWi2iclsHGM4P0NM85VV2yyFTtYd8elMT8h42MgXztxJ3BG43Ht9am2q7s22AOy7CuOVNRbVlMe1ll2fMFI5P8A9b3pJYlZXCrEPM5G3rmmw6EjWxCRIIxtXoN5/T+VMjXbJKQZFLqQqA5C+9Mcb3j/AHTYVMYc55HXNATbbtGgkBzvyB0FAh7LseBmaRY8/NvG7g01pHRJsStuzhVC9RmkIaO55aRUK4w5J+akVpGt1cTbirchlAyPrRYdyVmaOSLDQbXUZL8jPvTCSqM7LCWBHBOAQe+PSmSyFZmjTywoUsCBu6j+dKu7yImKR/P97eegz/k0WELGwddjIpXbuBjbBBHbnvSZ2Kp8nCucEBst+VK7NmUtEpeJsgpwGpQyA7HjKMw+Qrzjv+dAxGB+Yt5jGMbS340Oy4VVaQljuVVXrTRJCAzESgE7SxP9KJnw6ku7SRDog6CkMQurF5DMdxO19wGR6UkZSRo8FZSnOGGCfc00yJtjHmld3zA7c5Pf6UAoQZQ0cqkeWzPwR7YoBMmSIbHBWFtxzlTyaQQbp0PloBtxh3yc+wpkCoyosawsyjcoXg/TNOKgl8iNixwuGO760mMk2OqRrslLKxDYfjGaJEdVmEfnfPghRjAH86NgdgxEm3aAQX/iHSnIjqYo28wrk7/pioGKqYf5fMweMYBycdacGdBGWlYcchhkAVGG2xtHHI4J+6AM4H1NPib5mDSttK9HXcc+1IoQyyCMneMK2NpQ81P3ZB5PHz5POeOaZE7DyW85SxOCHGAB/jStKzhgnlHaeBjrzSHcSMrIyERLufjG4ce9KdpGWgY5O1sHA/Cnlsb0SKIEDeWz0NQoV3RkwMwfLKucc+tIocW2s4COsinGF6AfWm7ooiFhLo6jcvB5HqacXVk6y7CdrDHFI02xpJEZlkI8sjb0FAFVctOVcIyYyT05xTGll8tiDEw3cqB1qSNzJcFGiQsQW3A4GQKimk3RiVooh8w6DkmskaNllNwmSMRxncu4Fzn6io25R5WgO2JgOv3qmVEEoVbUux+YZOO3SmebE8LEpIFU4ZcnvQA7em6PdCYyR8hzn8TSHaol2tKJACrEjIJ9aDsVo0/eo+0bNx60heEqzfaJS5XEmR3BpoRIhDxIFmjCAblyPfmnbVaVpfkl7H2GOtNcB0VS0YA5jJGMg9aa8YVpGUI3mcZGQMfSmJimORVKBEDZyCp5AqVzvlExE7A9ge9RrCwQAqyuP41Oenb6UNIRcZSWQRkbhlevGMUxEiyk22RIu8HI3rk4pNxMyxOEl+TO5OCOOlNMrmESusRfJUkHnbjjinDY0rRsnzbd+6M5HFUhETMPs7SGIBMjeQcmlkaNWTfK4bhlXk/KfT6VFNJH5AMiuiM2Ceoz71JkCc5kYsi4AAyMYpksayloSyyxqJOSxAOTQ37u4SZCJAgwNhxnIpAsawKGeMCR8gnk57iliLLM7YDbwV/d/wAPpTZKdmQuWhVwryCRWz83Iq0qDzQDGGQ8lt3t2NV18yOJdvmZD5bce1S7gDjyQ0aggEuM49R60Feo1Jdlu7F1QMShDjPzetPUBnV22SiIDA6Yz7U13RY1ZpR5THhWGSD3z6U4Sn7QX2pN5eFOD2x1x+VUiWIIwU8tQF5ypU4xjmiYZ87ClQ33ctyD60bCuwPCpKtuOw4OB6U2ZfMeVliKMzbkAOcAVRNyc5e6HmeccR5Lqep/Co9xWLDlTIDgkr0HbigANLMzCURsgIOcYNMLERRLvTfzuJUkn/IFMm+o4IXkCcNGV5ZVwRimO3lxF3gZRuAIDZPT0/WnyfPJJld6om4Mgxk/SmYYBd0LIJCej5+Y0IGOIxJgeczAZJA4A68U0SqYQyuu2TuByGHb1oaXaHJjuFZBtZgMhvr7UJIirHiQBT86/L1HcnFMRKJQ0gKiOQqMbs9RUAjBj2COPKtvypwR9KcHiLSuoicHKNIegFNbCLGw8oiM9Yu+aAHsqsXYxBt/HJyVqJCyRIoeXbGTkY/rSfZy7yny2ZmPytu4+v1p7bn2Fmm2qvUYHT1xTAN0kcco8w8kFARkr6806MsvlHzleN/vqw4HPbFRiRkt1EkpAyckLlsHoKdHjfsMimMjKlvlJOOnvRYVxryPmQr5fynAVVzkZ6Zp82d8Y8qLaV3HLYx+XaoklYQK58oqW/eKowceuadjyzKsaxjBwoLc+uKLDuAkXaskkJw/yEA8fXNOB3SSq6OixkEYbdkegIpSgZgghZ92GOWxg+nX9aajgxbmjlBGU2A8H8aQDR5ZCKBIqOxHzcgEVJv27y/mYzgvtwCf8KY5EblCkkLqoZc/NkfUd6AQGBZJwsh6t0z6f/XpOSGot9AYBZY0aU/L8wCLmoi0eDJvhxJz0zkinvOASS0qlBsLryPTmkJEe2IuEIO5cLng/Si9watuSoySuGUJIUBXIJGKBbAQgBAWDbzhuozTfleJnVldZThjjbkjtTliBlUx7GVflJjPt1NIaQoiJ89thUs3yNuzin8uTuE7RonOc9fTimJEGBLcshydr5IHYU50bD4EmSQQ2/pUFiIZBGi7pCqtg7V4A+v0p6yMkchVjw2VLjJ96c25iNrSrH5eDgYz7nFCtJsjUthvutleg7UhoejHzCGZCpTJ3AYBpwd2EYCpIGPPYfWlWUrG7MI2KsMbh1z3xSkr8+9Y2QJnI+XBpMaGIQEZ1EJXds4PzHmgReXK2FyY1J+Z+RUirvaPdDHhxwF6r9aYpVUGYywdtmFPOaRQ04LxriTH3lXPFIiq65JkKv2A6mnvhfMfZJmP5SxcdPpSHAwirIQi7l7bQe9A0UwuS6CEK684PPHpS5jK7mt3RCc8Z49vpQSqtKEd1ZSWYHOcU5fLMSKTIEc8HHBrLoaDsxxybf3xlXoVz0NAkjEP+scRt8pBHQ/SnHAnkJnkLqpGByMYpq/cGyYLCeQf9qgB6yK0ylHyVXIyuD9KdGwnBCzg+Zycjj3FRuC1wjxyJKyDGMYpzxtsxG0LBj124xmmhChQ5QbYhswBlccf4UGFknkZUy0xKgrJgf4U1o/NkjKwKVQhSC360kCFllUb13/dC+1NCHojIinbLGx+/nkYoMvlSzIJSEYZUBMCoYZW8xMSNz9/d6U4yyhplV4mjTIAPOR2FUTckBJiQtFG27Kn5vyNLlQ8qCMxyKOQvQj2pvyhQ0kDFZewXBXmgyqQ5RmXy8h8ntTAP3KQxsRJGu7owznNOdkjdy8xBC44Gf5e1RqRJGqpJuCE9uv0pIpWPms0il5VwQF71RDCRVCRxh48DkEj7w7mmoNrzFVy0nyko2KXY37uNFiZU4z3P59qjUBYpl2lWm+fCt0xT6EdRUdhGmTIEz8yv0P40u4MJHMUeF4VQ2DjPFMDrujUl1QA7xIeD+NIWO2R5oUIBGSrcrSGSswVkBkISQAr8pO2kUqzSsu2QH5XZTgfWhzsZEe4UMCH78jHHvToiJWbCiRnGD/SqJG7RHsyMujfMVPLCm/Orf6kpufdu3ZO3vT1i2MjmNsrkOF4znpUO1l2HB3I2SN3YnpVC1JpFUi5YRy7CQVIfGDUquGSNvMxxyNnU9yagkidVIWNlZiSGBzilWcLMJTIEBX7pj9KYuo8hQk25d+wgIR8oIPXNM80Bo1+eMsMhw27/PSs3UdVS2tVeWPe7ZQ4IHFc3e+It0higjPmHkGM5/Csp1oQ3ZtCjOWyOyN1CFLtNKFLYY4p5uAir+9QkLgBRyR2rm7HznQPcZUtz5e7OKvorn2rhq4/pTR6eHyu/vVH8i950bLKotlPmdS7ZNSRbmdNiIpC7ABxkVBHFlcEkHsatQW4zwx57+lccsXVf2j04YCgvsFLSby11SzF1YHdD5jR7iCp3KcEYPvV541kV9+8Mw42PgD8Ky/Dd5FqUd/5Vl9kFreSWzIBgOVxlxgDrmtxLfIyc/nR9aqxekingaE1rFECROBEPPLDb8+F5zUSuxR1laHfGfkyMnnrxV7yD2P4Gq9yJFTdGEWTuxGSR6V3YfMOZ8tT7zysVlPIuajr5ECEhsHyWjYYJwFKn+tU7vUY4Nsmbfg4IHIwO9YGta+YHljSSNiPugrg5+grkrnULu/njEjhgx5QDGPpXTVxSjojgpYSUviO8fXkMzRQRRyOOUKtzz9KtSXzvg7djcHGc4rA0m2W0tkQBRK/LsB+lbVtC0vyqK86rjJyW9kexh8vgndq7JBLI5+Z2JPvUyo5GAXyfer9rYKpDMK0I41B+51rhdVnrQw1kZCJOq4VpMHsTwaZpyaxFc3zai8TRtL/AKKEUApFjoeBzn610C+WrhscKcnNZXhjS5NP0xoHuxfNJPJMZwSQQzZAHJ4A4prESivdZTwVOT95XJUi3hQY0Ug7unWl8gO77UVSwwecfhWpHAcjK/WnT26MBxW1PG1Y7u5zVcpozWisZCxYkDIEGwfMQ2B9aUQ/KGCkuOcowJNT3FkGjkUBcsMbj0FQLCVlQgAlF2/IcD6mvVoV41VdHzmKwc8NPllsPO/LlhLuzkEEYH4U+OXOG/eKuMthcc+9QrCyxLtRhtOW2NyfapwhEbtum3EjHfBrY50KkjGNF8xQxOGHlnj0zSMxj8wN5TAMCCQBuz7U9N7EEOwyMsduMmmrKzbF3Luztb5M4FIaJDjzJciMgLnepwPpTRxKqCLAK7sqc4pjEtGGBiLbtuAMkj6U5sky72jbZjbzjP4UihuELRnymHmE9Gyc0hCqCxWQchWctkmnPHzgxIFRNwKnAFCLGSirFw/I2MTg+poBlNMCSYiV9wXLjvtNKqgrEpncrn5dwwCaI5AsjusjKcfPx0H0oBR1ijMjEAkruXAJ9qxLZIW3SuxlIYjBCLkD3pqgBVQyxrGCdpK96errukJl2ueDtU4/+tTCu9I0eSNU3blz/F61SEx5QGczRiKYgYAAwcfSo5IVaAxBUAJ6q340uGaR5cIWAwcHjbjrSPCfKCKYs9QwPzD/AOtQAoj8yRCsb7VwuC/pQmQsiF5FkJypC5IApGJaVZPKlPHJDdx6imNNIttJtaTzAQ2CASBTEyQSYeLe5dTwQ/GB9ab5pImLJAzLx7kZ6flSK5lmUOyyxlRuD/LikDhYnZkgIB52tzVEk8oT9yAJSWwyhAcimpKscR2yFUJ2uzAcZNNbyxMqKLg4+bK+4pd0a224TJsOASy5OaYMQKp2bXSV05GB70qINkv7tQD93b2B/rSDh43QJIUAOF4z61F5OI5AI9rE9c8gmqIY+OHdLG3lvhQUYl+30/rTJxtt9u9wwfIO3t/hTht3qxEmNm05J696jlUCOJTNJlW5YLnI7daogWbe0ojLh4wmVz6jtUayDaHlhkRi2Qynj8f8alcmWR2kzKVGU6KS1MikYRpGyNHIzHBPzKTngUityXzNr7JLhBOmQSRnI9PypqJsMiJu3nEhETY/CmKwklkDNCzFcMCQDnPOKbIEEOyPzV8tuqnI5qkSWOWkYFJF+UAKG6v9aaIF8wEmUHbtcg9W7VG7SCKTEhAH+rXb8xbNQahM0ImMk3GzcoA5LU72BJsdNKbeFT+8Rk+Zy5zkenvWDrHiCRDKI5kDE8RhR3rK1rWSZVCyOdyEPu5y1c2biT5mMgZyehHWuGviekTsoYa+si7eXc88itIqMzHLZbjPtWxoGniNftMqBZG+6o6AetY+l2/2m8VSnyrhmOeMeldgvC15dao1oe1hqKtcswLz7VpRqu0Vm2waRgFGfWt+1sgFHmHn0rmUz04UmRKFUknHHarEcgIwFrRitFI+SMD3NTrZEDnAz7UGypnMaZf3l1e6rFeWnkR21wIrdwp/fJjO7nr6cVrRkjBKtj1o0q21QeIdYTUYU/spPJOnyADLZU+YDjng461ti0TaQOQexpytcap6GYF3c8014ww9DWmLRe3FV5IMHB6HpimmKVM8q+ImnfZ5VvIAEVztfjgN61z2ioy3TvK+5UA25HOT/SvUPFln9p0+eJhztP4Ed68tspPJt23Hc244OMd62jP3WmcNXDXqprqdbYjf06k4rqbCFY0461zXh9cohbuM11EAIwPbrXNOpc9ClR5UX4xkgZ4xUhdUPBJNJAhKMSMYGeaIlXDblLk9/SlZm3KU9RnhXT7triUW8AicSSk4CKRgt+GaTwtpsWm6PZWdq7yWcEIWOTu6nkNxxznNP8TQaTHoFz/b/nJptwUt5PLzuJdgABjnriugXTTFFHBCuyOJQgB64AwP0FaKnLlJuuYhU4z82cd6YxLHJqSW2dD3Kjoah3HOMUmmtzVJMeqblIPQ1TvbVVRgiIXYDknH4VoJ0psyhsZ6GtKVR0pcyOXFYaGIg4SMQKUmysZGPlOxuD70PE0aLxIhVslg2fl9KmuLc75DGgPmDGd2AKj8tldCikYGxirZ5r6CMuZXR8LODg3F9BzGRvNb9+Omznj8akD7jneQpTqE4Y1CkcqAGRpVIPJPIIpzB1yQzrz8uRwB34piiyQOC6EvtZhhiE6YpgZVCNKYyWJGCMn8aVywMiRyMEA+UFeGpxkAfAeNTs3E7c44oGRMVCuxCMc4BzgH8KkVwsMgMaEoAdwbFIsu1o9why4weM4pgb92vyxFskD3FIL9SrHIgEriQBGOGJHI9KkVUaRFMgLY+UMOCfakh+WJ3MqYbhjgZz2oR1LxsZUcgELuHf0rG5pYXcpZz56ndwQF6EdaeyhdqmSIIOVPqO9KjqY5D56Zbt7/AP66aoG2JVMSrHzuYfeB70xikbRKdkcmcjPpmomTfFGqqqlcMGUjtTymDKw2sG+VmzgL6VGI8LGNqDZzuVuSaZLHSKHlll2yAMP73U0w7ktx+9YSBssQnJzx1oCOTK4SQgjI2mneY5Xh23DO75KokDlp2yRImzndgEEVDI/+jLI0KElsfIeakMpcOJCrc5ViNpLehpm8OELIgOedh7fSmJk21Ufb+9JAJ3YI4NNBjFuR5q7c4ORzupN7LI4xMdiHnqD+FL8ptkJkVYydykgfMaoXoKmBMHUCUxjGE4496iki/dmJYmV2Y/OG6Yp/ytL5mEYldhKt29ajaALEgCbGViwZWycelNE6isD5jttlK7Auc8Fh6+1IG/1QdnyvEhUYCn3prSBpXK+YI2TIycAGoJ9QWF0Mkjg4w20AZNVdJak2b2HRMdsuAzShsqZOMDueKkQAPCEIUgcODuUH6VlJczzo3lgkk4Dv0C1ZS3c87ipHHy1yVMZTh5ndRy+rU30RYkMEiygNCVJwwIwc+uaUTpiLZPKmwbSEXr75rP0uWG+1TVLKOCQHT2RHmYja7sudo9x3raFko5AxXJUzGa0SsehTymH2mVpJXZSY2beDlSy5/wAmuW8USails4Cu6A/KyjP412a25AwOfrTJ4wEORjtWLx9R6M6FllJbHjhmkMrliGBH8Y/ipBKwUHKuT1HTFdP4m05WkeS2AjmHXHQ1yayMWAdhtXhgRjFKnUVTVGdWg6TszqPD0SpbFlXBd/XPArdHPA9aw/Dj77SMjGMkCuitE3TjPUVwVZ++0evQpWpxNzSbQoox1PeujtoEHJHNZ9iMxrxzWtCpHXpUo60iUOoGADx3p4bdikVAw4605BiqTNEkjPgsdUHiW+u5bgPor20aQQ7uY5gfnOMdCO+a1Y+oBWshdOm/4TKPVxfEW/2A2hsSThn37hKBnHA46ZrbXkg1cpX2FFWHFA/UYqKSLA45xU5NI/3TSCxzevW+YHb2NeEXTGO+kjxwGOPzr6MukWRGB6GvAPF1g2m+I3ifkFtyn1B5FCY400/kddox2opx0A6V1EMgcIAOlcdpsu1UA9q6vS8yc9u9ZQ3NqkLamxbrJM4iU9TWs6waa8aTpvkHJT/GodKMcE5mf7qKSM9yKpGVru5eWQku5yc11K0Vfqc0tdCt4r1m0kl0my1GwFzHf3qxW8YUEJIo3Bz9K3N88jlnlYt1JzWHPqHleJtK0v7CJxcQy3BuiOLcoOMcdW6dQa6GMc9KcpbXM4rccjygBWbeoOcGqt0V8wlVx7VfAqtdIpUkjp3pc1zWnvqVYz3A4olJUZHQ1JCpztp08e1TxxUM0kjHu1DyoBtG3k5bFVwofeY1ysnICvgcU+72eflxESBwG65qJIlGVCxgK27JOAa97DX9lG/Y+Ex9vrM/UlCbSNokAYbSAQcn15p0bNFtLl8j5XDANnPSmGIhGVQys/zDD/KOaGQFn2hyGUgDcDz3Nbs5BVeZCv8ArBtPQjIx/WlZmKvgFcH5V8vj3pV3R7Q7Ngrg5Gck0qO48ve7IB97cueKQxjOd0m0pjsAvUml8wbyFESkrubjIzSea0YDB2zuwFdMD6/hTlZtr7HVgG4GMZNAyiFVoyY2j8uT7z4yQachVpYwHR3RePlwCfamr8kZcSxBC2CQvRqkRlJGJQXCAAMuPyrEsQiMo481MHBI2/4VJwrpueKNkAK/LnI96BLG8DESgqxG75eBQMCSNt8YKjgAZ47UwBI1VXx5bq5wxPQH3qOWMK8LIEJTk+W3JOaRSoUoQmx+C2e/WnoGFzFJEi4jHIjPLUIGRGKTM5CSZJyGLZwTSOzNHGomlzGMMcYyfrShWCOArli33w3TvSs7OybGcBRhiqgc1aII1kCLIGdXfqhcdDml3eYISFRskk7B0JpS7JHIGKkjlGccn2prIfNiUgfOBnZxzVCYjYTzCUlULxu9venPKh2ozxoo5QYzx3qF5AsUjtFLtyMtnqPcVUu72O0CgXCE8EZX9DQ2ktRJc2xcnmQGaQKjl/lJHyge5rIn1JIVUAKrRncWU5/Cuf1PV2mMwVkYP945PrxWQ7PKVAPTj5D1+tclTFJfCdVPDN7m5datJdSv5KyMznj5uhrZ03TXcpLdM0koHc8Cq3h/TBaxiRwTM3Jzzt9q3iWC4GRx2rzq2KlPS57WGwMYe81qSRwIi8kU6WRIoZJFDOVUsEQZLEDOB7npUUVu8o+ck1Dq1nqhtoI9ECLObiMSyvjEcWfnIB4Jx2rmTTep6HI7Fjw9c3V7o9pc6hbJa3kyb5IUBGzk4BzznGOtbEYz71MloobKrgVOIAvJHWk2maezKbICDiqtyBtIP4Vo3EW3lTnPWs+dSc+tS3YpQOE19jHdMDzXE6o2ycuD8rdR6Gu48VoRcKfUVxWpoWjYDgkcGlhp8tQvEYfno6bmr4QuPMt3VvvK/wDOuz09sT4Pc15r4PuTFqRt3ZsSrxn1Fel6VgzqG71GJi41n5jwjUqC8jrbB/kAFa8bDbWPY4ArTVxjiqWxqlqW4z6Gpo1ByCarwAk4rTtbeMIZJ5AqDt3NVCLY21Hc56/02xfxdoupXF8IdQihnt7a1JA+0hhlsdyV68Vu+ScAngVj+IDog1zw7d6jJIl7DcvFpxBOGldMFTgdMDviujgliY4myFPcVv7O9rkKVmyvgDgHmo3x0q9cxQbQYZdwP5is24k2SAEH61E4OJpF82xFMuFJrx/4y2bR3dheIOGBXPuK9lyHQntXmnxdjDabaE84mI/SpWjKiruxyuj3AmtIZV/ujP1rvvDwDRD3rzDw5IE8y3bpnev9a9Q8MsBbgmsY+7Ox1VFzQuXtYlMFqwB4JAo06TclWtRthcafPnk4BBqhokMksmxfug8mrqTs1YxUIuHoW7S81BvE1zZtbBdIjtElS4KnLzlsFQemAPat6LPYVn6Fp2qJrGtNqjodPMsY05F2k7Nvzk455bsa6aC2APCD8aGm2YxtbRFABj2qC5RipBBwRW6YcDgAVDKpUcqDmnytdRq/RGJb7mt13DlTtz61NKv7sg+lWQhG4FcZOaiuBtU+lCZqo6anK3IjE8iuy/MQuCP60oCI4BWFdq7du7PNLd7XuPLZmDMdwVgNrVC5jLEtIpV+B8mB9K+koaU4+h+e43XETa7j1jQJGjqoAJPzP978PSk8vYXUAKu7cCG4x0wKQFWk3SeWuAFIC8D8aedq7QTEAoIwR1HUGtTnQMvySKm7DcqM8Um1hK4/ebCnA+9lqGiCRhSUCht3zNjI/wAKfsfyyEQgMwdcNgD6UhsCWVow7tjb84I6HsKVGdmRhIu09dwxxSFZVdwpkBPI6N+OaVmfeyNuYY+UYySRSGiiVwgV3jVXOQw7mpPmMwaKRHdRgArjj8aZ8qwgb0VWJxIB1b0p4LCUyb0kdV6YxkfSsiw3II/JMq7SeQV4zTt5WUBpY1KjaAR19OlMzG8XlLLGVc4x704kxy5kljVwu1lx7dfypiIyiNAQPJCO27cfX0pSpFwjoEkKr0U4/GlEY2bEaMIx3hsdT3FNZ3W4MwCyEfKQp4+tNCZAIgYGKDDbiAytmlDSmdGHmgBdrhfUc5okjP2fy9m0k5Dr3+hoPzStJibaUwSrdTVITGNK5h5MZcNxuHIXvSMf3gEmDEw5KcEHHoaRpmjthlh5m7BOOQvbNY+r6mIpZQXR4x91gMHNEpKO4Ri5BqWqLCju8RD5AIByeK5O9vnmlZGZyBzlV6VDfX73Mgd0X5zjKnn61Tab5mXc+4DBK964KtVz0R3UaKirsNymNsFNpOS3vW94asBLcC5ZRhOFK9DXP2sf2kxRxbSXbgEd+9ekadbpZ28Uca8gdB61xVp2VkelhKKlK72RpRxLGm9sL7U6P94wOMrUe1mIMp/AVbgXPReK5b2PZjHsWIlwvWoYrCeTxOupfbwbKK1NuLNCf9aWyXfsTjgDqKllkS0tpbm4ZY4IUMkjv0VRySfaqXhjS7bTbOaWwne4j1Cdr5p3PMhkwQfpjGKE7Jsvl1sdQmD0p5x0OMVVjZiBmrKjIqLlcpDMmYyD+YrHujtkx2rZLD5hn6VjXvEo96UnpcqMdTkfFkWSnrXFX8WVYgV3nir/AJZY64rlbiIFTXMp8szshG8DgZJpbPUlkjYjy3DDPr6V7DodzHdQw3CH5XUN9K8f19DDqDYYjcvAx3r0H4fTFtOKE52kY9uK9LFJShGoeVhU4VZ0uh6dYyfIP1rSiBY8ZrGsDuUCugtEwgNZwVzr2Lts6wr5hGWXHBprytcTNI3Ge3YVHfsFWNAMEjJpbUE1s3bQnzMrxVcaTYxaVc63bPOBqEUdqyjPlTtkK/UcDn1+ldMI9pKnOQcGsHxhqdtofh99RvLAX8MM0Q8kgEgs4UOMg8qTmumKYYgnJ9fWrT0Rm92Q7OmDzUdwvmLzjcKubBVK/BVVccAHB+lJ2sXDexXX5Frzv4w/LpVqQP8Alt1/CvSWXjjkCuL+JWnNe+HJvLBLQkSgevrWTN4/EeM2lx5NzFKOdp5+les+HJgYhzxxXkVtAz/eG1TXfeELzbEsTtkocfh2rkrS5XdHdCDcdT0+2jE0BXqCKm0eya0k2SLhc5JHcVU0u5UqFzxW0ZgIHZ5UjUIQZGIAQY+8c+nWlF8xhKNit4P0zUdMgvYtZvje3E97LPE24kRRMRsjGegA7e9dLGqqTkVzXgvSo9A8LabpkV4b5bdDi6Jz5u5i27qeOfU9K3JJhxz7V089mzGMXZIsPJkngY/lVeYrgFufaoxKATntVO+uGAHljOTQ5q1zSMB8jYLEng9Ky9QuCkTknPFWbiUJEMnmsDVJWKDIBBPQnApUY+0qKPcxxldUKMp9kUWYtKxUSK6HOMBsUq7QgQs2W+ZSyY5qMMQrEpjBxjdgMP509VUbgVIZMfdbgg9s19SlZWPzeUuZ3fUerh4ypkfDtgblwDTi4G8NIMEBD8uBUcIA/dlZEI+dTndin5LlUxIu4k/NyCRQNbCHakgZnj+RduAOlIqgNEHeL5MnBbrQWJBZnlAkO1gVwCfSlLKMsG2sw2Y2cD8aQEgjZYUUEBdxb7+ODSBHAcJv+8D17UxSoYKWiGxcYKk/macI0BQFk/dknHXdmkMp4dbcASosR5U4HNSxnfO8oaORwuGJHQVEVIURu6Io5QlfvDvUkbZWRhKpbJB+XBVTWRoBCSERiWJgDwGGM+lSSHYzu0iK/QoBnBqICNvIj84OOcZTgmnu4O4+cgLDBXYMA555o2AayBI1CeUqltwPY+tRsVaZ5VAfcCu5Dx9akZY1CASogHK5HDZ601YjtkYeWS/DEcAe+KpCfYgKGONQAFKnOVbP4UkvLO4E4V1zwcY+tBi4jOxN6fN8jcsazb+doxMwVgSMqd/PPtTbshWb0INVvjHGsaNhwfnbb+VcXfXck8sh3KdvI7ZP0rQ1S7kmkXLzYUbWIHesdbe6uAxijLnPykjGPevPq1eZndQpPoisZGDAFFLN1x2qH5TuYo+4ZBYH9a1v7GvNwz5Y9earzaXdRqcxFh2KNz+VYqpHa52exn2NPwhbeddNOT8iDCj0rvIeCNq5NYHhS0MNgjSZ3sc8108CBVycYriqy5pHs4WjywVyWCAsxLke5NaduYUA+UufaqCN5uF7fzrStoyQMClFJHS32M7xFd6W62uj6rbSTR6xIbVIYyctgbiSQQQo4yRW1HHGiKkabERQqr6ADAH5Cs/T7tb/AMT6hYtpv/IKSMpeyL1kkXLKmR2HUg1v+WCDkZrWUFZIUHrcpBcc9qerZXINJLlSyHkgZFQo+FIxWDib2EJ+YnHFZuogYjb0bkVoSPtcY79ao3/De2aiS0KS1OT8THdPGAegrClT5cY5PFa+qN5t2x7DiqCpvYv0A6V5s5e9c64rSx5741gKS714IIFdL8OHxbMpPUCszxdb+dDNgds/lVj4byfuRz3xXrc98KvI4fZ8uKb7o9e0wZCV09uBsrntDXKiunhXCiiiypooXsyPdKFJLbfm9quWzcCsa5Xy9SuOeARWhaTYApuerKdPsS+I7+80rw9f3+mWYvr23jDxWxBPmncARgc9CTx6Vt27F4InYFWdFYqeqkgEj8KxdVub1NFv5NIUPqawObVSAQ0uPlBzx1q9pM9zLpdk9/H5V60CNcIMYWTaNw4465qlNWIcNTRJ4qvcqJI2U9xTneoJZTjpQ6iBQ1uJbrui287hwahu7ZZoJI5FyrAgg1Pp7mQunden0qeRQBzSbuht6ngOs6WdP1We3C5CscZ9KjtA9tIJEPIOCPWu38bWG/Vg6jqvNc99jKA/LXnVHq0e5SkpQTOh0jUS8a7G59K1NZv9Pl8N6jBrd39j0+eEwXE2cFVf5eODzzjpXLWVu8Ns8oHzM3HtUetXVhLZ21prkUkkN5cxwRogPzSZyucdsipoyfOrHLWS5ZHqWmmGx0+zsrTAgtoEgjH+yqgD9BVk3Hy8kZrl4r6RB8yNx3AqcX8khxHE7H6VspSephZRN17gHPbPvVaW7VV681UjguphmRkhT3OTVyG1hhO5Q0r/AN5+grVRk9WZyqJbEBV5MPKML2HrWVqhy+0GMYBPzjP5VtXMn3iTn3rndQkY7/LJDduMg/Wu3AR5q8fI8XOKrWGl5kUcjEplY9z9cnIBFLu3Dc8S787MbsA/SmrITIVUpwA3C9T9advV5VGIVLDLHqQa+jPiehIp/wBZuRgqEAEHgg9qUERh12OrJg4zkY9M00Ajb5ixs5OCN3HsaUkHeJYxndtxkgGkWITscfLKpVSyjOad5gJwGkww3AN0Y06JsGQshXB2ja3BBpyMBKcCRSg4IwQR9aTBIaWVwwMjkSDjcvA9qehTDHeDu4YbcD8KROTtIkQoA478Uq4BCoXGPmXK5FIZUbcqRh2iTYflyOoNCMDI+94ySxDkDOPSmJhfLXKgr6/xCnwqAsrkphzh3PasTQkV8iJRIkrR8qOgNNEi/vAZVKn7wx+YpRl5Ytk0bsoyoIxn3qPzlET/AL4bHIBAQ4/PtTBkrkBoVzCiD5ox/eqEoWEu0KwkPJ3cDHrTgT50SF44wg3LxnINQXDrBZyHMYRjuLk5wfSi9tWK1yDUHSJw+BhBgAEc1y14z3jukajJP3geho1O6lu75SijaPlVUP4ZNXtPs1t4ggwWxyfWvPxGK6RPRwmE53eWxVt7COPBctI4HJ7UyGa6/ti4tJbTbaLGskFwmdrdmVvRs9AO1bDgKnvWXrUVzdafNFY3Btbk4Mco7EHOD7GvNdS7s+p7cKSS0RYbHpVdgGcDuTQrs6/O0ZkXAkEZ4DY5+n41Z02DzrkZ6LWSlqbql1Nazi2xDjpUzHe6RIxIHJqwyrFDn0FVdMGWeRurGrbS3OyMPd0Ni0iAxxWxbAKCSpbaCdo4LcdB9azbcFiNopPEFlrF5ozw6DcC0vGlj3XBODHHuBcrwfmxwM1KmpOw3DlVy94VuNVutAtJvEMMdvqb7jJBGMCIbjtU++MZrWYcVXywY4Bx2zSNOQcGr9qm7jVLoVbwEODn8aj2/LyOaewaaeMDqrZC+tWnhKsQRjPOKbncq1tDIuScBvQ1Q1aYJE7/AOzWpeIVJ9K5LVJXuJ/K6Rp19zXNiKqhE1hG7MsJ5jH3OSaSdNqYHSr6xhVx0xVa5HymvK5rs6kcnrEIcSDqMVk/D/8AdNcRkjKTEfSulv4+GNc14fK22vX0XTcwcV6lKXNQnE56sbVIyPa9Bf5B6108DcA5wcVw3h66GFz1rs7Fw/WilVsgqQ6mZqA3anJwfmANallZE89BUt5p/wDpKSqQykdq2LGPEYyAOKuzlLUiUtFylOayc2Vwlu2ydonWJ/7rlSFP4HBo8N2N/baBp8OuuJdWjhVbqRTkPJ3OcDPbtW3GuM55yCP0rG8FaPd6D4WsdM1HUv7Turfer3eSTJl2YZJJOQDjn0rpjBcpi7uRcaHPQHFQyQjvmtPOOMZpjIGI3YFS4IqxSsrQr5jrx70kpyTzWnHIv2ZxgbhWPcShUZjxmpdkkkTFtydzB1KzW7uSW/h4pJNCieNiFVXPQelXbfLvuI4zmtS3TcMkflVQhGW52c0oJWZh2OkRmyFsFQtuw2OufSsnUY9NtfEnh7R7zT/tVzfPNNby4BFuYlyXOe/OBiu1gVLa+SVvuE4JFZLanK/jiTSItOJsY7E3n29weHMm0RA4xkjk85raFGNvNHNUqSTt3HvaIgIUVRKbJgNxUHvW/ImRkj2rH1FCvTtzWXLZmcu4KyDoWc+wpJJwDyc/7IpiK8i/KuB6UjQLGu6Vsf7IpSuxIhlcyEnoo71jTtIZdyl0AOfUEdOlak0xk+VAAvpWTMNl0xBI+XBwf1rtyz+K/Q8TPG/YL1BS68hpFbPAI+WpCzZlKNj2C8H3qHy2UIzlxg/MN2Qc0uCFTJlUhiThs/LXunyqZMGXcSHXkZYhe9LG6jy8hPMYckjOKYu8RvsMoJbChgMYp3mON+z+7kNs6mpZSBzvVBiJWJ+bJNOyFwCqfe2jP86AzEkKyfdz/q+CaVWJ2k7AGX0zz6Uh7isVwQyKxB243cPTyCodvLCqhAJDYDUin/Vg+Tlhk8ZxQhLKu4RgknIPIGO9JjSKhAJjUyCMgfKEGcrSniKTLjYW+Y7fmBHSo45AJY1Mh3AfLsXOR2pN37ty0jkM3zcYJNY+pqWFffIGEu6RV4DLjjuahJVFZROTGzDAK8U8PtcsGIZFz8y/w4prlNkYZpApbgMvencWlgbIkDNL5bqMAKARiuU1u4EsrQJKojzncP4j3Fb2sXLwxyv5hVyNo2rkY9vwrk5VG1AGG3O4HbznvXJian2TalBbk+mw77l532nbwpFbKjAzVSyjKRD1b5jxirQ5FeLVqXeh9JhqPLBJkU2TwDVZl59TVlutMK1wyqu56dOlZGDdR2GiXF1qU8kkS3jxxyDrGH6ByO3ua63RIdoJPUmsu4hinheKeNJYW4ZHGQR7jvVvwlfT3Nxf21zaNbtayBEYZKSoRlWB9fUDpxW1OXMr9V/wyLceV27m5fFVt23DJIxxVnQdPEkSs/GRkCkuIPOiK/pW1pcIRUxkYUDBque7L5XayL1tBGgxGmfc1S/stL7xhbaqL5ZF0y3ktWsYm4SWTku+D128bSPQ1rPPDZWc91dOEggjaaR26KqjJP5Cqfgqy0qCyuNR0WSaaHWpjqTzTElpC4GOoBCgdAema3g7K5Eqaukajw5ztjNUriy83lchq2+AetRGEO5PT3pSimhpcuqMmKzEaqx+8D1qZoRu3GrZVjgH7opkvAxSQ9zD1SIBCQOlcLIn75zn+I13urELC/PauLkiwTXDjJXsjppIpsvFVpgCKvSAYwOtVJ+vTiuJbmqMO+TCkHr1NcLLkeIHaM4bGQa7rWH8uNz/ABHgCvPL64EWuI3+zg/nXrYJNp+hz4h2Sfmd5oWrtbyos6naTjcO1el6PfBtuWGDXjdnIsgBzxXW6DfyQgLuLIOgNZzptO8TVNWsz162mBXk5rQjlGBiuG07VRwGOPrXQW2oKwGCOaqFTuZuJ0lvcbXVgMkEEA1heCdPsdG0m5sdM1EX8SXs8kjAqfKkdtzRnHcE9+eatRXQwDnmsbwsuj2Fzr8GjSu0z6g9xfoxJ8u4kAJAyBxgDpmuuFT3XqYyj7yZ1wcd6Y0wH1rPe6UDhqp3WqQ28ZaWRVGM5JqXVK5TRuLgKG2nGetYV5eCSQRKfrXN6h4thupGhsm3YOC46Vb0w78EnLHvXPKpd2RtGlbVnR2q5ANalrwcetZtmpKDPbrWlEBvz3HFdVNsUi1Lb7lXGDmuf0GbWJPE+tWV/AIdFj8kWMmOZyVJkOc8gHgcCumjk3CNG4UHJrm9DttctW1aXXpkkZ9QkexRWBEVrgbFOAOeuQa61b4jmlfSJrSRsjFW6djWZepu3CtqeVZVWTcCx+8MdDWfcJulJXlTzSqR7GalfcxhcPCvlAcj09KryF5D85OPQVNfRBrg9uM5FUJpnhO1gA3rnP5VhNdyYksm2NOe1Y0gRnkO6PDt1JPUdsVoLHJIQWyF64PWqc6hLkDPzDkALnNdmWSXtGvI8XPIt0k+zGptByGjwQVJyQopylQY2Tyzj5Tt469zTUKSEjzF2P8AN93kkdjSO6PyGjw/BJXHI6V7Z8uO8ryypIyVOTsfdn2qfa5wDuGDuBVv6VCApcvEUxjaecAe9KE2srAodvBIfv70DRO6Sg7gXGTkHI4HfinfNhyDJ/s8DHucVCihtp7p12tnP/1qegwR93cpzlWzx6VIyRw+WK7xhcKdvBNCs/zbDJhgM4TjdTDvIyGIYNnIbPFKu99xUMzA5BDdB7UiiiYz5gX94zgZXZwAKQPGUUlZWiPyHPGD61IFBkXJlkYDAK8cY4pmY3jUhZGiVtu30b1rKxTFQK/mYWRWX5iBzx6ZpCFARhG4ViQPmzj3xUipy+2OUOBuwDnI9DSOqZjzE6rnGVbJFOwrnOeIplWdoSJBsGXJbBx24rFd1ZodyS7WOV7AVoawA1/cZVsrwzM3P1rM2LsjYCRgwJAJ6c15dV3k7ndTXKkdOo9etPjU4plk4lt43HTGPercYGOK8G7V0z6+mlJKSKLD5sGjjkGr0kGQSKqSIRniueSaZ2RsV5MDNV2fUs26aTcxwzRzrIyS/cmj/iQnqOOeKlmzkiqrSNG4ZGwwOQa0pz5XdDlDmVj0Oz2SOCpBXPrmtqBRjPevKPCeo6doE5sWuZIjqNy8kMUnKK5GSqnsD15716TaXm7ABrVrlemwld77ieKdVsrSDT9N1Cykvl1m4FgLdMfMGGWZv9kDr9a3bRRbxJBCipFGojRV4CqBgAewAFc5a6rc3Hiq8sHsAthaW8cqXjqcvK55VM8EAdSOc8V0Ucq461o+iCOt2XUbjnrTmkwOmarCQEZzTWlq+YLXJ2kqtPIACc1HJMAOtZV7eLkIGAz70nOyFykGpS+YxUdKxZosngVpyTxKPvj86qT3Ee07VLH2Fcc4uo7lqVjJniK54rKvnEY5yW9BWpdSyM2PlRfrzWJfzLErMTz+pohhm9WP2q6HP6xIQjNJwccVh6fpDXLNNIuWfpkdBWy9rcapqMcRQpCPmOeprs9O0UKijZXXd0lyxDR6yOPtdEZQApIHbFdDY6fIhUlQwrqItH46Vo22nqoA20oyle5M5poyIIv3ahoD+WamMMqgG2V0Hua6KG0XHTNTfZF28jFauXNozFabHPxHUFH31/GsexvoU17XbazXytQQxTXzkECUsvyEc88ewrt3tgVxiudWS1k8YX2lCyCXi2cV1JcgD96hbaFPfj3pRgrPQqU3dGZc3eqTQuyybFA4wOTXIak11Ox+0TyPz0J4r1p9OBjC44xXn+t2fk3bqRjDVjVXIk0dFGXM7GToUIjaRCMZNd3pCSIF2kMK4+xQLP8AWu40kgIuOeKyg+aRvN2R0NqWRlDkcgHiteEAkD161l2wBC5HJHQ9q04UA+YEiu+n5HNJl6DaJCxHA4GaxPCGj3ui+F4NP1XUP7TvkeSSS6yxD7nLADdzgAgfhVjW0jk0DUoru9SwtpreSKS6YgeSHUru544z3qx4c02LSPD+n6XDI8sVlbRwJIerhVGGP1611Rfu2OWfx37EMyGGQEZ2kZOKRwEiyDnPfsav3aZCnGCBisuSEqSOcZ59vehy5VYHHm1KN5gRuFG4sOo7VjSQsGztyf5V0bwkoAw/Kqc9v1AFc8pNvUTjoZkY3gk9azb8COYkCQnH8PYVrTRMhyhwf51lX7kyodgyTg5OMV14HSujyM2XNhn5WIEbYy8vhRuUgdM+tLGwXg7jGx3rtXJNRg/KSqK21scPyRUjAqzcFtgx9/nn2r3z5DcQEMTICMu3XZkn2IpxcMHIA+f5WO3p+FLtJJVdz7V3A7sYp5LDbhCQRu+9jFIoYoQOSrLyuw/LwKnQRgsQEJC7TxjH4VEjYAbEhDHcAOPxpVfzBkFwZDkrjkketIaRJ8ibTlCVGMkYxkelIpTcFIX5BzwQee+KUgSMCd2HPoMkinD94oyz5c4PAzke9SUUSCJRzK7ADaVOOD2pylRCPlkKhsEc9fWn/IWj5eQONyZOAPaoWkG0kISFbBUnj65rNFMnUO8khRMZGclvbpTHKJCpWAYwQMPkk04IjSOPKAJG4HdxwOlMR2MassMTAk8A9PegDkNTjC3k6spLA5LZ+8PWqRQKVymVcfJzitrxDAIZ5BhHA5JPXFY5xth/djbITtBPSvKqLlk0dkHdXL+hXASaW3IIOcjPIz7VvDg57dxXHL+5n3jcPKYE88Hmuyi+dVb1GfrXk4yHLLmXU+jyuq503Tl0LVv8wAYcGpZLMSKcCq8BMcm05x2NasDgLmsYpSPTu0c3eWTICe30rDuI2DEYP5V6BPEJVxiqCaYruzlQVUc1p9Xu9DaNWy1OGl05LsJ9oiWTY4dQ3Zh0P1q14Z8R3r2xe4tZI2jkaOSFycgqex7g+tdkNJUrkAVz3i/wxreoC1h0G8hto5CY7jzOGVcg70PXIwRgetbRocy5WTKsl71vkXPCXiS6k0tP7ekRL9pHYoANsalvlXI4Jx3rrbbVInX5ZFP41zUnh9Au0gnHAJ6/Wo4NK8vcpzwM8VLw8pNtaGi5UrJnZnUoV6yqPqRVK5162j485WPoOa4PxNo63cUOC6yRtkbWIqDRIpInaCYkuOjHuKj2dt2S3Y62518udsasB6mo1ukfLMC596rLbliAOM1Mmm7/ALztQuVbku76jTqEaHCoPwqOe9nkG2GEkn8hWtb6VCg+4CevNaEFmi4wo+mKpS7GbSORGnX1yw3P5YPp1q3b+G0B3Nln7lua7CG2HTFWhAu3FNXZDnbY42x0VVuRLjluOnaumtbFV5xViGAAjjoavxx5xxxQoDdRsrR2646VI0AUZq2E4FJKcD+VXaxHMVUj6U5lAU461JxTWpNFJtsAox71jG8uV8ZQaX9hzYS2L3RvQG+WRX2+WT05HPrW2ozWXfz6xF4k0mGzhWTRJYpzey4GY5AP3XOc8njgVcLFO5pMgANcP4utP9JVwOo5rtDOC230rK1y1NxZO+ORzWFb34NI2pe7K7PORHtfkV0Wj74wmH/dk/lWTcRlWrV0aURkA8oSARXDRlrY7Z7HXWMh56HHBJrYR/lGOawLZShzEcA9FPSti3Y7Nu39eK9ODaOWRR8bR6LeeG5dO8S3Eltp1/LHaloyQzOXBRQQD1KjtXTouwFBwF+XA7Y4rkfElxo76n4d03WrQ3E15eGSxXtHNEu4SHBHAB9+vSupjk98knJrpTskc9k5OxM8e7k1SeP5z6Ed6tl844NRNgrknn0qm0xRTRVaMEYz0qpNHyeK0yowPUVFKgOTisZAYVzDgHHWsi+hwpbAJx3rqZocjkVkX8HBGMelOE3Bpoxq0Y1IuMlocrzEVBLFC2GJQDr9KdCpQ8FB83Py9vXNXLqE+WQCcmqQ3ljuY8KVIJ7172GxHto67nx2PwTws9NnsOJKMflXIOB8pGR9aR3HIKKSOm7PIpieZxucnnBG7NKA7FG3P8vBywIx6VuzhHMwWTG0YUfLnJz7Cpn25JwOB0OTz7Go4zKMEsRhuRwRinjzHUkyMAGzjgj8qQx4Kl8Lt3YyMknn2p7koAoCHIzzk8+gNMXeoGDjnOODgVIS/wAw+dQrcYIIx9KQ0VDtMkYSMtvGVLHAB6Ypm7yt7sibozjrkMKcFVSgCg7+QGOMUhZRC7FF3K2OTwRWaLJjguRIsagr26cVHGwMcbqkRyx3AcfjRnLbSYwMBsgYwcdKQSFtrFkyTgjbjP40AZuvqjROreW4UZB6kj0rmpCv7s7EAcDbzkCux1FV+yTKu0ov3crnI9M1yMhAZQUjVj14yBXBiY2lc6aMtLFSVkMTsUGEPJz1966vRpfOsIXyOmOK5IspVsIp2ngAfe98Vu+FpwwmgOMrhwAMda83GQvTv2PWyypy1rPqb+3cvv2qeGT7qknOeaiBxTlXEgcfjXk0p2lys+la6mvB6mplKxLIMZ3rUdsMoDUojab5UBJ9q9OnOxKjcdbqCozWdcabpeseJ4LmS68+60eKSCSyQ4CGdMbm7htucVa+1R29tJNK4SGGNpHY9FCgkn9KpeGJdMeyl1XSYpkXV3+2SNNnc7EYBwegwOB0rSNSybIdPmaQ3Rbez0GG18N/2k91eRwvPAs4xIYdx4z0IXp68elXozi5XPAbg+4qLWLWKXy9S+wC81DTo5JLQKcPkryqnp82Mc1S0XURqumWOrW8ciRTKHCOpDIc4ZT9CCM1Mqu0vvNYQt7j+Qajb7Z2Q8gH9KjbTAZA4HOOtbOsL50rSAglhngYxVq2tw8EZx1ArGdmynokzIht90eD94Vat0wvzDkGtEW2GzinfZw2SODWbRBGkXzKezDAq0sYz9KZGMKAc7lNWAMcVN7EsFGDU4PT0pnAHvS5Ga0jOxlJEkUeAee9WIx24qvERnNTqTye1aKRLHk4BGKrScj3FTMRnmoW4pjWg0HtS4B69KjQ80/PBpNmsUSgcCsXX4dWfVdEl0ucJYRSyHUYiQPNjK/LjjJw3pitgNwDWB4p0671OXRzY3/2M2d8lzMCSBPGAQ0fHXOe/FQp2Lauh2nCW4vnByI0PJ9a6F4QYihAwRUdlAEHA5NXio2mnSjZajqPXQ8412x8i5YY46ismBmik4rufFFrvh81RkjrXDTApJk9q86tH2dQ7aT54HY6dOJYo2XqOtbdu42YH1Ncfo8xWPaOcdq6O0Y8MDg9wa7aVS5hOOo251O1PjXTdGewWa5NlLfJdsB/o4DbNoyOC3sa6BMZJIrmrHVr658V6pYSWRj062gheG7IP792HzKCeCB3x3roA5wARzXc2YRT11Lo6DbxxTHJK5HHzYpYW3Y4GKXHBwRSuJDYxuPPbJFOaPIHvREPl68Yq0kaumSx3dAKpLmIm7GbNFjjtWdeQ7ga3ZEyM8elUposjpUOI07nK3dryQBisa4gVGYnA/2sZzXY3cQIwBzWJfwDGRwR0rTD1XSmmcmOwscRScOph7Ynyyug3cFsdPakEahWbegDfKTjpj2qXHIwDgtnp1P9aYSrYyJcMc4GOor6JWauj4WScXZiFEBJynTaSARj8KEZFfhk+7tJwenrTiVYFh5p3HBA9af8rM2fMxu2kDH86LBfqLD5YHDJuHyk4qTYgYFSMoMHg8g0o2gN8smCdrDHftzT1AJbcJcfddc9fxpDTKCoqujBUJfDDceh9KYuVEjbVDK3GOc+tJGwdoj8i7vv4GcH/wDVT03c7CQxb93tXqO9ZGg5ny+0spTHJ285xxSB5gI9+5mB5BXgin7n807t7LtAyV744/Cm/vdqghxIp5JOQaBBKSyzFPMMZGUwvAzXH3albrC5BxiQqvfrXYSq7iRog4QjI+bGD6YrmdXt5I5l2qxGMOScE1zYmLaub0nqYkjMFLEkOD8u1eSO9WbC6eDUo9pzGRgkrjmmOsgXaQ2/d8vPQUx2KSHcJFUD6/NXnTXNFo7KUuSakjsEuQRzwaDdxqfmbisBnuSowM5HSqklvcSnkEfjXgShqfaU/eR6Lps6yxLtbcD3rTgLRtlcjPUDrXn/AIduZ9Oby5WLQk/9813FtdJKoYHPvXTGr2Hy20MbxdqCaV9lg+xPfLqFylosIHBD/eLcEYA9a6DTtNjjjRECJDEAiqowAo6ADsKqfadQm8UvbJZouixWQkNw4+aWct91T6Ada3bYYB5Fa3V0mSm3sTJAqoAifQmsa7j1r/hKYkjigm0Oa1IYjCyQTg/mwYcYHT+e75hrO16xTVtGvbCWWSJbmJo/MiYq6E9GBHocfXpWl4icWVbuP5dp4IrVtINtvEMfwisDRWSUppD6il/qOnxRLeSAbX5HDMvbIFdUABUJWbuKbukM8oA571G0YHIA5qyc96hY0GaZVlTHzCmI+4e9WJFypqqF2EqTnPNS1fUbH7+M5p0bDjJqIAc+vSnAYwaaRmy0jc8VLvHNVA+DT2kwp5qybk5YdelRMSeKhEvOKkVskHNWC3H4460dj3owaGIA/CplsbRIpZQkec1z/iXSrXWtMh/tK/GnwW93DcrOxAAZG4U5IHJOK05m8yVUAOO9VfF+n6TfeEr+38Rzvb6SAkk8yEgoFdSCCAT1x271jTf7xGs1aDOujXLMxGCTnHpT3IxTIXWSJJEYFXUMp9QRwfypzLkZNdEWZvVmfqEXnQsh7ivPNUtmimZSORXpki5/wFYOvaeJoTIoG8c5rDE0udXW6OihU5XY43Tbnym8pup6Guss3WWOPnn1FcXeRFDkcHPWtPQro+YpDng8qa5KNS2jOipG+qOh8Py6s95rP9sRrDbLdbdOA2/NBt+8SOuT681voTnOa5LwourWulGLXbgXN+Z5HLhtwWMt8ig4HQV0cTuU5Ir1HP3tDkiny3ZpxEj+Lr7VKM5HNUoyepbmrELEjk1W5LVidCNoHPJq15wK7MYB4Zh6VSUEng9KmUfKOlPma2Ikkx28Fmx0HANQSpnrxmrHTpio3GMnOaSfclaMozoCOKxdQjAUmt2c4GfQVj6krOmE4qGV0OTlZS4CqScZBJximNtLIB3GcFuBVm/iKEhCd3XgZqqvmDeI87TypKivosPPnppnwuNpezryj5iq6sVwvXnG7pTw6EJvjBLHkMehFRkSLuKAgY+XAGCachckuoyGA528Zre5yWJ0cSKmUAJOMMfTvUkeCFLxpycY3dx3qALJt3ANjGM4GM1MuWxtzyMZ28FqQ7FFSVeIq2GPEmxe/rQCzI4y5YN8hPGPbNCq2IgrFmXh9vHelyxjkUAjzGwuW4X61kzUkG9HDLv27cMM55IqOKDCoC2XBzkNyacEKyFlwAFwQD19zUeAAqGSIkHO7HX05pokkk5eUlVy3RSeRWbqcG7ynYLtXj5jncKvNjMjb4wzcMuPu0PEu2MbhkfcAXduFTKN0NM5C4tGEbJuABbcGJ6e1UzxLuGCq8EK361091aKIHUMuGYgttyQ2K5eeLbNISFyV24PGPevPrU+VnVTnc6tYgyqQO1Na374qxpWJrOA5z8oFaQtcjkV85Ug7tH2tGacUzC8k4PFWLF54JVEeSpP3PWtqOwDYqtr2hm/0W406G+SwuLweVFM3J6gkKMgk4B6etZwpSclrY3lOyuReE7jVYrOf+3JTNdSXEjqEwVijJ+VBgDoPX1rpIb5R6j6iix09LaCKNASsaKgLHJOBjk9zxWgkYU9OK6Um3chS5VYg+2AjChmPsKdHHJOfm/dp79atDp6ClXk5/GrUe7E5voYuurpnhuK78VjTJrm9tbXyJWtz+8aDeCSQTg7euTyAK6C1uIrq2huLZxJBOiyxuBjcrDIP5GkA4PQj0Pes3TZtYPiHVba+tYf7JVI5bC6i4JyMPG467gec9MVvuvQx2fqbDtjioS2aGYdD0qEnnioK2H57VWkG1sn7pNTb8Hmo5sMpxjNQwuRluelLnIOKYoBANSAADk0k9SWiPcR05oLFvc0pQ9QKVEPpWiMxEGTVqJeKiAwelSK20/WqbKiWBjFU724WJfUngAVLLOEQ5IFZZZZrgs56HArOTubxJLWOVpCzYGTUniBbL/hGtUOtRNPpi2zvdRrnLRqMsBgg54q3ahcdRVi6EYsLozRCaFYXZ4iM+YoUkrz64x+NTTj71y5vSwuh3VteaNp91p4P2Ke2jkgyOfLKjb+mK0FyetZHg/UrXWPC2lahYW32SzuIA0Nvx+6UEgLxxxitcnnNbcvK2jNNNJiEfTFVLhAykcYqZ39Kryvx2qroaRx+u6ZtYugyp7YrlbtZII59jiIsjLvJ4XIIz+HWvSdRmiWImRlA75PFeUePbzT7nT7u1afy4Jx5TSqQMZPTn8q4p0VzpxOmFRuLRu+DtQTTNJsNOuLoyywRhGlkP8ArD1zk/Wu5tLtZI+GGD0NeS6datc2UY2lGiwir6BQAP0re05pIHUbpYx3GeKpVJXuy/ZxSSR6TBJk4DVajOK460vpARtkZh6Yrbt7qaQDCH8a6I1DNwN6Jh3/ABqYOM8dKzbYMB8596uDGfmPFa810YyVmT5pjkkcU0yKOM00yM/3cgVNyLEUqcc1RuzgEJyavupbO41XlQc4pgchqcRyXYHOelZW0lgoK5HzHBIOK6vULfcDXNygLIxcMAnBI9PavVy+pdODPms6oWaqr0IvlBXa4LA7hjIJqTCFQY2Vix3YGQabwCxUSZUcZI5FTIVAACuAo4zgjn3r0mzwRVHB3OCSdwAJz9Kl27u67mOQQcEU1PlbCq3yDPbgUoOcDc2QMjcAeKQyl0K7iPlzyT96mlUVZAMbHOSQeF98U9SirGAyjB+TAzn1pMLiYk4YnDkLyOeKzLH4BcbBGWCY29PqaTMWxELAxk8ZXvQSVKgM28r8vyihShjV3jcDPrnB+lMQjMQ0m/cDjDbU4p68PblCWAGFwMce9I7hnlDI29cZO7GRSSOGMQKZ8wZBc4xTERON0LEl/L3YdcYz71yGpxCO9mwzgjOQRn5frXYSMDExKAKpAKluCPWuX16PGpzqijJUMWVuDx0rmxS91M1ov3rGp4Uk/wBE2AlgjEDd1rr4FDD61w3hSVTNIijaCoYDOfau9s14GTXzuIVps+wwEuajEuQxgDmsua20jWPF1sxuXk1Pw+DIbZSdkZmXhm4wWwOMHitncsMMksrBY40aR2PQKBkn8hWd4Pm0/VNM/t7TbGSzOrn7RL5oxJIVyoZuSOg4x2NRC6Tl/Wv/AALnW1dpf1/VzbWMHpTtntzUir19KkC5xQimiHZ9KRY8VYCdaGToauIEYGMc1j+LNLudZ0WS0sdQl068DpLBcxk/K6tkBgPvKehFbLcA8ZqJj+XtWsXZ3RnNXVipBeQ3gl+z3MFw8D+TOYWBCSADcpA6Hnp2zUvcVzmrS6N4PnuNakt54hq91DBdzR8xRPghZXHRR6sOSTXT42nBHINOpG2qM1K+gzbg011yQQRU5IycGq8rbTmuaUjVIhTI3AjjOQalK8ZHNM3ADKjn0p6kEZ6E96hsdhVHOakA/OkQcDPNKSBz6U1OxPKGOahnlWPBPLdh60Szj7sfzE8cURQHaXfr2FWm5aFJWKsiSSSrkjPXb1xVuG2wBwKltoR97uauoqgc1eg72IYohk5WrCryB6inh1A7ZpwkXzE3/dzyfahWHcw/BOsXeueGbXUNQ046bdSNIj2uCNm1yoxkA8gA/jWy8uMgZrA0DVtUl065fxLAlteJdSpGAAN8AP7tsZPUVO13PdRsttGUBP8ArH/oKub96yFD4U2W7m7iiUmRgv1NZU99NcMVtU+X++amTTi8gac+YRzk1cYQ2yZbCqB3ojTctWU5pbHPzaU90C1y7Pnselea+MrTTLSSC11MuFluFESrn5nXkZx2r1G81N59yWUZbtuP3RXnHjGxhfX9OttQEk99PHJcwsB8sQXgn8elXKnHddOwRm9pdRfC+s289/NbYJGN4fHH0ru7aKORQQQc15npkaWepxErhXOw/jXoVjasFzG5APauRb+6dU0jbt0jQjpV+N1XoKzbaF8jkVqRQ4xk81qk2Y3ROspYYANWUBbAJpkMfYfSrkcIBBq1F9SZSQ0KoHIyR61J1HSpQozxSrgdAAatIyciDYfWopIeKsS8cim9U5oJcmZF3GNprkr9dl0RgZzzkZrtrpetcnq6hZlJ4zx1rpwkuWqjz8zp+0w78tShtAIYqCwPZex9qULhNowSW6Adqaw4UEnhcHJ5qRBsA3HHl9ck17p8hYlUYDcKSDj7p5HuKQ/czsGQ2AQDyPpSr8qAO3OM5z1FKN4C5IIX1bGRUjM7KF0ILMpb5AvBBp7FTvA3Hb99fXNM2rhCoJ3cgE420uU+d9uCnbOQ1SMeUUusYiIJGFJbIHemMyhfNES4zggNyKcrKxAwgDL94HpTBL8qswQnJyNvX8aAHb1RpUKx8LkZ5JoLr5kW5Y8Nyc84NIzna2wYTG5Pl/rT03M0ZXKcfOFGcGmIZn92CyISOPXI+lc74miBuQ4C52ZG04Bx2rom3CPgjzSeqrzisbxOmI0PBUcKWGDn0rLEK9Nl09JGToNwqarCNiqZEIGO3evSLBwUFeWWcxjv7dmUdQDlcba9M0tgyKDXz2MVpJn1WVTvBx7Mn8SarcaRplvLY2Dahc3F1FarDg7QHOCzEDhQM8niugRUj/dxBBGvyqEUKoA9AOgrAil1j/hKooo40j0FbJmkl4LSTlsBR3AA5PY1vx1zbJI9WOrbJ0HvipVqNR61IM4popgeOtIeQM0pIApjk9qadhDX65qNlGfY0rP1zULyYGK050iGrj2ijkBSaNXjJGQyhgec9DxWT4futWuW1KLW7GO2ktrpo4JoiTHcQnlXXPOR0PvWmJOc1keIbLUL2XSptK1E2ctpdCWVHBMVxERhkYDqcdPf8we0T91kONtUaz1UmUZPzYI5xTJdRhliD2csc6OSEaNw6nnHUccHis+a0uJGLPKxGc7RwKxs2y7lpryKBmDsBj3qAatFyFR2A6EL1pbfTFaXceRx1FaUNkv8Qz3o5EO5nQXdzcvhAIoz0LDmr8VpNL/rJCR37VejgXHAH5Vcji24xTSSFcrQWscSZVefXvSTZxgCrbA5GcHHNV5Ooq0xobESBjaaSecImWyMd6r3l+lqoAOXbgKOpqlFBcXknmXJwueE7ClfWyKt1ZJ9snnci3Q7R1JqVLW5mOZ52Vc/dXitK3t1jxheBUu3OMVoodzPn7HNeGdL1S3m1c666TxvfO9gwwSttgbVOOhBz15roiqImSOKztI029sda1+7u78XFnfzRy2sGWJtlVMMvPABPPFQ61qJVxBB80rdx2+tbytF3M4Ny0H6hqKW2FUFpG4CjrWetrNfSeZeH5OyDoPrTrG1KnzHJaRurNVppZMYRQQPaocubfY2tbYnitoolxwAO1c3qeqQTeIb/SHsE2W9is4vmHd2x5Y4/Hg/hWpNHPKSN5Hpiuegg1e/1LWYL+N4rG1mSOzfaQZ1K5ZvQjPHFbQnGzSRnKLurs8/1WdIZW2sMg5HNd94ZvRf6dDOp4ZRke9cl4t8LGDMyhsd/apfATtFYvb7irwyHB65B5rhnFRPRupRuj1W0K7Rjk+tacRBGO/aua0+5BUbhj6d63LaUNjAq4SOaUS/G2DwKtxgnqKqQ/p6VcjfP3ea1M2S84wTxTeacozyaVhx1pkMjIz9KRhThSP0pkMpXKjFcxrcQJBPQGuqn5HtXP6zHuiY+lVF8skyKkeeDj3Rz2V35AJGdhwev4U4EFuVzztPzc05VcgHYSMYOQMZ9qUIcqSW5GDkd6+hT0ufDyTvqJxwdrMQccNSOwwSVJIOCAe30pUZhw657Y24xSjdxuX5T94baQWKGQqAkLkn5hjI/KnAko+0KMH5CB1/CkAc7cF9+cNgYyO1KA4WQckk7l9QakocHBYbthQryCuAPSmjzHUYLBgcHKU9Vfcu8OV2/MDz9Kb5TKyDLBgcgl+tAhmGAk8oSbM/LzwPwqUEq6kbjtGGAOCfemPGpMx+UBucFuRzSYAnQuRlVx8xzu9DTARTIUUHO8tlSSBx6ZrP15Gks5A2SM/LznafWr74MaqdgUnOfQ1DcRiSG5VjH8y4yOAo7HFKa5osE7M4o70dCyucfeOc5r0TQZg0cTk/KQCfpXn8odZEKhW25yFP3q1IHhuvDb6ddXws/tytaJIMbtzfwqD1JGRXg4qHMkfQ5XU5ZuPc7vwxaahYx37atffbJbm8kniCklIYjjYi56ACujiIIyK5zRFS2sba0twwit4kiTJ7KAB/KtVZXUAEZJ9K82TbbZ9FFJJI1VYU8Pj0rOWRwBkjPpTlZ2B3EqKabHYuO2apy3PlffyB60pG7IVyfc1GbfH3iWquVsQxryMkhct9Kge6B4AP0qZ7QOcgY+lCxBGG9VyO+KrlsSRoZ252jb9aQLcynhtgB7DrV5E/KrEaZ7cUCempx2nW2ieDb2y0iMzwf2xdSyW+/mFJMAmMHomey9zXVPGPSprq0imVPMghlkjPmQ+coISQA7Wz269RyM1leGL+91TRIrnVtOfTtQDvFNbsDgMrEbkJ6qeCDWktVzfeYp2di4oAJx61ZUAVEqYJBFTKOMAVki7gHwSKnVyR71AV+YHpVmM4Uk4qXqVdEZYKpOayL++IkWGDDSt+Sj3q7qdyIoyUALngCs3Trc72aTBYnJoV1oWtrj7SwJk82U75T/Ee1bEMW0A46UkMZUcdKl3YJDVvTiRJtj2fgkce1NMgX8qjZgeQazNVvxbxjvI3CgdzWi8yLX0MSSOGy8Y6zfWt55t9qUECSWnH7lYxtEnXOD9Ku2drtJZyWcnJY9TWPY2NhF4wa7muWOu3Vht8jPymBXzuAx2PHX8K6VsABM47/wD1qU5czTZVONrpCqOSF+bnpViGDIy/12iltounGM9qndgo6496cVcpvoh4ijVl3YC55wOa53w4dXS0vT4ieM3LXkpgSPb8lvkeWCV6nGff1rQuLtpBIkABl2kKx6BscH86yPDOn6hpvh6xs9XvGvdQiUie4LFi7Fiep5OAQPwrVTSjZE8j5lcTxJAtzZSovJIyM15v4fnNnrjQMcLMpGD6ivUbwjBHcV5B40Y6fqZlhO10bep96zqwc7NHTQdrxZ6tYhWj5GRWxbx4+6SAK47wtq6X1lGWwkuAWT0rsrdw3fgisYvoKaZfhyDnOfwq5Fu9Rj6VVg568GrsfGBjmtUjJsnTJP3qkZQB71Go/Cn5GOvPrVoykMb9fSmt+tObk5zUbU3oKxXmHFYuopuQ5rbm6VlXi5Vs0gOW24DZcDPGOeDQe/IG7jjOAafIuydwQxOdy44oDAhSQ5P3ueOa9yhPngmfGYum6daUROikBx84wOuAaRQDuAYAY2nBNKSG2lSwJ+YDpzUROSuAw3c4JxgjvWpzFNxJ5SKeinOS3X8acn/LcqcK3B54FCopVD5h2knb8ucHvTuPnxuAX75xyRUoocqjcoTaWCdA3XiolRCqgumd2c88fjUn3igydwGV3LTVEewD5wrHkZ6ZpoQrKv71i5X+8oXI/OmjBZAC2duUKjPFPkcIJhyxXAJzjP4U3gPGjDIIypLYx7UwGbYxGpDsylscD+KiTGZd5YkL8+5e3tTWYFFJUYzggt096kZjmUE5AHrww9KGI4q4Uef8rKzLnaGGM0eGY9O1HWI4XLy3mmN9pRQSETeMc9iafdFDcsfuj5mznOB3pPh5c294kl7b232Zro5bdjc4UkAmvGrXUJM9nANKrG56fZR8DbWlFFheOCaoaefkFakfIFeSfUJj0QDgdanWEt1PHpTYxVhTxWkRtjRCPSneUCPu1IKeOelaqxDbKbR7ahlUHg8Vem6VVcA1EikQI20gH8KtRHHHaqzqKSGQg7W7d/Ws9hvUvMehPNYup22qN4j0y+s7+OPS4Y5I7+0mOFZSMrIh7OD68Y/GtcN8vNRXUMVxazW9yiy28yNHLG/IdWGCD+Bpp2ZjKNx2VIDIQysuQQcgg9CDTlXmub8PPpnh6Sx8IQXlzLdW9qZ4Bdcs0O88K2ADt6bR0ArpC3FOatoJaocc856UySTahzxinF8D2NU7t2ZW29h1rO1zRIq4M1xuboOavW8Y44qnbfdLf3jgVpQnA5H5U1uWThQq9xxTHI79fWnOTgDIqF29RXRBmbIridYo97EAAZrn7fffXjXMgzGpxGD6etO1mY3VxHYw8FvmkPoP/r1p2sIjVV6Y7UTd3ylR01MfUJ9Is/FmjC6jkOt3NtPFaOAdvlr80innH6VuWsZc7nHP06ViazeWVv4h8PLeWQmur25ktbS4wM27bMseecMOOK6dFAHAqmuawk0roXeIlyenv2rEu71rqfyLb7g+8/rS6/ftAqxQnLvx9Kh0yIQwjnk81NSf2EaxjpzCazpsd34d1K0lvEsBdQNB9pcgCLdxuySPX1FXILdNL0qzs1csLaBIQ56ttUDJ+uM1geOP7L1HRF0vXJjDa3tzFEm04MsgbcsY4PUirt4Lu5Ykfu1P41SmowSRKi3NtlPVL5EEjE8eleMeObyfVtZS0t1OCRuYdhXr1xo3mZ8xySeTXMyeHorW9lbBLPgAnrVwreRqoa7lix0oyaeklqzJPGgwVPXArb8P6nczRhS481DhkYYpumK1sRG+djdDSaNGg1K5U8Ojk8ehrKpBWTLUm7pnYWeoE8SqVOK1oblHUENn8ayLWMFOcVcRVBAAqowdtGYuxqpKh6mpvNUD5Wz7VnovFTKitjGR7etUoyIaRdDKfemtg8g800RYGQCMdu9NdTj5TTfN1IsnsRyfNWfcrnNW3LA1WlORzUj5TmtSjK/MoGVPeqhDMxZAAB0JHWtbUF3BgO9ZSMSRlxlecZr08BPRxPnM5o2lGp30GPw5Kg/7Py5BpSzNuwOD0G3vTWJJXa4LA5GD1FMGWcclmzu6Yr0LniMr8CMMR8rHGM8D/wDXSnCrKCMBeeDkNTF3BPlyzgjOB1FPJY+YCMEZ2nFQUITGVUDABHUN0psbr8pWNc5O4DrUil8/OuU2jI2ikKuTEpyOcE+opiYjHIZVXPGUJXr+NAfDDnC9WG3PPtSvuUPtYhCOPmxt59KGBUqQeQMEE4yfWgQm5ti4HzY5AXPHbikdWLHd1zlRt70u1tibmBK8g7vvD/61JyVk2kbWPc8KfrTA4TxPc3Nr55srVbi5LqqqVIAyw5OOwFaWjypFqcRwoL5XgY5qHXI79PE8MiMBpwhYyLkMZHPT8B1zUSGSO4iYgllbJPUYzXl1o3TiehQnyuMj0/TmyorZg6Vzmly7kU5rft2yMg14i0Z9fF3Rej4FTAVBGelTCtEMk/nTs8e9RZJNKOeKrmAJOlV5OBVlhkU0qMYx+NVYE7FDjPXFDEH/AAqw6CoJBtpOI9winH3TwRUhfcPl5qmwJO48YqxGRgEcetQ1qJopa1EY7SXUrewgvtVs4ZGtEkwrZI5RX/h3Yx71Lol+dT0iyvvs81sbiFZDBOpV4yeqkH0NXcenNZAi1ePxVNcPdwy6DNagCGTCvbzg9V9VYcnJ4qtHG39ehOzuacjM3AHSmyLtiY+oqxHHhfeobkfIVqYxsrlEESbfLAPHJIq/GGA6A1RLfvgg7DmtCE7RSirsJbAASe2apapcC3t2djgAE1cdsZNcn4gnN5fxWcZ+UNvfHp6VvfljczS5mS+HojOWups+ZKd3Tt2FdBIvHA7VBp8QjjUL6dKszfKnTv2pQWl2U3qYniHVZ9FGjG3077aLvUIrOQgEm3R85l4B6Y9utbN5MIULdetY/ibUdVsNJSXQIFuLw3ESPEy7sws2HI5HQc1Frt0GZ44iduSAc9q1bUYJiim5tGcZjeam0pPyjgVuR7dgFc/Zko2AOO9bEDHviuWLu22dTRS1v+xptb8P6fqsbyX8k73Vgqg7VkiXJZiOMAHvXQeWCflz+FYaX9hP44h0p7HzNTttPN4l4wBEKO2woO4LfliuoRB6V1W0SOdPVspmLjlSTWdd6cJpQ23AHSt/Yc4pfLGOlJxuUp2OVuLExqDgkDpWHqaSWd7DfWwJPSRR/EtegSwhlOQMGuc1G1Ic7R8mCMU3tys0hPW5paRewXkCyRtnI/KteOMMOOtcFBBNaSiW0fYSPmXsa6jS72aVQCRuHY8VMZNaMUo9UbiRH1qVUI/CooZmPG3D+lWo5eB3PTFappmLuSRoWUHd74pki4yeaUMy8rwfSkZ92c05NWJVytL3PeqkoFWpuc1Tk65rC5aM68X86wZsxu4B5Hr6V0N3hgfWsK9U+dwQPc+ldeDlaovM8zNoXoN9tSupVVY+g6Z6ijcQhwOFwRznPtSjeAuSuc9z2pTkAgsB/FnPb0FeyfKFHaRGFBG0H5ST1z1pWDbHCuoDffx/DR91Exu2lsrgcg+9K5wrnnGfmz1NQA5DtClSGO3ov86asYUR5cbifkIGOfrT1wSoG7pkH+lMDjy1A3FSSOTnFMYrkM02Tg/xZXPNIOJFbd8wXjaM5FNcqVkDA7sjnd1pTjzSPbIO7H4UxDEKnbydmTtIHfvQhCq7MeN2XBGMH1pd4VY8rkE4wTjBrP1yWx/suW31C5NrHfMbJXVvmZnBA28HnrTBK7sYcunS2t9qFxPfC7a9lM6FRhY48ABV5I49R1qBUbEQDBioyOMbq2dSsYrDT7S1tUKw20KxL82cqBjH1rHUZKbC2cfLzXnVvjZ1Qd9TtdAnEltE/qK6m0c7R6VwvhicNDt6bWrtbNunPWvDqK02j63Cz56aZqxk4qdSQKrRmp1NOJ0kop+PxqMdaehNXoIf1FAXil9M0nPpxWiJ3IpQOaqTkDgVak77eT71WZfzpMpEQQEHucUINrbT+FWESo5lxyKloLkinj6Vm69o1t4g0W90u+DfZruMoWU4ZDnKsPcEA/hV4HdgLVmJcDFEbp3QmtLGXot/ZtLcaNDfveajpMcUV35oxIcqNrngA5HJI4zVyY5ZfSsvxVPHoNnd+I7fR/t9/FEkMxiOJTb7+cf3guc4rQmkUokiZMboHXIwcEZHHY+1aSjpcmD6EEB3zyN17VpJwtZlmCEzjrzV/cMVlTV2VNlXVblba2kkZsbRmuc0GFp5HupeXkO7nsOwqXxJMbieKzQjk73+grR0qMRpjApzfNLl7DiuWNzWiwFHYU26faAc8Uu/C8GszVJvlwOuO9brRGa1ZgeMZdVfRLuLw7MseqEIYHbGB8w3A54+7mp3UOd7cnjIqprdpc6hpF7bWVwbW7miKRTgkeW3Y5HP5VahR4bW3jmYSSJGiO4/iYKAT+Jyayk7xNYq0iS3hL46CtSCFRjjPFV7eMhBkYFadsoOB+pqIItsz9D1Ge78R67YSad5Nvp4hWK7KkG5LruYA46KeOK6VAMVh+FZ9Zu01T+3bVbVIr6SKxQDBe2GNjnk5J59OldAq7cHp2rqas7I507q4wqT2xRgDpyamIGMUqqMU0gvYrvGWXn6VTubbKngD3rUcZKgDpSSRAgjrx1ocRqZyawBZVVh1yK1rC2RgrAAdqjvLZo5lcD5B1qS2kKO+BjndUWtqa3vsayW/TGKsiFUOc47NUMEgZevNTsxIHeq5kZNO4ORjHX3quwwcg8U8tjg1DK3FS5XGlYik5yRVeT2qYnj+dRP0OKzZRRuFG05rn74/vBuyAM8gZrfvG2oTXOXbEy8gED1rowmtVHn5m0sPK5GwCk7ScA5xjsaQgc98ccelCg7ckYA9R1FN+YENjA7jHavcPkCvklRhcnPzD/Ckcv8w8v5uSvH50Z4j54B+XnrTRzG+G249+hqRskAbJDLhTjHGOaUb+C6dM5BXAIpFcljk7htwRn9aVDgxsXDHnHJ5oATc+PkHy/wsAPyNL83LLHlTnjg4pAFZZDuXJPPHINDZLNnG7HIPP40wBi3ylQS3R8L1rHeSx1HxEthJEZr7TUW9SQr8kW7gA8/e74IrbG390hYbcZVuufWsXw3enVtMOoSWS2Lyysg3KQ7KhIUtwDzzwelMa0uyxrqu9q5xyCNvHOa5pzkLujOMcnGMH2rq9QTfZ3GD82OccY965fEitu4IHUA9feuLEK0rmtF6Gj4fkC3DDAUtzj1967uyfKjjFeeaaxiu4ckMCSM5rvNOf5BXjYpWmfTZZO9K3Y34GyKtLzVC3Y4q7GTWEWekTj2qQdqYpp+cVaAeTxSDJB7ChR+NOB7VaYiLaCeOlRug7VaC5H1qFlwMVQ0RLxUU/Q4qwBxUNx0OOppvYLFa0OHPf39K0VHFU4UCqPWrcRJGPSlFWJkDEjkcEelcvAutLquspqbwz6c0iSafKmFdVI+aNlHof4j1/l07nr6VyPjXSF121gtBdTWdxHOlxb3EPLRyKeDjoeMjB4qk0tGKz3RtW5KgCp538qFpCeAM/Ss/R9SstVE0thcR3AgmaCUp/BIvVSOxqPxTcmOxEKHDzEKPXHelFcibfQb95pIyNP3Xd5NduOZDhc9lHSuitgFXFZmnQCKNQPStLcFwAOfeopp7sqTJi2Dkmsq9PmTbedtaH3hnGfftVNk/wBIINaSehMUVNSsRe6beWruYluIHiLjqoZSN34dar+H7BLTQtPtorhbtLeBI1uFIIk2jG7IJ/nWxIiyROjAlXVkYexBBrL8FQaZbeF7G20K6N5p0CtFFMTkthjuzwOhJHSj7LQX95M04kJwD0Na1qgB5Gf61Vtotw5FT6hbT3WkX1taTrb3U1vJFFM/SJ2UgMcehOeKILUc5WRB4Lt9Zt/DttF4pnSfWd0hmdCCAC5KKCAAcLitzGRWf4esZtO0PTrO7uWuri2t0iluGJJlZRgtzzyfWtTGMH1rd6tmK0SI9pNOQe1OxyPSnYwc9u4o0Q79BOlSR46Yph560qk7gAPxqosh6iXMStjcvG0is0Q+U7ADIYY5rUkP51WnUnkdevFKdmXTbEtI9yjaMt3HpU+D61VgkKs24de9Wt4YDFZWTNbsjkY4qvIWI5qy2MVA2DUWsO5BzimyNtFPk471UuHHJzUvQLmfqMwCn3rDJG8uW+brj2qzqk+59imqmduenBxjOcivQwFPVzZ4Oc19qK9WIAoPU5HHI7UjFcfMT/d6YpDub05OD34pvzDG5RkdePyr1D54r5UBAF+XPGOCDTm6NkEjoff3pr7wqfu8uDyMdqcwO1srjnK8Uhi4USAKSSV5yc/hQrR4XgjnPBztpMhTuK8EY6dD60/5mQCRQR3xjJoAYdoJ3ZJBAIz1pzIgcAgnAOG3YJoG8pgbRzgE46Uz5iTt5Udsjg0wKPiKa/TRpZNEtxPfnCxIx4Q7gCT7AZNaIYmEGT5iPlYg8Ej+IVQubbUpdc0ya3uBFYW6SG5iBwZ3IwufVR1q/h1zhfnHPHQj0oG7WRHcIHjnyWAC885yK5NhslIQkHGRnkV2BRh98D5h8oPHNcpdqVupVKbQOpxiuXErZmlIghYboWUnAbIBrvNKcMq5rgQRlQ8ZXsSBjFdZoE2+FOT6V5OMjome5lU7ScDsrV8qKvRn3rKtWwQM1pRMDXEme8XEPeng5qBanH3elXcRIp5pwHNMANSrVIGOHXnoajZcgnuOakOcUx/atLgiI+pqFl3HNSuO3c0KpA9aE7jehFtx0p6/LzzSgZobIGKsgjlbg1hTuZbo+3ArVu32xN6gVmWKFyW75rOXYtK2pnX9zp/hOZNQGmyEaveRw3tzACfLYjCSOvcduPxqPVpDd655Z+7bjB781080gt7Z3YkADJNcP4Mj1WeC8k1uKMTC5fy5osbZoz91sD7vpg+lXV+BLqRDSR08EZCqcUsx+cDtjFSqNqD2qEAyO1StiizEPkzULx/vC3Xk1bjX92fXFMYZAPvTYiJFZnAXGTWN4IOkHSJYPDyyJZ211NCyuDlZQ2X684ya3kT95x68VkeFL3T7q51y20yw+xGx1B4bgAACaUgEycevvzVfZYnujoYE2t9OazvGul2mteF7zSL/AFL+zIL4pD9oyuc7wwQZ4JYrjFbCDGKyvFVro2pTaDYa3O8cz36XFjEjEedNECwB4Py4PQ4+tVS0kmZ1NVY6KOPYoTGAqhQPTAxUgTIxnigHcxJPJ5NPBx061Qhu3GQeopcZOO1JJz0HNLHQMR1xjH3aQZAqZh8pHaoCCp2n8DTeglqMJYvk9KG61If0phHHUClsVcrsMMWFERBX/CpHXINV2Hlj8c1LLTJyOOtRvx6UhcEYFRO/GO9QwTGSNisu/m2o1W7h9oP0rntRmywUkn1FKMXOSijOrVjRpupLoUpPmdnJGepGe1NJwoLOcAY+tLuQMcqTjjrjim5C4YL3xzX0FOChFRXQ+LrVXVm5y6i4GBk9sHIzTHPJGM7jgZFP35b7oGc5OKYGbBzjp+RqzMr/ADbAC2RnKnOee4pcnbIM5APz47UnyiMFskZ5Hp70FgQxAJx+OfWgbJE+8Rx9zPIxkUqj7gV8Z4U4/nTFIL8DaAMDtg0KpBXKYBznjFIQrANG4xjnnjoaayHe+4jO3LccY9fypWDgElfmJGDjrWfrl5ZWtk0epSSRW90fsqsgJdnkyNoI59ee1MaV3Yj0LT4Ibq+1G3vftg1KRZUdeUVFGAg5wQOea2OsYG7CknHqD6VW06wh061tbG3j2QW8YiVSc7ce9TnaIwWGcnBAP5GgG7u47DHflxgDB9q5zUlkjvnK7WBAyPX3roSuVZsfKPfO4Vi6wmLjcM8L1zWFde6VTfvGagcFWGHxyQOpH0ra0GQ7mDcENxWLGp2x4Zt/JUGreizeXchSwO7ivLxEbwZ6mBnyVl5nf2j5Gc1pwHArDsnyoxWxCT3ryrn1K2L6H3qxHnFVU7VZiPFapgywg71IMVEh7VJnvVImw/tzTDyDRuzTW9c1Vx2ECg5x1p5AAzTA2O9G4scdauImhCMMTniiThTTgD3qOY4XFadCTMvzhSO7cUlpFt+YDim3IMk645Aq/Cn7s+wrKKuzR6Iw/FFwY7EoOr/KB9ax7jRJLu40e8tr+Wyl02YytgbkmiK4dGXOOR/EenNXPETeZfWkPbdk/hWvZqVUY4xzQ5v2l0KUVypEVrd2t9p0V5YTx3FpLkxyxNuVhnHB+oIp9quTzisPfpPhW/0/QbSzmtodWlmmikUloRN95o/9kkcgDAro7ZQB2qprlemxEZXWu5OBjNQsuGx6GrA561HcKQQ3bODQ1oNbihfasnRdTe88Ra/p0mn/AGZNPkiCXAUgXQdM7s4wSOnetmPkCqFnd6tL4o1GzurULo0FvC9ncBTl5G/1ik55x6Yq47MlvVGygwCMcjFY95Po8/jfR7C7tmm1u3tJr60lwcQJnY569T05B/CtsYIz+FZOmapa3vjTVtNXT1W80y1hLXxAyyy/MIwcZxxnriqhuzOb2N8cfjThnuc0fw8daFxSGLznPpSg7W9j0pRikPP1pgSZzUUq5HNPT3oaquRsyqG7HrRnikmGTxTAxwAetQzVajs5I9KjmG5T708k9ajkYYxmpbEQk4wKjc4pXbP1qCZwFIqGy0Ub+Xahz6Vz0js7ljjHX8K0NVlwCoyfWsxiu3uQK9HL6X/LxngZxiNqK9WCnB5bse/al6dWyQPemAgg4Vj269qRt/3enqPavTPCA7Rn1PHSkyuD8p5/DmjL9gM4xz60xs/3gPXnvQCGfNtGcbunHGRTXckuCcDsc/dPvSBlEfIyuefY+tOO0lwFGe/+0KRTQ5V+YnIJ24Kg9vWkBwY/mBB6c9TSBssMZA28H0PpQu04YAg8gg9vcUCFQ/KwydufU5HtWZPcWd54mGlTWhmmtoFvxM/KwPnauP8Aa7g1pgDIDdSwwc9qztCvbu/tJ7i+sxaHz5I4VOQzxqcKWz3PPtQVHZs1ASrjJzx6/e96T7wBDNkH7xPB9qTALIMY445xtPpSjHlhicAtjHoaCBR8ynaSGzwew9qzdbjJTPccD61pkDZIc/KevH61Wv499pMGIGAM+uPaoqK8Wiouzuc6fmAVhtOM/jUMEvlzxuFx83OO1WJAyEbmDALgAcGqSZaQDfkjLAjvXnPVWOyL5XdHfaXNlQM10EDZUetcboM4liQ5zkfrXWWTggA14klyux9hSmpxUl1NWM1ajxiqcPY1ZVqpMosKakXBqBT6U9WIq0x2JDx9KTtmmk0p6Va1Cww8mpUGRUeOakUkVpAUhx/XtVW5f5W/SppGIHP4VTmboD1NXJiiivaqWkYnrmr7kqhGOTUUEeCcDHOakuP9X9KUNEEtWclfjzPEEXUhUJroYRxz6VhIN2vSHnAUc10US/LzWMdZMqeyIbqORomEJiWfY3lNKMqr4OCe+M9cdqz/AAtNqVzoVrLrlkLLU8FJ4lIK7gcZXHQEcgds1qy/eWsbUbGWDxHa68NV+yabBaSQ31vMx8p1+8sg5wjA9W7gYrZWejMXdam4vanOm9GFIrI6RyRsrxyKHVlOQQRkEexFSxcsaXWwX6kEXGMiqUMesnxlIzGM+G208ALld63W/rjrgr+FajptbI6H+dZsthqMniuw1GG82aTDaSwXFoWOJJGOVcDpkdMmrgraMUndXNqLk4PGeKy/DuqX2oXmtxXunmzgsr021q7KwNxGBnzOeoz0I4rVi2iVRJ93v9Ky/CMmtTaKJPE8Sw6i08o8tQoCRbj5f3ePu85ppaMmT1Ruqe/agnDcAc0gAHQj8aG5yPSkx6Dsg9qCewP6VGrcinEmmmIcWA4ycdaaX460wjjJ7UxzjHP40C0EIJPBpCvFKTnimO3BpjuMYnHvULtzz1pXbJpmOpNZSZSGE4BwPxqldyBYyfSrUzAKT0OK5/Vbnny1Jy1KEHOaiupNaqqVNzfQoXMrSSM5AGenPao/mRVKkdc9R0ppwFAPfkAimMAuMDkDNfQ04KEVFHxdWo6s3OXUe7kfxfX6U1scKSTxg980KoLfKpwO9KobOOMf0qjMY2GJPPXB46U0nJzjH+NOBO05IwODUZAJwT7ZoHqM2kKSAAf6elPXedxCEZ/SoyB5RVvXPHf3qSPdmXB7f99D0pDE+cyAFQePmUnr70nzb0BPIJ6H71OXDONuenGf5VGWUheNuCQRn9aaEU9c/tAaPe/2SFa/xiDewAViepzxxz1rQiWRYx5jq0oRRIw4BbAycdueay76znudX02aO7EVvZyPLPCpOZ9y4XOOw64PWtRgNzAfN6H1FDKe1h4LbhgHpzgdfelyRt+UEnrgdRTMgFSScgdc4x7Uo+UIW9TjnpQSO6gkDnOB9PSkkHmJKCvXoB/I0xZCEPUAnke/rT42OyTGSp6nv7UPVAcveYjmYAndt69h7VnxbVYN5e3I/I1qa2m2eXfgKQCcdqzVHzNlwcL0x2rzmrNo6k7q5uaDOSWUgKR8wArtLF8qK8602VYLqH52wRtGa7jT5eBXk4uHLO/c+lyyrz0uXsdPCcgVZTpWfbyZANXUesEekWUp/FQqc96cDiqAmpcgVFuyRSmqTsDQ/PpS5phOKa8mF461tFktBKcnbUBTdIPapU6eppV5bpVPUL2HRe9NueV96U/Lz2NR3Jyh+lO9hW1Obt/m1ec+4FdFEPlrAtExfuxH3ia305TmsKe7LqDZOn0pk0EN3ZzWtzEk1vNG0ckbjKspGCCPpT3+6OeRToeOnStFuZMwdEutL0fULfwfaLcxSWlktxbeeSwli3EEK5+8V7jsOnSujj4NZevteW+lXtxo9tbXGqxQs1sk44Y9SmRyMgHAzgnGauaXcPdWFrcT20lrLNErvby/eiYjlT7g1b197+rkLTQvsodCPyrB1TSFu/E/h3VG1H7M2nGdRbEjF0ZExt5IyRjPQ10KEbeK57xZaaVJfeHr3Vr02clnqCtZ/MAJp3UqI+h6ge3Srjvch7G3cxTyWU6WeBdtE6w56Byp2k/Q4NV/DVvf2fh7T7bW7g3WpxwBbqfduDydyDxkdunaoPFlhJqvhrUdOgv10+a7i8lLpuPKJI56jk8jr3rVto/s9tBCCzCKNI9x5LbVAyfrimn7oa8w8dcGpd2BxUR5GD3/AJ0o9MmkkMceuSPxoH1NAB2/LyaYWYA4BosIczVGRwabvJOe3SlZuPahsdhhJwaidx9aWRs9KhOSfQVLY0gyeTTXYAEUE4zVaeXA9hUPQpFW/uPLRiTxXOSSGRyxYDJ4z1FWtTuBLNs7e1US43YbIz1NengKHKvaPqfPZtiueXsY7Lf1HL8zcEDn8qRySTg4JPA9DRGycjawJ5znvTS3PyIB6Z9a9E8XoNQqRkE+tC8jABPt60E7AdpAyc/jTA3T5vegNheSTxx6e1Ix5wSOnakLbW2gE4GPzph5PT2pDGjcM5PfK9OnpT9xAcAduM9jUcqBS3IIBG7H86co3F+c/KOncUiiRm5UHoByM5z701izbCSCVOeD1HpQi4K8/wAOATTAin5XGQcqVPYdPypiMrRYbCS5v9a067+1Lqbp+8z8qhAVCL7ZzWuxOJBuxnqCelRWtvBZ2iW9tCsVvGdqxJwFHsKc4A3g8twCM8Ggcnd3LCsQzLxnb0J6+9PyQQF645z396r7Rvxznbxzj8Kk242nO0YyP8KCb3HKCuBj5v4uOooOctuHI6dhigLlEAc4JyMjpT9xWI4I256+hoDqYWuoCdwGSRjr19qxBGEyAAM9D6Guj1ZQbaUuc8jdjtXO/eEg+92PuK4q0bSOiDuhhchj0IxyPT3rs9Gn82FH55GD9a4qTZhjySBjjv7Vu+HLsK5hz23Lzn6iuDFw5oX7HqZZW5KvK+p31lJk8elaEb5PSsawcEZrYjHQ8V5aufTFxO3epQPaoI8gdeamU5rQQ7aKAT25FNzyfSlHrVIBWx6kVGgLOT1HTFLIc4A709FxVR1YnoPVTigDBpyfjSkfNitiBjDNV5jlWBq0y4FVbrhcgdeKJFRMyBADn0NaUf3RxVOJcjj0q9FwMdazgtRzGleD7U6PI6UuOcetCj0q+pmwl5UMO1YtvbXdh4m1DULrVozol1DGq21y237PODgeWTgBWHUdSTW+BuGKyvEGjWevaPc6Xqce+1uFCvg4ZSDkMp7EEZBq07PyZD1Wm6NoZAwRg9CKw/Go0MaVaXHiVZTZ2t9BLC0e7KXG7EZOO2T9Kn0PWLG7vb/SLaaZ73SfLhuEuB+8IKja+T94H+93P1qDx1f6bpnhO/1HW7D+0NOtNksluACWIdQpGeOCQaqN1NIiTTi2HjXTLDVbW00vWdQ+xCa+ieIAjNxLGdwjGeua6R3LOzEcsc1zusPo174j8O22pPK2qp5moaei52/KuHZiOOh4z+FbqMc5U5o2SSDdtjyOKQdiOtP4I6dPSmMAGJU/UGkFxwPHFMY470mewpGPH+NNBYQ460zdSsPXk1Gxx0qWMG5zjpTCMe9A9j+NNkcAdakoimbArF1S68uPjqeKu3k21T6Cuau5zNIzclRwPetKFJ1p8pzYzErD0nLr0Iw7AEkAk9fakyx64PGPXmg4A+Ue31puR1IPPBr3krKyPkJScndi5YhjvAHTPWo3G4HLHOelPzwMLnJ5FNPA5UehzTJGfKVGPr+NIck8KB+FObOQARz2A6U3GMHBPekOw/JHO4YH8qjbk5GfQ0PkdAAPeo+jZ3D3+lAxy5fI2hew/wADSggbsrwB6cg+tR8AuCcj2704FedvPy8e/tSGSKckbl3Aj86blmkG4j0+vtQCABhiFAwPVaapBxuB4zn296BCh8fxcZwPX6GnDkvj5V9M8qaawAKkqTk84PX3pXIYuDySc/WgB4JDSY5GOQex9acCSAGKgbc89/eoiQrMByQBg/0p7MCRkZGM9f0oAkA+7hM9/wD64psgQKeDz1H9aBIMLuJVewHao2YFAM5yfvAcj60D0ILhC8DhV56c9xXOvEys4XHXg5/SunXC7c8jPP8AjWFq0CxSHaSELZIB/WscRHS5dN62KDbir54z05zii3mNrcLKB8q4z/jSSMB5nUjPzYqGRgN4BbOOQe4rjaT0Z0Qlyu66Homl3AYKQeCMiugt5eBk9a4Lw5cE2sfzEgfLz1FdfZzZjwa8Sa5JOJ9jRn7WCl3NpHJ71MrZ4qlbNnvwatrjtTizQm7e9ANM3nFNLYB7U9hoehy5z2qbPHFV4eBz1qcEVcWTJD0bB96eDznvUG7n2p6k1smRYkc8VA43Kwx1p5/OjsaL3GkUIR27jIqwv3uKilyrK49cGpBg4IqI6Ow5ajnz17inrSHG00J61ZDJV68HiiVflzjDD9RTkGRTz93mmtdCOpz3ia9utH06TVtI0ePUrwPElxHGv7+SDdg7Mcsy5yFPHU9qqeOfHOgeGbS5guri3vNU8otFpWDI8rdQjhQ2z/gXSk+IOq6hplhYadoLhNZ1q6FlaS8HyARmSX/gK/qfaqfgvwvceB7LxDFaSWt75zNPp1xMo+13EnlkmOVsDdlxwAc8mtoRXKnPf8/+AYzb5moieGfG/hbxR4qgitFCa5BYjbJcIYmXeRvt0DYLEHngcjkV3SnDkdK8+0pYfiPpeoWni7w+LG/s/Ija6Vdk6TtHuLRtjcuw8AZINaPgDVdQurXUtI1yRZta0K5+yXEwPNxGRmKXHqy9fpTqRS1j06Cpyez6nbZzTCCDmmo+QMnBpSR65NZp3KegMcdD9aY7A0hbGd3aoz8x4BoGkBYn6U0Dn3pQhB/+vStgZz+lLcojY4FVp3wOeoqWZsCsnULkImQaiT6DWmrKGrXJOVUjcfyrKBC43MPUc0+VjJIWIPPr2qMDB+6M44Jr2sLR9lDXdnymPxX1ippstgZs8lsd6ROFID49PcUY6EAUhz1AXHXrXUcIpI6Fs44ppIJ7+lOUHHJBB549KYeDgNn6DtSAa4ODgDNKxLLjP/66R9oHGSOnNMZipUY5xz7UDQD3yceppu3bwAMUpcHP8qaGUZ4Iz60gAsRuIHQjoOlL1BBIIxkAUDHzDGOMjjj6URAZXChcjJ470WGKSW24fcT2pSw+Xa3ToDSBgxHBB/i46U0r8oyPmJ5IHUUWC4bxkAFgM4x6GnBgC4Z8EEcf4U0qdo6sCfTtQwJyI9xA+6SP0osK4522lgHyO4x196dvA5LYOPTrUbE4JRSR246etKRkZUHGP7vQ0coXJPN6DIxt7jr/APXpgGSp3Bc9DikOcAKO3OB3pckBSF+Yj5gen1p8orj0zhMAcE4PrWdqyZVHPBBxn+laCZ2qGAznjJ4qjqeGi9Ru6Z4rOqm4suFrmLKAqttUA5/yDVV1JZtwwvH4GrrBcEY6noe9V5V4I2nr+dcB0l/w7Ntnmj3ccEV2dk/AwfwrgNHYJf4xtzkfWu4smOAc15eMjadz6TK581G3Y37ZzjmrsbZGTWbA+VFXIzxXNE9Qtg88UrgkgfnUaE9BUwxmtBCquBxT8mmqecU73qiRy5NPB4pinBp2RVpksWmt6UE+9J25qkNDCOG74NMKmNsr90/pT/4iPWlBxz7c0twYDDCnqp9Kbt28j7pP5U4H0pp6kMmjPAzx70/HzdTimRnnB6U84xwMVRD3OG8ehLTxx8PtTuHC2cd5cWTseiSTR4Q/mCK6XWNCstaexi1RJM2V2l3A8chRo5F75Hb1FP8AEOjWfiHRLvStTRmtblQCUOGRgcq6nsynkVykeseLfDUItNd0O48SW0KhYtU0plMsijp5sLc78dSOvv1rZPniuV6oyfut8y0Z0nhbUNW1Syu5tcsls51vZooIghUtCrYRiD3PPTg1zng1hefEXx9qNuVa0Elpp4dTkNLFGd/5EgUybXfFviKI2vh/Qbjw9FKpWTVNXKiSEd/KhHJb0J4H6103hvRrLw5odtpWnBvIgBJkkOXlc8tI57sT/hRL3E77voJXk1bZGjvKfQ1KJDgc4quzjODSLKO+AaxUraGrV9SZ2Jpu7I9qjMuT1pN4/ChyBIk3cUx3AGM1G8oAqldXaxKSxCgVPN2HbqLdzhVPPSuY1G5M74H3AcH3pb3UGumKxkhP51TOGK4J4H+RXp4TCP8AiVDwsxzFNOlS+bDOCSTn3xSOyknqKAB6ngfpTcKAR83pmvTseFdCEknIBz3pysvBCkGkIXn5mxjkUhCgZyw57UrBcGccYXGOgqNnx0wD2pykZ7kd/X60mDnIA/wNFgv2GqSTznHqKDg5BP5n9aOhyG+gFNBBcYHbjNFh3FCnn5j16gU1sE5wTn1p5+9kHHP6U1mHQUASL93Pcr2OaaPlZQOTj160o2ggbdvGePWkUcruXH94VNx2BRkoc89s0mACuS3yn8qlyWCjA6/eHeo8kYyRnPBpgOl6kjhs8gCh2wz5PI6+/wBKaQ3bHXgVIQcEKoHHU9RQFiN/mLjPzEc46GlLc4zzt4OP880pwCQo4I5HpTchWPY4/wAkUXAkG4KufTA+nvTW2lUBJx0GP60qM24A4BI59/egltowOR196LgyNeAuQcZIx71X1CMPasQrZzyM/rVwM24YADAfTNKQzLggD39vSm9VYlaanHvKAxVgeDyv9RSmcMrg55/WrOpWrJIfmUfNkE/yrMkQgEb1yTkY5x7V50lZ2Z1J3JYZdlyHXOVcHB7iu802QMoIPHavNpSwzl8ZPYdDXb6FPus4d3XaK4cbFWUj2soqWlKB10OBirkPJFZVrLkgVqQMRgV5x9AXYjU4AxVdMfnU6niriSxSOMjrS5460hPORTTwTV2Fck3c07NQZIOB09aeG6UJisS00tmkBJ70mcGmmKwMNwGDgg9aB1+lL601ucYOGp7gTIR+FLj05H8qgDkEBhipQ/FJSuIcGx61KrnjNVmYZ4709GJA9qvmJsTB/mxmlL/LnioSRio92OO1HMKw+Trmoy3XIprSVE8vGaTYWHuQfQfjVdnIPtUctxj0qnNdkcEjFZ3GaXm47ioJrxYxlmAxWTPcyBSxO1cVzN3dyTzNvJ2g/KM10YahKvPlRzYvExw0Odq50V7ry5ZYAHb17Csia5luPnlbd6AdKpJkdOuOKsJwAvfsK9yjg6dHXdnzWJzCrX0bsuw/ccYxgAc8U7/ebBA64pEBxkbT9aUA/wAQB/qK6DhEBY55GOmcUm4+oJ9hSsCMen17U3BAAOPegBxfLdqQksAcqT2pGPTKjPv2oJAGML07+tIdgyVHUex9RUbtxg544+tSM/AyB7e1R7l55OOvFA7CLn+IAD+tDsCcknNMAABIH50Nyck4x6UgHk/LwOPWo92P4h+VBweQSSab05GARQCJVIVlwT04LUgKjaV3A+/ag5yOQ3HT1FPB+58wY9PrSGKm0Z5Yc5HtTSFDbtp69uhpy42gZ6GmLgFstj5vu+lAD5CGOR65z60SD5mIPOOCe9Icgsc456D+lEhO5+fqP8KABm5LMS3H+RQc7j3GOD6e1D/LkHGSO3QignPPbHX1oEKpywypxjn2NPIAxktx1x2qInkDJ6df6VKDnbycAUAImSVGCcdvSnIQB0xzyPT3pmcMuG47H/GpDyFw2Oe/8qdwM7V7YTQZBIIP+TXLOuxdpG75uf8AGu2lVmjHTnof6VyV4pSQjpljgjn8K5q8bNM1pszZGBTG043dP611Oh5OnQleoHeuYuCcYJA57Cun8PLu06Pb1ArzsWvcPXyz+IzprCUMgzwa2reTKDn2rmbdvL4YVr2z55U8eleUz6SL0N+M/KPWp1asyCRgOOatIzEdKqLBotlhgGmls8CosNnH8qcCavmJJCaQNzSA9aTk0XArLeX1xq1xp+kaFqGqTW8EVxM1tJboqLI0ioP3sqEkmJ+gPT3q0YPEx/5krWv/AAJsP/kmtT4W/wDI9eKOf+Ybp3/o29r1Gvaw+CpVKUZS3Z5VbF1IVHFbHjH2bxP/ANCVrX/gTYf/ACTSG28T9vBWtf8AgVYf/JNek654u0bRNRi0+9nuJNQlj85bWzs5ruby843lIUZguQRkgDIq94f1vT/EGmR6hpE5ntJCVDGNoyCDggqwDAg8YIBrb+zqPmZfXap5UbfxORhvBOsn/t6sP/kmmNa+KP4PBetfQ3Nh/wDJNe00UPLqL7h9dqniq23irv4L1n/wKsf/AJIpwt/FIP8AyJes/wDgVYf/ACTXqGv+IbTQ7zRba7jneTVbwWMBiUEK5R3y2SMDCHpk5xxWxR/Z1Hz+8PrtU8ZMHijH/Ila1/4E2H/yTTWt/FB/5krWv/Aqw/8AkmvYNQvIrC0e5nWd40wCIIHmfkgcIgLHr2HA5PAqn4p1u28N+HNR1q+SaS1sIHuJUhALlVGSFBIGfqRR/Z1HzD67VPJ3s/FTdPBes/8AgVY//JFV307xa3/Mmav/AOBVj/8AJFe0x38D6UuoMWjtjCLglhyqbd3IGe3pTdE1Wz1zSLPVNLm8+xu4lmhl2su9CMg4YAj8RS/s6j5h9dqniT6R4tfg+DdXx/19WP8A8kU0aJ4qByPBer59TdWP/wAkV7J4s8Q2nhjR/wC0r+OeSDz4bfbAoLbpZFjU8kDGXGeemetbFH9nUOwvrlU+e7nQPF8wI/4Q3VR6f6XY/wDyRWS/g3xo0rMPCGpc/wDT3Zf/AB+vpqit6OGhRd4GFeo8RHlmfM48HeM85PhDU/p9rsv/AI/Ug8JeMu/g7Usf9fdl/wDH6991TX7XTde0TSZ452udWeZIGQAopjjMjbiTkcDjAPPpWvXQcf1WmfN58KeMMY/4Q3U/X/j7sv8A5Iqhq1jrei/Yv7c8PX2nwXcxt4pZZ7Z18zy3kxiOVmHyxtzjHFfT9eWftA/8gnwv/wBhn/2zuqTRM8NCMW0eWl/lHycDpzStypPJHr7U3GMEdetGeOcgmpOEBk9efelZR1YZ96a3ydAfxNIMAfLjn3pXBAuR1xk0HngHvnimtwwwRxSFgxPJFAxQSMeg7moyQA2Tn6U5iW6fmaY31A9qSATOQAoalUkEEY4/nTTxjLGj8h+NAFgHGNy/lSxsABhO/IFMXh15wR69qF24BIYEH8vekgJS2cHAyT24zQ4I5AXAP+c1HgYyM9aUnP3lz7jvQA5mIYcKM+vagbiT0B9D2pCvzZ27h2J70pwyE4JwOtADG3ZccKOuPSnMx3HawXI5H9RSNj5js3DGM+lJgsx4GMfkaYMer5DAsASPz96ep4zkZ2/nTB91gRhgPTpQpy2MAcfMMd/WgBYwSy4I6Hj1p6g/KfUfnTVGDkgYxyP6ilyBt47UADKSF+XP9RXL342zMNueeR7etdTklQGyMVzOogeawbIHPI7VhX2RpT3Mi5PAAAzzn0IrqvDOTYQn0GDXJzuAi8MQP0Ndd4Y/48YwRjIzXm4r4D18t/iM32t/MXK9RzSW7NG3OcVZgBVQ1StAJVyvXPQV5Ul1R9DFkltNkgA81pxMxAPFYiq8TYYZq9BIR/ERRFls0vn44NSKrnjiq8UjY+8KsJJn0rRIhjvLfPJpBG2etO3+hpMmnZCuavwtUr468UAnP/Et07/0beV6jXl3wu/5HrxP/wBg3Tv/AEbe16jX0uE/gx9Dw8T/ABZHlfjqDT9M8bS6xH4sl8HanPapBJc3kML2V7GpYqAZON6luQGVsdsHNcpNr1x4hi8EX/xGit18Km5vorieaFobO6ddq2s8yPwiOA5UP8ucHuK9/orpMD5+8S3Pgq41TRtM0q18KQaAtpcz2+o6zDJc2hYy7Xhtod6K75GRtboRsBFYnh240a70L4Qv43ubSTS1h1aN5NRk2wkJIqxq+8424VQA5I4AOa+nKyNR0C1v/Eej61NJOt1paTpCiMAjCYKG3DGTjaMYI79aAPBrbTbTUbTw9aCEyeFLrxtN/ZcXzJG1mbWThOn7ov5mAOCD6GrOu2cGj3Pi/SrOFrXwjaeJdMe/tLZSsUNpJbxvNhF+7GXKlgOMZ7V9D0UAfNHi/wDs/wD4R/4i/wDCHfZ/+EN26Z5f2LH2T7X9pXzPJ2/L93Zu28Zx3p/xJfw++nfFT/hMTZv4pV3TSUvAGlW18hDCbYHkDcZNxTvndX0pRQBzj2Saj8O/sclulys+liPyXUMHzFgAg8GvDNBPhuw+Gvw6vtNGk20+maxp8viCS3WNJLdhFNHuutvKkM5GX6ZNfS1FAHzP4z1TTNY/4WhfWt1HcaXJqegg3ETHY6h4wzKw6jg4YcHqDV/xBGgm8bS/CPyjpA0KFLhtH+aF7rz8sYyhAaXyN+Sp3cryDX0TRQB89wDS18P+JxoHizw/dWp8NXpk0nQ9Oe3jJ8viaYGaQJKOnzBXbJznbxoa7oWkaN4N8DTtYQ22gXk9q3iG4VPmnj8hjGbmT7zxeYVzvJHIHSvdKKAPFJP+Ec/4TDwX/wAK7/s/7J9u1PH2L/j2+0fYf4MfJt+7nZ8uc981gfDLylm8PPd+K9H07xR9sVdUsU02RdVu5ed8VyxnJdSTneY9o+Urt6V9FUUAFeV/tA/8gjwvnP8AyGe3/XndV6pXlf7QX/II8L4OP+Jz/wC2d1QRU+B+h5YQD/ez6Up5YZB/+vSKOM800kggLyKg8kXoDkZwKacZ4UA9+aCfnOcfnTScNz0PWkMUgD7ppEPHHNITg46Uh67hmkAZA9APU0ZBx0B+lNGCScfKKQk7T8wA9aAGvknjJpCCB8oGPTPalAJ6ZI/rS+3AxQMmVuVHoTSq+4jnueDSckDGDz+P0oU/Tr0P8qQD0x03EYOcelIchzycZzgUwZCnBHB/L2pxc4OCox2PagRIcENuJ5546Uxv4uTnHbvRzuIJ2+3pQcfMAcD+7/hQMVsEkMT060vGTjkgY+opNy/NufAx09fcUhIBb3HbvTFYcxznGScY/wDrGk3YbndwMc9vaghcn5u3bvTmClskk8Y470AHIOcFsDH0oYjO0A8D8qMAnhj04/woG1jzuPHUfyoAAcjv04wOlYOqgrO2CB8vPvW8zBc/MemAR29qxdQ+aZuRn3FYV/hNKe5zl02fvE5I/MV2Hhj/AI9IfYdK5W/jxlsLnHPsa6rwycWkPrivMxT9w9fLf4jOri6DbVlFz8w4NVoCdoarak4BH5V5zPfiwcBsBxz/ADpBHz8pzTztYEH8KcqEUrXLHx/L16VOhA6VGm4dRU6AKelUiWPUj1pyn3pQBj7tC49KZNzL1TQtI1SdZ9T0nT72ZV2LJcWySMFyTjLAnGSePeqf/CH+GuMeG9G/8AYv/ia6AnrRkiqU5LRMXLHsYI8H+GeP+Kb0b/wBi/8AiaD4N8N/9C3ov/gDF/8AE1vhjQzHHFP2su7Dkj2OfPg7w2BgeHdGx/14xf8AxNIvg3w1/wBC5o//AIAxf/E1vh8jB/lTlfNPmlb4mHJHsYH/AAhfhrr/AMI7o3/gFF/8TTl8F+GOp8O6Of8Atxi/+JreB5p4HPUfhRzy7sOSPYwf+EN8Mf8AQt6L/wCAMX/xNNbwb4X7eHNFz/14xf8AxNdBimNxzVqcn1JcI9jAPg3wz/0Lmi/+AMX/AMTTJPB/hhUz/wAI7o3/AIAxf/E1v5wKrzuMHmh1JdyVCPY5yfwp4aAwvh/R8/8AXlF/8TWPd+GdAJKR6FpQI7izjH9K6a5lLcIapOuAD37VPtJPqVyR7HLah4b0KC2Zl0bTN2M/8esf+FYsOhaRs50rTj/27J/hXUa5IBCVB+tY0BOB09ea9fL23dtnh5q+VxSI08P6Mw/5BOm5/wCvZP8ACrCaBoYUE6Nph/7dU/wq0uR/dx3qyrdgenoK9Bnjcz7mcfD+hAj/AIk2nfT7Kn+FS2ujaVZ3AmtNMsoJk+5JHbojDIxwQM9CavbiSSDj8KE+YHJNIOZ9xynu2T7UMQDypJ9aQcLwD+JppYADIwPc8UCEcngbefrTsDHIprHntSA4PB5+lSA7PakJJ9setICxJ6/Smk5xuHHuaBgpODxj60Z+XkgD2FIzBR70quCeB07YpMAzwM5J6Uwdc8A0OWYk4x9TTACO4x3xQMtJjuD1604jOQfXr6j/ABpgKjjJ4OcUpYZPDZzyO1AgI9u/X1pwTqQAfSmthsDng9u9PYYbH3iO/rQAHJI6YHTPX6U5jwxUAKOx7UxuT0J9/UUmQxO0ZX1oAc2CWyAuBnFK2Y2IXAGM+v401/ucLz2Pp9aOQpz6flQIcyks+CM45/xFLvOWGccdu9NJwTyOAOvalxjcOBQMV3IZhxkikZsE/MfmHYdaa+MMOhx0oYkZHQkZ+vvTEK/Q4bnHp1rGvHInbcR+PetZgQ7duOQKxtTOLonOOmaxr/CXT3M+/TIJ2c+ua6Pw8MWsfY4rBuhujOBnPUg1t6Ax+zxj0rysV8J7GWv94zq7VsBc9K0I8MMZ+lZlscDPar0I4zmuE95EhjbecGpUyMZpyDjNSfX86mxVx8bKRUgx0qJcbsd6mUDdz1pgPH1ozzSH0OKTHoaolgDg1Jlcc1HjnFO2+uPrQA4gDpmkYUuMj2pp9qTQ7gUzTkXHakUmnAHNUgQ4UpxQCAKaz8cU9gYMcDmomahiSajc4HWi5A2WTC81nzsxGOAKsSNz3qu6EnJzikMrmP0JyahuMInABx2q4fkB/rWZfOdjEd6aQjmtZY/Zm7MWqhbkhFBwRirOtv8AIqj16VXiBCCvZy74Wz57NX76RdgPOBirCsD3xVVOnJ/SrCD5ec4PcV3s8klbp+FJtGeOlAP1/CmFucc0gsOckEZwR703GW+6PxPSkPOCRmgcc/L/AI0NgOBIzwMelNDBc8n8KN3B/mKAcHr19KQxWPPBY5ppADDj86aV7jqPekJI+8RQAp6k9aFJwfvY9RTQx28CjnHPApMaFfp0pCflGP0pueetNJJbjJFIGXmYc84wfSgsdxXOD7UwnO4AjAPT0pxOCT9PwoAG256kdOlDHLnknPp3pGIBbnnPbt9Kd8o3Z7+n86AFdhzzn+tNJJDFSfr60jH73PP86M8tznp0HWgQp+dT94kYAozzyGYdj/Q0r8ZOTkj86QYIJBPT86LgBPGAufTP8qdISchRgcZJ6qaaxUnOCc4/GkY4cnBIIwD6/WmArDnIx1p0hY5yqj8ajwMnjK0Bcn5Tkds9qYmSEfMTlV9R6ViatkTnLAD0x0rZbqeAP89Kx9WHz8Hvxmsq3wlw3KiOXU5xnPatnRsiPHvXPIxD4JG3PTuK39Gb90Oe9eVil7p6+XP96dNbOdoJrQt2yOMcdqybY4OOxrRiypyOleej6A048YweKkC8ZqvA2cdPrVlW9MGmA8DK5I/KpVJx6imJyOPypy5HT8qAFKnGepoJPHalzk8EU0g5yOaYhd2TTwc4qPbznGKM7TTTESFtppu8E8Un40u2i9hrUcrVItRAU8cd6Ex2HkcVG3NBJpCcDJNMlsYep5qN29BkCnOcjjgUzAGfSlsBAQ3J/KmE4XLD61JITxUUpyAoz70AQynOTWPeknK9q1ZjgetZV0P3ZYnBNNbiZy+ssPMjUDnOahjY45OKbq75vEPT2pUIxnJr3sCrUz5rM3eqWoyc896mXnpk4quh+tTDBU5z7EV1M80kLfU0DABIH600DgHPPc0ob5uOKTAVzhc8CkBz35+lDsB6ZpAwAyeOOopMYEggcmlHOO49SaZuwcgfjTs8dMUgAnGQQKZgY60Eg0g5PXFACnIx1xSdc9qa+eB/WlJ4wOtIdgBGOlIe55H40n8jTTxnOKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The abnormal orientation of the fingernails shown here demonstrates rotational deformity because of a metacarpal fracture. Normally, all fingers are directed toward the scaphoid and there should be no overlap or rotation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9798=[""].join("\n");
var outline_f9_36_9798=null;
var title_f9_36_9799="Functional mitral regurgitation";
var content_f9_36_9799=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Functional mitral regurgitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9799/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9799/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9799/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9799/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9799/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9799/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/36/9799/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with functional or secondary mitral regurgitation (MR), the papillary muscles, chordae, and valve leaflets are normal. There are two major causes of this problem: ischemia and any cause of dilated left ventricle. In these settings, MR may result from one or both of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Annular enlargement secondary to left ventricular dilatation (",
"      <a class=\"graphic graphic_figure graphicRef79932 \" href=\"UTD.htm?5/22/5476\">",
"       figure 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Papillary muscle displacement due to left ventricular remodeling, which results in tethering and excess tenting of the leaflet [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/2\">",
"       2",
"      </a>",
"      ]&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19865?source=see_link\">",
"       \"Cardiac remodeling: Basic aspects\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A rare cause of functional MR is standard right ventricular (RV) pacing. RV pacing simulates the effects of left bundle branch block, with dyssynchronous contraction of the left and right ventricles. This dyssynchrony may alter the timing and function of papillary muscles and mitral valve apparatus, resulting in MR that can be severe, even in the setting of otherwise normal cardiac structure and function [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/3\">",
"     3",
"    </a>",
"    ]. Dyssynchrony from either RV pacing or intrinsic conduction disease can be improved with biventricular (BiV) pacing. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Cardiac resynchronization therapy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Functional MR in association with systolic heart failure will be reviewed here. There is clear overlap between functional and ischemic MR, since the reports of functional MR due to heart failure include patients with ischemic cardiomyopathy. The clinical features and management of ischemic MR, including MR in association with myocardial infarction, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiographic studies of functional MR have shown that regurgitant flow varies during systole: there is an early systolic peak, a midsystolic decrease, and a late, smaller late systolic peak [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In one series, the respective values for regurgitant flow at these three time periods were 144, 13, and 62",
"    <span class=\"nowrap\">",
"     mL/sec",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/5\">",
"     5",
"    </a>",
"    ]. These variations occur in association with parallel changes in regurgitant orifice area and are more closely associated with changes in transmitral pressure, which drives the leaflets toward closure, than mitral annular area [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ratio of flow at the two peaks also correlates with QRS duration, and cardiac resynchronization therapy, which shortens QRS duration, reduces the early but not the late regurgitant peak [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Cardiac resynchronization therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It has been suggested that mitral valve tenting is the most powerful predictor of functional MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/2\">",
"     2",
"    </a>",
"    ]. Tenting results from tethering of the leaflet, which is due to papillary muscle displacement secondary to left ventricular remodeling. Reduced tethering and therefore tenting may be a major mechanism of the long-term benefit of cardiac resynchronization therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although patients with advanced heart failure can develop left ventricular thrombus, the frequency is much reduced in those with functional MR. In a series of 91 patients, 57 percent had MR and 40 percent had left ventricular thrombus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/6\">",
"     6",
"    </a>",
"    ]. However, both MR and thrombus were present in only 8 percent, presumably due to the significantly higher flow rates in both diastole (15 versus 9",
"    <span class=\"nowrap\">",
"     cm/sec)",
"    </span>",
"    and systole (29 versus 16",
"    <span class=\"nowrap\">",
"     cm/sec)",
"    </span>",
"    in patients with MR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=see_link\">",
"     \"Indications for antithrombotic therapy in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some degree of functional MR is almost always present in patients with severe dilated cardiomyopathy, regardless of etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ]. The determination of MR severity is typically made by echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    .) The frequency of functional MR can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A review of 50 patients with dilated cardiomyopathy (36 idiopathic, 14 ischemic) referred for heart transplantation found that all patients had at least moderate MR by Doppler echocardiography [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/7\">",
"       7",
"      </a>",
"      ]. Left ventricular volume and mitral annular dilatation were more pronounced in patients with idiopathic disease.",
"     </li>",
"     <li>",
"      A second report consisted of a chart review of 1241 consecutive patients with an LVEF &le;35 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/8\">",
"       8",
"      </a>",
"      ]. Echocardiography in these patients with less severe disease revealed that 49 percent had moderate to severe MR and 34 percent had moderate to severe tricuspid regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Functional MR is also a common problem in patients with end-stage renal disease on maintenance dialysis. In this setting, volume expansion rather than intrinsic cardiac disease is primarily responsible for the cardiac enlargement. One study of 21 hemodialysis patients with both mitral and tricuspid regurgitation assessed whether valvular regurgitation disappeared with aggressive ultrafiltration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/9\">",
"     9",
"    </a>",
"    ]. After intensified sessions resulting in a decrease in body weight of approximately 5.4 kg, mitral and tricuspid regurgitation vanished on echocardiography in 13 and 14 patients, respectively. Among those with persistent abnormalities, the degree of regurgitation was much less severe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data from retrospective observational studies on the prognostic significance of functional MR in patients with left ventricular systolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/6,8,10\">",
"     6,8,10",
"    </a>",
"    ]. In the chart review of 1241 consecutive patients described above, patient survival at a mean follow-up of one year varied inversely with MR grade: 1004, 795, and 628 days with no to mild, moderate, and severe MR, respectively. Severe MR was an independent predictor of mortality (hazard ratio 1.85).",
"   </p>",
"   <p>",
"    A similar relationship was noted with the severity of functional tricuspid regurgitation, resulting from right ventricular dilatation and enlargement of the tricuspid valve annulus. Severe MR and TR often occurred together. Data on medical therapy and other prognostic factors were not available.",
"   </p>",
"   <p>",
"    Right ventricular dysfunction may be a predictor of poor outcome among patients with functional MR. In a prospective study of 356 chronic HF patients with LVEF &le;45 percent and moderate to severe MR, right ventricular systolic function (as assessed by tricuspid annular plane systolic excursion) was an independent predictor of freedom from all-cause mortality or hospitalization for worsening HF [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/11\">",
"     11",
"    </a>",
"    ]. Those with tricuspid annular plane systolic excursion &le;14 mm had an absolute two-year mortality that was 27 percent higher than those with an excursion &gt;14 mm. Pulmonary artery systolic hypertension was a predictor of mortality upon univariate but not multivariate analysis and pulmonary artery systolic pressure was not significantly different in the groups with and without evidence of right ventricular systolic dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with MR due to primary valve disease, functional MR imposes a hemodynamic load on the left ventricle, contributing to eccentric hypertrophy and dilatation that increases the degree of MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given an unproven long-term survival benefit from mitral valve repair, treatment of functional MR should emphasize optimal medical therapy of HF and, in appropriate patients, cardiac resynchronization therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/12\">",
"     12",
"    </a>",
"    ]. If mitral valve repair is considered as an alternative to transplantation, the patient should be informed that, although symptoms are often improved (",
"    <a class=\"graphic graphic_figure graphicRef61873 \" href=\"UTD.htm?39/5/40029\">",
"     figure 2",
"    </a>",
"    ), there is no clear evidence of a long-term survival benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with functional MR and heart failure due to systolic dysfunction should receive standard therapy that includes an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker, a beta blocker, an aldosterone antagonist, and a diuretic. Large randomized clinical trials have shown that these drugs improve cardiac function, relieve symptoms, and enhance survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More limited data suggest that ACE inhibitors and beta blockers also reduce left ventricular volumes and the degree of functional MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/1,13-17\">",
"     1,13-17",
"    </a>",
"    ]. The supporting evidence primarily comes from small studies and can be illustrated by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a randomized trial, 28 patients with chronic systolic heart failure (mean LVEF 29 percent) were randomly assigned to increasing doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"       captopril",
"      </a>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/13\">",
"       13",
"      </a>",
"      ]. All patients had functional MR with at least 5 cm2 regurgitant area on color flow Doppler. Among the 23 patients who completed the study, the 10 treated with captopril had 3.1 and 5.3 cm2 reductions in regurgitant area at doses of 50 and 100",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      respectively, in association with an increase in forward stroke volume.",
"     </li>",
"     <li>",
"      In a second report, 45 consecutive patients with chronic ischemic and nonischemic heart failure (mean LVEF 24 percent) were treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9577?source=see_link\">",
"       carvedilol",
"      </a>",
"      and compared to a matched control group [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/15\">",
"       15",
"      </a>",
"      ]. The patients receiving carvedilol had an increase in LVEF (24 to 29 percent), a reduction in left ventricular end-systolic volume, and a significant fall in mitral regurgitant stroke volume (50 versus 16",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      compared to no significant difference [57 versus 47",
"      <span class=\"nowrap\">",
"       mL/min])",
"      </span>",
"      in the control group. The reduction in mitral regurgitation was closely associated with an increase in forward aortic stroke volume.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, fluid removal in patients with end-stage renal disease also may be beneficial, eliminating or reducing the severity of MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mitral valve repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral valve repair, specifically mitral annuloplasty, has been proposed for selected patients with functional MR due to systolic heart failure, although supportive data are limited to observational studies. Although symptoms may improve following mitral valve repair, there is no clear evidence of a long-term mortality benefit.",
"   </p>",
"   <p>",
"    The efficacy of mitral valve repair in patients with nonischemic dilated cardiomyopathy will be reviewed here. Valve repair may also be part of more complex surgery, including coronary artery bypass graft in patients with ischemic cardiomyopathy and viable myocardium or ventricular reconstruction or volume reduction surgery as with the Dor procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35143?source=see_link\">",
"     \"Surgical management of heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the early years, mitral valve replacement in patients with advanced heart failure carried an extremely high surgical mortality and was largely performed out of desperation in critically ill patients. As surgeons gained more experience and expertise with mitral valve repair, the surgical mortality improved substantially and the use of mitral valve repair for patients with dilated cardiomyopathy has become a reasonable option, even when mitral regurgitation is not severe [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both experimental and clinical observations have demonstrated that left ventricular performance is improved when the subvalvular apparatus, including the chordal and papillary muscles (",
"    <a class=\"graphic graphic_figure graphicRef79932 \" href=\"UTD.htm?5/22/5476\">",
"     figure 1",
"    </a>",
"    ), is left intact [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/19\">",
"     19",
"    </a>",
"    ]. Factors that generally preclude mitral valve repair in patients with heart failure include primary mitral valve dysfunction, significant aortic insufficiency, and long-standing mitral regurgitation antedating the onset of left ventricular dysfunction. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=see_link&amp;anchor=H18#H18\">",
"     \"Surgical procedures for severe chronic mitral regurgitation\", section on 'Chordal preservation'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In small studies of selected patients, mitral valve repair in patients with cardiomyopathy led to a reduction in end-diastolic volume and an improvement in left ventricular performance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Mitral regurgitation diminished and, when patients were studied four months after surgery, there was frequently an increase in both left ventricular ejection fraction and cardiac output (",
"    <a class=\"graphic graphic_figure graphicRef79564 \" href=\"UTD.htm?32/55/33662\">",
"     figure 3",
"    </a>",
"    ). These hemodynamic benefits were associated with an improvement in heart failure symptoms and exercise tolerance (",
"    <a class=\"graphic graphic_figure graphicRef61873 \" href=\"UTD.htm?39/5/40029\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Long-term outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are only limited long-term follow-up data regarding mitral valve repair for severe heart failure associated with severe MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. The largest study to date was performed at a single center and attempted to assess the difference in patient survival between mitral valve repair and medical therapy alone in functional MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/23\">",
"     23",
"    </a>",
"    ]. Among 419 patients who were deemed to be surgical candidates (LVEF &le;30 percent, moderate to severe MR, and no cardiogenic shock or significant comorbidity or other valvular disease), mitral valve repair was performed in 126 (30 percent).",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      30-day postoperative mortality was 4.8 percent",
"     </li>",
"     <li>",
"      At long-term follow-up (to &gt;2000 days), there was no significant difference in patients who did or did not undergo mitral valve repair in terms of mortality (48 versus 38 percent with medical therapy alone) or in the combined end point of death, implantation of a left ventricular assist device, or urgent heart transplantation (49 versus 41 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the baseline characteristics and medical therapy in the two groups were largely similar, confounding by indication (ie, operating on sicker patients) could not be completely excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/12\">",
"     12",
"    </a>",
"    ]. Only a randomized trial can definitively determine whether or not surgery is associated with a mortality benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lack of proven long-term benefit of mitral valve repair or replacement for functional MR is reflected in published guidelines from major societies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The 2005",
"      <span class=\"nowrap\">",
"       ACC/AHA",
"      </span>",
"      heart failure guidelines note that the effectiveness of mitral valve repair or replacement for severe secondary mitral regurgitation in refractory end-stage HF is not established (",
"      <a class=\"graphic graphic_table graphicRef68693 \" href=\"UTD.htm?15/22/15724\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The 2010 Heart Failure Society of America (HFSA) practice guidelines note that isolated mitral valve repair or replacement for severe mitral regurgitation secondary to ventricular dilatation in the presence of severe LV systolic dysfunction is not generally recommended [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The 2006 International Society for Heart and Lung Transplantation (ISHLT) guidelines for cardiac transplant candidates note that isolated mitral valve repair (not associated with revascularization or ventricular restoration) should not be routinely performed in patients with advanced LV dysfunction and HF [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cardiac resynchronization therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pacing modalities that provide atrial-synchronized biventricular (BiV) or left ventricular stimulation to optimize cardiac pump function are referred to as cardiac resynchronization therapies (CRT). CRT improves survival in selected patients with systolic heart failure who have ventricular dyssynchrony as manifested by a QRS duration &ge;150 msec. A detailed discussion of the rationale, benefits, and data supporting CRT is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10823?source=see_link\">",
"     \"Rationale for and mechanisms of benefit of cardiac resynchronization therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As mentioned above, right ventricular pacing induces ventricular dyssynchrony and functional MR [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/3\">",
"     3",
"    </a>",
"    ]. On the other hand, CRT often improves functional MR in patients with ventricular dyssynchrony. The acute effects of CRT on functional MR were evaluated in a study of 24 patients with BiV pacemakers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/27\">",
"     27",
"    </a>",
"    ]. The effective regurgitant orifice area was assessed during BiV pacing and with BiV pacing turned off. Active CRT was associated with almost a 50 percent reduction in the effective regurgitant orifice area (25 to 13 mm2), which may have resulted from more coordinated left ventricular contraction. Long-term benefits were noted in the CARE-HF and MIRACLE randomized trials of CRT [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Compared to controls, CRT produced significant reductions in LV end-systolic and end-diastolic dimensions and in mitral regurgitant jet area (eg, -2.7 versus -0.5 cm2 at six months in MIRACLE) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The preceding observations were made in patients with predominantly mild (1+) to moderate (2+) MR. The impact of CRT on moderate to severe (3+) to severe MR (4+) was evaluated in a study of 98 patients with indications for CRT [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/30\">",
"     30",
"    </a>",
"    ]. In the 85 patients surviving to eight months follow-up, significant improvement in MR (reduction by at least one grade) occurred in 42 patients (49 percent). An ischemic cause of HF was significantly more common in MR nonimprovers than among MR improvers (74 versus 48 percent). Survival rates were higher in MR improvers as compared to MR nonimprovers (97 versus 88 percent at one year and 92 versus 67 percent at two years). MR improvement was an independent predictor of survival (hazard ratio 0.35, 95% CI 0.13 to 0.94). The findings suggest a significant benefit from CRT in this population and also highlight the importance of careful patients selection for this treatment, particularly in patients with ischemic MR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/17/11545?source=see_link&amp;anchor=H10#H10\">",
"     \"Cardiac resynchronization therapy in heart failure: Implantation and other considerations\", section on 'Scar burden'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    The benefits of CRT rapidly wane if therapy is discontinued. The magnitude of this effect was illustrated in a report of 20 patients with advanced HF treated with CRT for a median of 427 days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9799/abstract/31\">",
"     31",
"    </a>",
"    ]. At 72 hours after elective temporary cessation of biventricular pacing, there were significant increases in mitral effective regurgitant orifice area (4.8 to 9.1 mm2) and mitral regurgitant volume (7.8 to 16.0 mL) and regurgitant fraction (13.8 to 27.7 percent). These changes were associated with a significant and marked decline in the maximal rate of rise of left ventricular systolic pressure (711 to 442",
"    <span class=\"nowrap\">",
"     mmHg/sec).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22402150\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Functional mitral regurgitation is generally caused by annular enlargement secondary to left ventricular dilatation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      papillary muscle displacement due to left ventricular remodeling. Right ventricular pacing is a rare cause of functional MR. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some degree of functional MR is almost always present in patients with severe dilated cardiomyopathy, regardless of etiology. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Prevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The severity of functional MR in patients with systolic dysfunction may be a predictor of mortality. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with functional MR and heart failure due to systolic dysfunction should receive standard therapy that includes an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker, a beta blocker, an aldosterone antagonist, and a diuretic. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Medical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Isolated mitral valve repair or replacement for severe mitral regurgitation secondary to ventricular dilatation in the presence of severe LV systolic dysfunction is not generally recommended since there is no proven mortality benefit. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac resynchronization therapy (CRT) improves survival in selected patients with systolic heart failure and QRS duration &ge;150 msec. CRT may reduce functional MR in some patients, particularly those with nonischemic cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Cardiac resynchronization therapy'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/1\">",
"      Trichon BH, O'Connor CM. Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated? Am Heart J 2002; 144:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/2\">",
"      Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation 2000; 102:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/3\">",
"      Barold SS, Ovsyshcher IE. Pacemaker-induced mitral regurgitation. Pacing Clin Electrophysiol 2005; 28:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/4\">",
"      Hung J, Otsuji Y, Handschumacher MD, et al. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol 1999; 33:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/5\">",
"      Fukuda S, Grimm R, Song JM, et al. Electrical conduction disturbance effects on dynamic changes of functional mitral regurgitation. J Am Coll Cardiol 2005; 46:2270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/6\">",
"      Blondheim DS, Jacobs LE, Kotler MN, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991; 122:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/7\">",
"      Strauss RH, Stevenson LW, Dadourian BA, Child JS. Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. Am J Cardiol 1987; 59:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/8\">",
"      Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/9\">",
"      Cirit M, Ozkahya M, Cinar CS, et al. Disappearance of mitral and tricuspid regurgitation in haemodialysis patients after ultrafiltration. Nephrol Dial Transplant 1998; 13:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/10\">",
"      Conti JB, Mills RM Jr. Mitral regurgitation and death while awaiting cardiac transplantation. Am J Cardiol 1993; 71:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/11\">",
"      Dini FL, Conti U, Fontanive P, et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 2007; 154:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/12\">",
"      Mehra MR, Griffith BP. Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. J Am Coll Cardiol 2005; 45:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/13\">",
"      Seneviratne B, Moore GA, West PD. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J 1994; 72:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/14\">",
"      Keren G, Pardes A, Eschar Y, et al. One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo. Isr J Med Sci 1994; 30:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/15\">",
"      Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/16\">",
"      Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999; 83:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/17\">",
"      Groenning BA, Nilsson JC, Sondergaard L, et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000; 36:2072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/18\">",
"      Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg 2001; 71:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/19\">",
"      Carabello BA. Is it ever too late to operate on the patient with valvular heart disease? J Am Coll Cardiol 2004; 44:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/20\">",
"      Bach DS, Bolling SF. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995; 129:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/21\">",
"      Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/22\">",
"      Chen FY, Adams DH, Aranki SF, et al. Mitral valve repair in cardiomyopathy. Circulation 1998; 98:II124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/23\">",
"      Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005; 45:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/24\">",
"      Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:e391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/25\">",
"      Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010; 16:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/26\">",
"      Martin-Rendon E, Hale SJ, Ryan D, et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007; 25:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/27\">",
"      Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003; 41:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/28\">",
"      Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/29\">",
"      Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/30\">",
"      van Bommel RJ, Marsan NA, Delgado V, et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation 2011; 124:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9799/abstract/31\">",
"      Brandt RR, Reiner C, Arnold R, et al. Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy. Eur Heart J 2006; 27:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8144 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-2.133.93.82-D9A3241E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9799=[""].join("\n");
var outline_f9_36_9799=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22402150\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mitral valve repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Long-term outcomes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cardiac resynchronization therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22402150\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8144\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8144|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/22/5476\" title=\"figure 1\">",
"      Mitral valve structure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/5/40029\" title=\"figure 2\">",
"      MV repair symptom heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/55/33662\" title=\"figure 3\">",
"      MV repair in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8144|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/22/15724\" title=\"table 1\">",
"      ACC AHA Rx refractory HF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19865?source=related_link\">",
"      Cardiac remodeling: Basic aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/17/11545?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Implantation and other considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=related_link\">",
"      Diagnosis and management of ischemic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7048?source=related_link\">",
"      Indications for antithrombotic therapy in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/36/10823?source=related_link\">",
"      Rationale for and mechanisms of benefit of cardiac resynchronization therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35143?source=related_link\">",
"      Surgical management of heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=related_link\">",
"      Surgical procedures for severe chronic mitral regurgitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_36_9800="T wave (repolarization) alternans: Technical aspects";
var content_f9_36_9800=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   T wave (repolarization) alternans: Technical aspects",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Sanjiv M Narayan, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9800/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/36/9800/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;T-wave alternans (TWA) refers to beat-to-beat variability in the timing or shape of T-waves on the surface electrocardiogram (ECG) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. TWA therefore reflects temporal heterogeneity in ventricular repolarization, which is an important mechanism underlying reentrant arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the term \"T-wave\" alternans, alternating behavior may also involve the ST segment and U wave (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/2,5-8\">",
"     2,5-8",
"    </a>",
"    ]. As a result, the term repolarization alternans may be more accurate, but is rarely used.",
"   </p>",
"   <p>",
"    TWA does not involve the QRS complex and is distinct from electrical alternans totalis. This term refers to an alternating axis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    voltage of all ECG components and is typically seen with the cardiac motion associated with large pericardial effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23669?source=see_link\">",
"     \"Electrocardiogram in pericarditis and pericardial effusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TWA was first linked to ventricular arrhythmias in the early 1900s in cases that were evident on visual inspection of the ECG [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Visually apparent TWA was subsequently reported in a variety of settings including ischemia and long QT syndrome (LQTS) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TWA of sufficient magnitude to be seen with visual inspection is uncommon. With the recent development of computerized filtering and spectral analysis tools, TWA on the order of microvolts can be detected, and microvolt TWA (MTWA, now often used synonymously with TWA) is both sensitive and specific for predicting ventricular arrhythmias in a number of clinical scenarios [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/1,2,7,14-21\">",
"     1,2,7,14-21",
"    </a>",
"    ]. TWA has been approved by the United States Food and Drug Administration (FDA) for noninvasively predicting the risk for life-threatening ventricular arrhythmias.",
"   </p>",
"   <p>",
"    TWA may accompany pulsus (mechanical) alternans in severe cardiac failure, but may occur without mechanical alternans, and vice versa [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4,22-24\">",
"     4,22-24",
"    </a>",
"    ]. In patients with congestive heart failure (CHF), mechanical alternans has been noted in tandem with alternans of muscle sympathetic activity and audible vascular bruits [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Alternating behavior unrelated to TWA has also been reported in conduction through the atrioventricular node and bundle branches, and in pacemaker firing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Alternate-cycle periodicity has also been described in a number of other pathologic processes, including nystagmus and spasmodic torticollis, among other conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The technical aspects of TWA will be reviewed here. The clinical utility is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5898?source=see_link\">",
"     \"T wave (repolarization) alternans: Clinical aspects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE PATHOPHYSIOLOGY OF TWA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Until recently, microvolt and macrovolt-level TWA were considered to be distinct entities. However, studies from isolated guinea pig and rabbit hearts now suggest that these forms of TWA may differ only quantitatively and represent the same pathophysiological processes of dispersion of repolarization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4,32\">",
"     4,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distinct hypotheses have been proposed to explain TWA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4,33\">",
"     4,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tissue heterogeneity is the primary mechanism &mdash; According to this hypothesis, dispersion of repolarization results in differences in electrical recovery time and conduction among myocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. Longer recovery time, or delayed activation time, in some myocytes may alter their depolarization from beat-to-beat [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/32,36,37\">",
"       32,36,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alternatively, TWA may be due to dynamic functional tissue factors. These include the rate-dynamics (restitution) of repolarization and conduction velocity [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. Steep restitution of repolarization enable small variations in beat-to-beat timing to be amplified and lead to large alternans of action potential duration (and TWA) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/36\">",
"       36",
"      </a>",
"      ]. Similarly, very early beats may engage restitution of conduction, enabling conduction slowing that also contributes to TWA and potentially arrhythmogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/38\">",
"       38",
"      </a>",
"      ]. These mechanisms may be exaggerated by altered activation sequence (eg, an ectopic beat), or existing tissue heterogeneity [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Newer evidence suggests that the above mechanisms may not contribute to clinical TWA, even though they clearly explain repolarization alternans in animals. The major reason for this departure in thinking is that clinical TWA must be measured at relatively slow heart rates in order to be predictive (&le;109",
"      <span class=\"nowrap\">",
"       beats/min)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/39\">",
"       39",
"      </a>",
"      ]. However, these heart rates do not engage steep APD or conduction restitution, and APD therefore does not fluctuate at these relatively slow heart rates [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Instead, the mechanism for TWA, and its arrhythmic link in patients at risk for sudden cardiac arrest may be influenced by mechanical and ionic abnormalities in heart failure. Acute volume overload exaggerates TWA in a canine model, suggesting a role for mechanical stretch [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/41\">",
"       41",
"      </a>",
"      ]. At the ionic level, abnormal calcium cycling is increasingly emphasized in the etiology of TWA, and may underscore the prevalence of TWA in patients with heart failure and cytosolic calcium loading [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4,42\">",
"       4,42",
"      </a>",
"      ]. Pharmacologic models of long QT syndrome in perfused wedge and intact canine ventricle also emphasize the importance of L-type calcium channel fluxes in causing TWA [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. Notably, ionic mechanisms for TWA may differ between disease states and species: in Langendorff-perfused (normal) guinea pig heart, TWA may reflect abnormalities in the transient outward current (Ito), delaying full repolarization of certain myocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/32\">",
"       32",
"      </a>",
"      ]. Cellular explanations of TWA in humans await further study.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once it has arisen, TWA results in a dispersion of repolarization that may cause evanescent barriers to conduction, with wavefront fractionation and predisposition to reentry in isolated guinea pig hearts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/32\">",
"     32",
"    </a>",
"    ]. This is particularly true under conditions that cause TWA to become discordant [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4,35\">",
"     4,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=see_link\">",
"     \"Reentry and the development of cardiac arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An important issue relates to the relationship between T-wave and mechanical alternans. Studies in ischemic canine and porcine ventricles have shown that visible TWA accompanies mechanical alternans [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/24,45,46\">",
"     24,45,46",
"    </a>",
"    ]. Since this association holds even in paced isolated feline myocytes, it is likely, although not universally true, that microvolt-level TWA yields a mechanical effect [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/47\">",
"     47",
"    </a>",
"    ]. Further study on electromechanical alternans is required to explain, among other observations, why their phases may be differentially affected by ischemia, intracellular calcium loading, rhythm disturbances, and other processes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/24,43,47\">",
"     24,43,47",
"    </a>",
"    ]. Finally, studies have demonstrated that alternans in human atrial repolarization may provide an index of vulnerability to atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     METHODS FOR ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;TWA was first determined by visual inspection, allowing the detection of electrocardiogram (ECG) changes on the order of 50 to 100 mV to be resolved by routine ECG amplification; resolution beyond this is limited by biologic, electrode, and electronic noise (and even by the thickness of ink on traditional ECG pen-plotters) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. However, such large TWA is rarely seen in patients at risk for sudden cardiac death; rather, TWA of a few microvolts discriminates patients at risk for SCD from ventricular tachycardia (VT) or ventricular fibrillation (VF) from those at low risk [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/44\">",
"     44",
"    </a>",
"    ]. Recent studies have therefore used Fourier spectral decomposition, which provides excellent sensitivity for detecting TWA. Time domain approaches have also been described and may enable the study of temporally varying TWA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regardless of the analytic method used, ECG data are first collected from the 12 standard leads of a surface ECG or, orthogonal Frank XYZ leads [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. Concentric Laplacian electrodes are often used commercially to reduce movement noise via spatial averaging and 'far-field' subtraction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/20,44,50\">",
"     20,44,50",
"    </a>",
"    ]. ECG data are subsequently digitized and analyzed for TWA, using either commercial TWA analysis systems or a variety of custom, user-written software packages [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Spectral methods of frequency decomposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spectral decomposition can detect very low amplitude ECG fluctuations by exploiting the concept that, by definition, TWA is periodic at a frequency of half-the-heart-rate immersed in noise with different spectral characteristics. Frequency decomposition represents consecutive ECG beats as a voltage time series. Decomposition of points in this series using the Fourier transform generates a series of sine waves that describes their periodicity; alternans represents the special case of alternate-beat periodicity.",
"   </p>",
"   <p>",
"    ECG sequences are first identified, excluding ectopy, fusion complexes, or other disruptions to periodicity that can artifactually degrade (or potentially augment) spectrally determined TWA magnitude [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/7\">",
"     7",
"    </a>",
"    ]. Sequences are typically analyzed over 2n beats, where n is typically 6 or 7 (thus, 64 to 128 beats), so that efficient fast Fourier transform (FFT) algorithms may be used, although the discrete Fourier transform (DFT) may be used for arbitrary length sequences.",
"   </p>",
"   <p>",
"    Beats are then baseline-corrected to the mean of the T-P segment and registered in time to allow corresponding time points within repolarization to be compared between beats (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    ). Although several alignment strategies may be used, we have found that cross-correlation alignment is superior to other methods, such as alignment to pacing artifacts during pacing, QRS fiducials, or peak QRS voltage or JT alignment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/7\">",
"     7",
"    </a>",
"    ]. Cross correlation (dot-product) QRS alignment has two phases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      QRS complexes are aligned to a chosen template QRS",
"     </li>",
"     <li>",
"      This array of template-aligned beats is used to calculate a mean QRS complex, which serves as the template for a second alignment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional iterations are not typically required, since the mean squared error of beats converges after two iterations [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/51\">",
"     51",
"    </a>",
"    ]. Similarly, aligning beats to a precision exceeding 1 ms by linear interpolation does not significantly reduce inter-beat mean-squared error [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TWA is then computed using multidimensional spectral analysis. User defined JT intervals in the series are represented as a 2-D matrix JT (n, t), where \"n\" indicates beat number (0&lt;n&lt;63 or 127), and \"t\" the time point (within the JT duration). Most work to date has concentrated on the entire JT interval, although JT sub-regions have recently been analyzed (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/21,44\">",
"     21,44",
"    </a>",
"    ]. A Fast Fourier Transform (FFT) is used to compute power spectra on unwindowed time-series, column-wise for all rows (across successive QRS-aligned beats for consecutive J-T time points) (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Power spectra are summated into a composite in which the magnitude at 0.5",
"    <span class=\"nowrap\">",
"     cycles/beat",
"    </span>",
"    indicates raw alternans, ST (in mV2) (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    ). The dimensionless T-wave alternans ratio (TWAR) represents the difference between alternans and non-alternating periodicity (spectral noise mean), prospectively defined within an adjacent bandwidth such as 0.33 to 0.48",
"    <span class=\"nowrap\">",
"     cycles/beat,",
"    </span>",
"    measured in units of the standard deviation of noise (all in mV2) (",
"    <a class=\"graphic graphic_figure graphicRef59117 \" href=\"UTD.htm?34/51/35645\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/21\">",
"     21",
"    </a>",
"    ]. TWAR greater than 0 indicates TWA detectable above noise; TWAR greater than or equal to 3 has been shown to predict ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/2\">",
"     2",
"    </a>",
"    ]. The mean absolute voltage difference of alternation (V",
"    <sub>",
"     alt",
"    </sub>",
"    ), across the JT interval, may also be estimated (",
"    <a class=\"graphic graphic_figure graphicRef52566 \" href=\"UTD.htm?22/46/23264\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef74249 \" href=\"UTD.htm?20/59/21437\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Limitations of spectral decomposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although very sensitive, spectral decomposition assumes that TWA is of uniform magnitude within the analyzed sequence; it cannot, therefore, study non-stationary TWA. Analysis is also sensitive to the sequence length (number of RR intervals) analyzed; longer sequences imply sustained TWA but average its magnitude and increase the likelihood of ectopy occurring within them, while shorter sequences run the risk of detecting TWA when alternation is transient (the limit case being two dissimilar beats). The optimum number of analyzed beats has yet to be determined, but 64 or 128 are typical [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/2,7,17\">",
"     2,7,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Computational variables",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectral noise window may significantly affect both T-wave alternans ratio (TWAR) and mean absolute voltage difference of alternation (V",
"    <sub>",
"     alt",
"    </sub>",
"    ). While some studies define noise in a remote bandwidth, others have selected a bandwidth adjacent to alternating periodicity (such as 0.33 to 0.48",
"    <span class=\"nowrap\">",
"     cycles/beat)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. Since TWA may smear around the 0.5",
"    <span class=\"nowrap\">",
"     cycles/beat",
"    </span>",
"    frequency from respiratory modulation of ECG amplitude, the non-stationary manner of TWA, and R-R interval variability, TWA detection becomes more specific when adjacent frequencies are included in the noise term.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Measurement noise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement noise ultimately limits the sensitivity of any detection method for microvolt-level TWA, although the spectral method is relatively noise insensitive. Biologic noise often occupies distinct spectra from that of TWA. However, other alternate-beat periodicities may occur; individuals have a tendency to pedal at a sub-harmonic of heart rate during bicycle ergonometry, which artifactually creates alternans and must be avoided. Although respiratory periodicity is prominent at 0.16 to 0.22",
"    <span class=\"nowrap\">",
"     cycles/beat,",
"    </span>",
"    harmonics of this fundamental may occur at the alternans frequency, degrading detection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/51\">",
"     51",
"    </a>",
"    ]. Less significant biologic noise includes muscular activity and other oscillations. Technical factors include noise from electrode contact and electrical connections and are generally of low amplitude.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other spectral methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several other spectral methods that have been used to measure TWA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Complex demodulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complex demodulation has been applied successfully to elegant demonstrations of TWA in acutely ischemic canine ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/6,53,54\">",
"     6,53,54",
"    </a>",
"    ]. Complex demodulation models alternate periodicity using sinusoids of variable amplitude and phase. Unlike the Fourier Transform, relatively few beats are required for analysis, which may increase its temporal resolution for studying non-stationary TWA. The TWA uncovered by complex demodulation thus far, however, are large, and the sensitivity of this method for clinical TWA in the 1 to 10 mV range has yet to be demonstrated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Karhunen-Loeve (KL) Transform",
"    </span>",
"    &nbsp;&mdash;&nbsp;Karhunen-Loeve (KL) Transform is another method of decomposing the shape of the ST-T segment into a series of frequency functions to determine TWA magnitude. One study has successfully applied the KL transform to demonstrate TWA after acute LAD ligation in dogs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Time-domain methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Time-domain methods quantitate beat-to-beat electrocardiogram (ECG) alternation without relying on a mathematical description of periodicity and may therefore be used to assess non-stationary TWA. Time-domain methods also require a lower computational overhead. However, these advantages come at a theoretical cost of reduced sensitivity at the microvolt-level, and while their clinical utility for VT risk stratification has been established in several thousand patients with a wide range of comorbid conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/56\">",
"     56",
"    </a>",
"    ], they have yet to be compared to spectral methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Modified moving average (MMA) method",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been considerable interest in this approach which creates a weighted rolling average of beats in alternate odd and even bins [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/4\">",
"     4",
"    </a>",
"    ]. After a series of beats have been averaged in this fashion, their subtraction produces T-wave alternans magnitude. This method has been applied to routine ambulatory recordings has been shown to predict clinical events [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/57\">",
"     57",
"    </a>",
"    ]. Recently, a small prospective study compared MMA to spectral computation of TWA in patients at risk for SCD followed for three years [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/58\">",
"     58",
"    </a>",
"    ]. The results showed that MMA amplifies the magnitude of TWA, but at the cost of specificity. Conversely, two additional studies found that the MMA method had value, both in post-MI patients with mild-moderate systolic dysfunction and unselected patients undergoing stress testing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Nevertheless, further studies are required to validate whether this method can be used to stratify patients with traditional indications for ICD implantation. This approach is implemented commercially in electrophysiology recording systems manufactured by GE Marquette Inc (Milwaukee, WI).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1549774\">",
"    <span class=\"h3\">",
"     Simple averaging method",
"    </span>",
"    &nbsp;&mdash;&nbsp;This method has recently been applied effectively to detect repolarization alternans in electrograms from implanted cardioverter-defibrillators, which have both limited processing power and limited storage of beats for analysis. In a proof-of-concept study in 10 patients, simple averaging of intracardiac repolarization revealed alternans of 78&plusmn;62 microV prior to spontaneous episodes of treated ventricular tachycardia (VT) or ventricular fibrillation (VF) as opposed to 13&plusmn;10 microV in control recordings [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/61\">",
"     61",
"    </a>",
"    ]. Applied prospectively in a multicenter study of 63 ICD recipients, this approach revealed alternans and non-alternating repolarization periodicities that was significantly greater before",
"    <span class=\"nowrap\">",
"     VT/VF",
"    </span>",
"    (62.9&plusmn;3.1 microV) than during baseline rhythm (12.8&plusmn;1.8 microV), rapid pacing (14.5&plusmn;2.0 microV), before supraventricular tachycardia (27.5&plusmn;6.1 microV), or during time-matched ambulatory controls (12.3&plusmn;3.5 microV) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/62\">",
"     62",
"    </a>",
"    ]. Logistic regression revealed that the odds of",
"    <span class=\"nowrap\">",
"     VT/VF",
"    </span>",
"    increased by a factor of 2.2 for each 10-microV increment in",
"    <span class=\"nowrap\">",
"     TWA/V",
"    </span>",
"    (P&lt;0.0001). This relatively simple and computationally-efficient method holds significant promise for using repolarization alternans as a dynamic index of vulnerability to",
"    <span class=\"nowrap\">",
"     VT/VF.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Correlation method",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    correlation method (CM) has primarily been applied to uncover TWA in patients with long QT syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/63\">",
"     63",
"    </a>",
"    ]. The method first involves filtering and baseline correction of the electrocardiogram (ECG), followed by the alignment of consecutive ECG beats to their T-waves, rather than their QRS complexes. Corresponding time samples from successive T-waves; Tj; and the median T-wave, Tm, are cross-correlated to yield a dimensionless Alternans Correlation Index (ACI) at each time sample (j). In the presence of TWA, ACI for consecutive time samples will alternate above and below unity (",
"    <a class=\"graphic graphic_figure graphicRef82556 \" href=\"UTD.htm?37/56/38797\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    TWA is defined in terms of the number of alternating beats, N-CM, and the amplitude of alternans, A-CM; in the special case of stationary alternans, alternation is of the same magnitude between beats (",
"    <a class=\"graphic graphic_figure graphicRef65863 \" href=\"UTD.htm?33/59/34749\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Limitations of the correlation method",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although one stimulation study detected TWA using the correlation method (CM)and spectral decomposition with equivalent sensitivity, a subsequent study of 19 patients with CAD found that TWA magnitude (both A-CM and Valt) was larger than the 1 to 10 mV typically detected in clinical risk stratification studies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/63\">",
"     63",
"    </a>",
"    ]. The comparative sensitivity and specificity of CM versus spectral decomposition in this patient population requires further study. In addition, the minimum number of beats required for CM analysis is unclear. Although two different consecutive beats clearly do not constitute alternation, the arbitrary minimum of seven applied by CM requires empiric validation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study successfully described TWA following acute coronary artery ligation in a dog model using standard deviation of the QRST integrals from successive beats [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/64\">",
"     64",
"    </a>",
"    ]. Other time-domain methods have similarly been applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1549805\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T-wave alternans (TWA) refers to beat-to-beat variability in the timing or shape of T-waves on the surface electrocardiogram (ECG) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9800/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. TWA therefore reflects temporal heterogeneity in ventricular repolarization, which is an important mechanism underlying reentrant arrhythmias. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While historically detected by visual inspection of the surface ECG, TWA can now be measured using commercial systems that use frequency or time domain analyses. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Methods for analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Substantial data in several thousand patients now exist to support both the spectral and modified moving average approaches to detect TWA. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Spectral methods of frequency decomposition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Modified moving average (MMA) method'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The quantification of intracardiac electrograms from implanted cardioverter defibrillators may provide an intracardiac measure of repolarization alternans (or \"T-wave alternans\") that reflects a continuous index of vulnerability to life-threatening ventricular arrhythmias, as it appears that such repolarization alternans increases prior to ventricular arrhythmias. (See",
"      <a class=\"local\" href=\"#H1549774\">",
"       'Simple averaging method'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/1\">",
"      Smith JM, Clancy EA, Valeri CR, et al. Electrical alternans and cardiac electrical instability. Circulation 1988; 77:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/2\">",
"      Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/3\">",
"      Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/4\">",
"      Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 2006; 47:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/5\">",
"      Lee HC, Mohabir R, Smith N, et al. Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction. Circulation 1988; 78:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/6\">",
"      Nearing BD, Huang AH, Verrier RL. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science 1991; 252:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/7\">",
"      Narayan SM, Smith JM. Spectral analysis of periodic fluctuations in electrocardiographic repolarization. IEEE Trans Biomed Eng 1999; 46:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/8\">",
"      Habbab MA, el-Sherif N. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations. Pacing Clin Electrophysiol 1992; 15:916.",
"     </a>",
"    </li>",
"    <li>",
"     Lorell BH, Braunwald E. Pericardial Disease. In: Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald E (Ed), WB Saunders, Philadelphia 1996. p.1476.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/10\">",
"      Herring H. Experimentelle Studien an Saugentieren uber das Electrocardiogram. Z Exper Med 1909; 7:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/11\">",
"      Lewis T. Notes upon alternation of the heart. Q J Med 1910; 4:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/12\">",
"      Kleinfeld MJ, Rozanski JJ. Alternans of the ST segment in Prinzmetal's angina. Circulation 1977; 55:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/13\">",
"      Schwartz PJ, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 1975; 89:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/14\">",
"      Smith JM, Cohen RJ. Simple finite-element model accounts for wide range of cardiac dysrhythmias. Proc Natl Acad Sci U S A 1984; 81:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/15\">",
"      Smith JM, Blue B, Clancy E, et al. Subtle alternating electrocardiographic morphology as an indicator of decreased cardiac electrical stability. Comput Cardiol 1985; 12:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/16\">",
"      Estes NA 3rd, Michaud G, Zipes DP, et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997; 80:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/17\">",
"      Hohnloser SH, Klingenheben T, Li YG, et al. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998; 9:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/18\">",
"      Gold MR, Bloomfield DM, Anderson KP, et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000; 36:2247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/19\">",
"      Narayan SM, Smith JM. Exploiting rate-related hysteresis in repolarization alternans to improve risk stratification for ventricular tachycardia. J Am Coll Cardiol 2000; 35:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/20\">",
"      Hohnloser SH, Klingenheben T, Zabel M, et al. T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol 1997; 8:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/21\">",
"      Narayan SM, Smith JM. Differing rate dependence and temporal distribution of repolarization alternans in patients with and without ventricular tachycardia. J Cardiovasc Electrophysiol 1999; 10:61.",
"     </a>",
"    </li>",
"    <li>",
"     Braunwald E. The Physical Examination. In: Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald, Braunwald E (Ed), WB Saunders, Philadelphia 1996. p.13.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/23\">",
"      Kerensky RA, Lewis JF, Azar GJ Jr, et al. Echocardiographic assessment of wall motion in ST-segment alternans during coronary angioplasty. Clin Cardiol 1996; 19:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/24\">",
"      Murphy CF, Horner SM, Dick DJ, et al. Electrical alternans and the onset of rate-induced pulsus alternans during acute regional ischaemia in the anaesthetised pig heart. Cardiovasc Res 1996; 32:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/25\">",
"      Ando S, Dajani HR, Senn BL, et al. Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure. Circulation 1997; 95:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/26\">",
"      Gottdiener JS, Goldman M, Di Bianco R, Fletcher RD. Bruit alternans. Chest 1981; 80:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/27\">",
"      Chawla AK, Sapru RP. A.V. alternans with concealed conduction in the atria. Indian Heart J 1977; 29:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/28\">",
"      Cohen HC, D'Cruz I, Arbel ER, et al. Tachycardia and bradycardia-dependent bundle branch block alternans: clinical observations. Circulation 1977; 55:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/29\">",
"      Kleinfeld M, Barold SS, Rozanski JJ. Pacemaker alternans: a review. Pacing Clin Electrophysiol 1987; 10:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/30\">",
"      Norr&eacute; ME, Puls T. Nystagmus alternans. Acta Otorhinolaryngol Belg 1981; 35:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/31\">",
"      Priglinger S, Priglinger S. [Numerical reflections concerning alternating torticollis with nystagmus and binocular functions (author's transl)]. Klin Monbl Augenheilkd 1981; 178:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/32\">",
"      Pastore JM, Girouard SD, Laurita KR, et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999; 99:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/33\">",
"      Adam DR, Smith JM, Akselrod S, et al. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol 1984; 17:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/34\">",
"      Walker ML, Rosenbaum DS. Cellular alternans as mechanism of cardiac arrhythmogenesis. Heart Rhythm 2005; 2:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/35\">",
"      Weiss JN, Karma A, Shiferaw Y, et al. From pulsus to pulseless: the saga of cardiac alternans. Circ Res 2006; 98:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/36\">",
"      Kobayashi Y, Gotoh M, Mandel WJ, Karagueuzian HS. Increased temporo-spatial dispersion of repolarization during double premature stimulation in the intact ventricle. Pacing Clin Electrophysiol 1992; 15:2194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/37\">",
"      Hashimoto H, Asano M, Nakashima M. Alternation in refractoriness and in conduction delay in the ischemic myocardium associated with the alternation in the ST-T complex during acute coronary occlusion in anesthetized dogs. J Electrocardiol 1986; 19:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/38\">",
"      Banville I, Gray RA. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol 2002; 13:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/39\">",
"      Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 2002; 13:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/40\">",
"      Narayan SM, Franz MR, Lalani G, et al. T-wave alternans, restitution of human action potential duration, and outcome. J Am Coll Cardiol 2007; 50:2385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/41\">",
"      Narayan SM, Drinan DD, Lackey RP, Edman CF. Acute volume overload elevates T-wave alternans magnitude. J Appl Physiol 2007; 102:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/42\">",
"      Narayan P, McCune SA, Robitaille PM, et al. Mechanical alternans and the force-frequency relationship in failing rat hearts. J Mol Cell Cardiol 1995; 27:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/43\">",
"      Saitoh H, Bailey JC, Surawicz B. Action potential duration alternans in dog Purkinje and ventricular muscle fibers. Further evidence in support of two different mechanisms. Circulation 1989; 80:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/44\">",
"      Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfalls. J Cardiovasc Electrophysiol 1996; 7:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/45\">",
"      Hirayama Y, Saitoh H, Atarashi H, Hayakawa H. Electrical and mechanical alternans in canine myocardium in vivo. Dependence on intracellular calcium cycling. Circulation 1993; 88:2894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/46\">",
"      Shimizu W, Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation 1999; 99:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/47\">",
"      Rubenstein DS, Lipsius SL. Premature beats elicit a phase reversal of mechanoelectrical alternans in cat ventricular myocytes. A possible mechanism for reentrant arrhythmias. Circulation 1995; 91:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/48\">",
"      Narayan SM, Kazi D, Krummen DE, Rappel WJ. Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol 2008; 52:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/49\">",
"      Narayan SM, Franz MR, Clopton P, et al. Repolarization alternans reveals vulnerability to human atrial fibrillation. Circulation 2011; 123:2922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/50\">",
"      He B, Cohen RJ. Body surface Laplacian mapping of cardiac electrical activity. Am J Cardiol 1992; 70:1617.",
"     </a>",
"    </li>",
"    <li>",
"     Smith JM. The Stochastic Nature of Cardiac Electrical Instability: Theory and Experiment. [Ph.D. Thesis]. Massachusetts Institute of Technology Press 1985.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/52\">",
"      Mart&iacute;nez JP, Olmos S. Methodological principles of T wave alternans analysis: a unified framework. IEEE Trans Biomed Eng 2005; 52:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/53\">",
"      Nearing BD, Verrier RL. Personal computer system for tracking cardiac vulnerability by complex demodulation of the T wave. J Appl Physiol 1993; 74:2606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/54\">",
"      Nearing BD, Oesterle SN, Verrier RL. Quantification of ischaemia induced vulnerability by precordial T wave alternans analysis in dog and human. Cardiovasc Res 1994; 28:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/55\">",
"      Laguna P, Garc&iacute;a J, Roncal I, et al. Model-based estimation of cardiovascular repolarization features: ischaemia detection and PTCA monitoring. J Med Eng Technol 1998; 22:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/56\">",
"      Verrier RL, Klingenheben T, Malik M, et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011; 58:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/57\">",
"      Verrier RL, Nearing BD, La Rovere MT, et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003; 14:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/58\">",
"      Cox V, Patel M, Kim J, et al. Predicting arrhythmia-free survival using spectral and modified-moving average analyses of T-wave alternans. Pacing Clin Electrophysiol 2007; 30:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/59\">",
"      Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007; 50:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/60\">",
"      Nieminen T, Lehtim&auml;ki T, Viik J, et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 2007; 28:2332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/61\">",
"      Swerdlow CD, Zhou X, Voroshilovsky O, et al. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms. Heart Rhythm 2008; 5:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/62\">",
"      Swerdlow C, Chow T, Das M, et al. Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients: a prospective, multi-center study. Circulation 2011; 123:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/63\">",
"      Burattini L, Zareba W, Couderc JP, et al. Computer detection of non-stationary T-wave alternans using a new correlation method. Comput Cardiol 1997; 24:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9800/abstract/64\">",
"      Green LS, Fuller MP, Lux RL. Three-dimensional distribution of ST-T wave alternans during acute ischemia. J Cardiovasc Electrophysiol 1997; 8:1413.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2113 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-5846377118-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9800=[""].join("\n");
var outline_f9_36_9800=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1549805\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE PATHOPHYSIOLOGY OF TWA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      METHODS FOR ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Spectral methods of frequency decomposition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Limitations of spectral decomposition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Computational variables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Measurement noise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other spectral methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Complex demodulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Karhunen-Loeve (KL) Transform",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Time-domain methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Modified moving average (MMA) method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1549774\">",
"      - Simple averaging method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Correlation method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Limitations of the correlation method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1549805\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2113\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2113|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/46/23264\" title=\"figure 1\">",
"      Spectral computation RPA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/51/35645\" title=\"figure 2\">",
"      TWAR equation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/59/21437\" title=\"figure 3\">",
"      Valt equation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/56/38797\" title=\"figure 4\">",
"      ACIj equation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/59/34749\" title=\"figure 5\">",
"      Amplitude alternans equation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/7/23669?source=related_link\">",
"      Electrocardiogram in pericarditis and pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=related_link\">",
"      Myocardial action potential and action of antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=related_link\">",
"      Reentry and the development of cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5898?source=related_link\">",
"      T wave (repolarization) alternans: Clinical aspects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_36_9801="Mechanisms and predisposing factors for sleep related breathing disorders in children";
var content_f9_36_9801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms and predisposing factors for sleep related breathing disorders in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Gerald M Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Ronald D Chervin, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/36/9801/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/36/9801/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normal child is the gold standard for sleep quality. Children have a brief latency to sleep onset and then breathe quietly and comfortably during sleep, without evidence of increased work of breathing. Sleep efficiency (time",
"    <span class=\"nowrap\">",
"     asleep/time",
"    </span>",
"    in bed) is high (greater than 90 percent). There are few behavioral arousals during the night, and the child awakens in the morning refreshed and ready to learn and explore. During the day, children are normally very alert and do not appear tired or sleepy except during discrete nap times.",
"   </p>",
"   <p>",
"    A sleep related breathing disorder (also known as sleep-disordered breathing) is an abnormal respiratory pattern (including apneas, hypopneas, respiratory effort-related arousals) or an abnormal reduction in gas exchange (hypoventilation) caused by upper airway obstruction occurring exclusively during sleep. Sleep related breathing disorders in children occur along a spectrum of severity, ranging from habitual snoring on the mild end of the spectrum to obstructive sleep apnea (OSA) on the serious end of the spectrum. &nbsp;",
"   </p>",
"   <p>",
"    This topic review will discuss the normal physiology of sleep in children and the factors that disturb respiration during sleep and contribute to the development of a sleep related breathing disorder, including OSA. The evaluation of the child with snoring or suspected OSA and the management of the child with OSA are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40217?source=see_link\">",
"     \"Management of obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SLEEP STAGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;After six months of age, a child's sleep can be divided into rapid eye movement (REM) and non-REM (NREM) sleep and scored polygraphically using the AASM Manual for the Scoring of Sleep and Associated Events [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9109?source=see_link\">",
"     \"Stages and architecture of normal sleep\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/53/11092?source=see_link&amp;anchor=H2#H2\">",
"     \"Sleep physiology in children\", section on 'Sleep states'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    REM sleep is a physiologically activated sleep state characterized by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Generalized muscle atonia",
"     </li>",
"     <li>",
"      Increased cerebral blood flow",
"     </li>",
"     <li>",
"      Desynchronized EEG",
"     </li>",
"     <li>",
"      Variability of heart rate, respiratory rate, and blood pressure",
"     </li>",
"     <li>",
"      Increased upper airway resistance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During REM sleep, bursts of phasic events have both central and peripheral nervous system manifestations, for example in the form of pontogeniculooccipital waves and muscle twitches despite the atonia, respectively. Most dreaming occurs during REM sleep.",
"   </p>",
"   <p>",
"    By comparison, NREM sleep is a more quiescent state characterized by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduced, but not absent muscle tone",
"     </li>",
"     <li>",
"      Decreased cerebral blood flow",
"     </li>",
"     <li>",
"      Synchronized EEG",
"     </li>",
"     <li>",
"      Regular heart rate, respiratory rate, and blood pressure",
"     </li>",
"     <li>",
"      Increased upper airway resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    NREM sleep is subdivided into stages N1, N2, and N3 by EEG criteria, which roughly parallel increasing depth of sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/1\">",
"     1",
"    </a>",
"    ]. NREM sleep, REM sleep, and brief periods of wakefulness alternate in a regular and predictable pattern throughout the sleep period, defining the ultradian rhythm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9109?source=see_link\">",
"     \"Stages and architecture of normal sleep\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The NREM-REM cycle length increases from 60 minutes at infancy to 90 minutes in adolescents and adults. NREM sleep stage N3 is also labeled as slow-wave sleep. Slow-wave sleep predominates in the early part of the sleep period, whereas REM sleep predominates in the latter part of the sleep period. A normal night's sleep for a child is comprised of 5 to 10 NREM-REM sleep cycles woven together seamlessly, so that the transitions from one cycle to the next are behaviorally inapparent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHANGES IN RESPIRATORY PHYSIOLOGY DURING SLEEP",
"    </span>",
"    &nbsp;&mdash;&nbsp;During sleep in a normal child, there is a modest increase in upper airway resistance and a small decrease in nocturnal ventilation. Overnight polysomnography (PSG) studies in normal children have quantified these changes, establishing norms for nocturnal ventilation in children (",
"    <a class=\"graphic graphic_table graphicRef62237 \" href=\"UTD.htm?38/40/39564\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. These normative studies have demonstrated that there is a small decrease in oxygen saturation (0 to 7 percent) and a rise in end tidal PCO2 (0 to 13 mmHg). Brief central apneas are common in children, especially in association with movements, but obstructive apneas are never normal in children.",
"   </p>",
"   <p>",
"    The decrease in ventilation is caused by both an increase in upper airway resistance and a decrease in central respiratory drive, as detailed below [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15459797\">",
"    <span class=\"h2\">",
"     Increased upper airway resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the nose is the site of greatest resistance in the upper airway, the pharynx is the site of the greatest increase in airway resistance during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/7\">",
"     7",
"    </a>",
"    ]. This increase in resistance is due to the decreased size of the pharynx associated with relaxation of the pharyngeal dilators.",
"   </p>",
"   <p>",
"    The pharynx provides a conduit for air, solids, and liquids, and is intimately involved in breathing, digestion, and speaking (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78760 \" href=\"UTD.htm?34/62/35813\">",
"     image 1",
"    </a>",
"    ). In its role as an organ of respiration, the pharynx must remain patent. In its role as an organ of digestion, the pharynx protects the nasopharynx and larynx while it directs solids and liquids into the esophagus during swallowing and out of the mouth during vomiting. In its role as an organ of speech, the pharynx provides a steady, highly regulated flow of air which is variably directed into the nose and mouth.",
"   </p>",
"   <p>",
"    To fulfill these diverse functions, the pharynx is constructed as a rigid tube with a mobile, collapsible segment in the middle. The collapsible section of the pharynx is controlled by at least 20 sets of paired muscles, which can alter its size, shape, and dynamics, and behaves like a Starling resistor (",
"    <a class=\"graphic graphic_figure graphicRef79617 \" href=\"UTD.htm?35/20/36173\">",
"     figure 1",
"    </a>",
"    ). The collapsibility of the pharynx is a necessity for it to fulfill its roles in digestion and phonation, but is a liability in its role as an organ of respiration and is central to the understanding to the pathophysiology of sleep- related breathing disorders.",
"   </p>",
"   <p>",
"    The pharyngeal dilators are a group of muscles that provide the postural tone to the pharynx during wakefulness and maintain pharyngeal patency in the face of the subatmospheric intraluminal pressure generated during inspiration. The pharyngeal dilators that have been studied during sleep in adults are [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Genioglossus [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/10-14\">",
"       10-14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Posterior cricoarytenoids [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tensor palatini [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Nasal inspiratory muscle (the alae nasi) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During wakefulness and sleep, the pharyngeal dilators help to maintain pharyngeal patency by tonic contraction (which is present throughout the respiratory cycle)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    phasic contractions (which are synchronized with the contraction of the respiratory pump muscles, thereby helping to stiffen the upper airway prior to and during inspiration). During sleep in individuals without a sleep related breathing disorder, there is a decrease in activity of the pharyngeal dilators that results in a decrease in pharyngeal size and a concomitant increase in upper airway resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/8-10,15-19\">",
"     8-10,15-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a group, the pharyngeal dilators can be considered accessory muscles of respiration. Their activity during sleep is modulated by the respiratory control center of the medulla which receives input from the pharyngeal mechanoreceptors. The mechanoreceptors are the afferent limb of a complex pharyngeal reflex that maintains pharyngeal patency during inspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/20\">",
"     20",
"    </a>",
"    ]. These reflexes have been demonstrated in both children and adults, and they augment activation of the pharyngeal dilators in response to negative intraluminal pressure and hypercapnia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Topical anesthesia of the pharynx and glottis in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/24\">",
"     24",
"    </a>",
"    ] and children [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/25\">",
"     25",
"    </a>",
"    ] during wakefulness results in a substantial decrease in upper airway size and increase in upper airway resistance, suggesting that the pharyngeal mechanoreceptors play an important role in maintenance of pharyngeal patency during wakefulness. These reflexes likely play an even more important role during sleep in adults and children with sleep-disordered breathing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15459804\">",
"    <span class=\"h2\">",
"     Decreased central respiratory drive",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the increased upper airway resistance is reversed by nasal CPAP or is minimized by having patients breathe a low density gas, there is still a small decrease in ventilation, suggesting an independent decrease in central respiratory drive during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/18\">",
"     18",
"    </a>",
"    ]. This decrease has been attributed to the loss of a \"wakefulness respiratory drive,\" the nature of which is not completely understood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=see_link\">",
"     \"Control of ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5500564\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other important changes in respiratory physiology during sleep include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A decrease in load compensation",
"     </li>",
"     <li>",
"      An increase in the contribution of the intercostal muscles to inspiratory effort during NREM sleep",
"     </li>",
"     <li>",
"      A decrease in lung volumes during REM sleep",
"     </li>",
"     <li>",
"      A decrease in synchronization of the pharyngeal dilators with diaphragmatic contractions during REM sleep",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18246274\">",
"    <span class=\"h1\">",
"     BALANCE OF FORCES MODEL OF UPPER AIRWAY OBSTRUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharyngeal narrowing that occurs during sleep can be understood to result from a balance between forces that tend to collapse the airway and the pharyngeal dilators that attempt to maintain pharyngeal patency (",
"    <a class=\"graphic graphic_figure graphicRef66838 \" href=\"UTD.htm?5/14/5358\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/26\">",
"     26",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    This balance is affected by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The skeletal and soft tissue anatomy of the upper airway",
"     </li>",
"     <li>",
"      The neuromuscular tone of the pharyngeal dilators",
"     </li>",
"     <li>",
"      Suction pressure generated by the inspiratory pump muscles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The primary effect of sleep is to change the neuromuscular tone of the pharyngeal dilators and possibly their coordination with the inspiratory pump muscles. Pharyngeal dilator muscle activity decreases during NREM sleep in children, and decreases further during REM sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/13\">",
"     13",
"    </a>",
"    ]. These changes in tone of the pharyngeal dilators result in one of three possible outcomes (",
"    <a class=\"graphic graphic_figure graphicRef66838 \" href=\"UTD.htm?5/14/5358\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Normal sleep",
"      </strong>",
"      &ndash; During sleep in normal children and adults, there is a small decrease in the size of the pharyngeal airway, resulting in a small but clinically insignificant increase in upper airway resistance.",
"     </li>",
"     <li>",
"      <strong>",
"       Obstructive apneas and hypopneas",
"      </strong>",
"      &ndash; OSA in most adults and many children is characterized by repeated transient collapse of the pharyngeal airway. These events are known as obstructive apneas if the airway closes completely or hypopneas if it closes partially.",
"     </li>",
"     <li>",
"      <strong>",
"       Obstructive hypoventilation",
"      </strong>",
"      &ndash; In obstructive hypoventilation (OHV), there is continuous partial collapse of the pharyngeal airway, resulting in increased upper airway resistance and continuous hypoventilation, associated with hypercapnia and hypoxemia but without cyclic discrete obstructive events. This finding is common in young children but less common in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/27\">",
"       27",
"      </a>",
"      ]. The International Classification of Sleep Disorders (ICSD) classifies obstructive hypoventilation as a form of pediatric obstructive sleep apnea [",
"      <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/28\">",
"       28",
"      </a>",
"      ]. &nbsp; &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OBSTRUCTIVE SLEEP APNEA AND OBSTRUCTIVE HYPOVENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep in children with sleep related breathing disorders is different from sleep in normal children. For children with sleep related breathing disorders, the increase in upper airway resistance during sleep is exaggerated, and can lead to markedly increased work of breathing, with snoring, obstructive sleep apnea (OSA),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstructive hypoventilation (OHV), resulting in sleep disruption, hypoxia, and hypercarbia.",
"   </p>",
"   <p>",
"    Sleep related breathing disorders in children ranges on a spectrum from snoring to obstructive hypoventilation to complete obstructive apnea. The precise point along this spectrum that is defined as abnormal is subject to some controversy. There is a growing body of literature describing the physiologic consequences of sleep related breathing disorders in a child, which include impaired growth, systemic or pulmonary hypertension, and myocardial remodeling. In addition, there appear to be associations between OSA and neurocognitive and behavioral problems, including attention deficit disorder and poor school performance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    OSA and OHV are present only in the sleeping state. Normal children have no obstructive apneas or hypopneas during sleep. In adults, up to five apneas or hypopneas per hour may be normal (ie, an",
"    <span class=\"nowrap\">",
"     apnea/hypopnea",
"    </span>",
"    index of less than five per hour). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link&amp;anchor=H16#H16\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\", section on 'Information derived'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15286?source=see_link&amp;anchor=H12#H12\">",
"     \"Sleep related breathing disorders in adults: Definitions\", section on 'Apnea hypopnea index'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Airway collapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;OSA or OHV is caused by complete or partial collapse of one or multiple segment(s) of the extrathoracic airway during sleep. This is the result of the cumulative effect of two factors, the relative contribution of which varies among individuals: (See",
"    <a class=\"local\" href=\"#H15459797\">",
"     'Increased upper airway resistance'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An anatomically small upper airway",
"     </li>",
"     <li>",
"      Decreased neuromuscular tone of the pharyngeal dilators during sleep",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The upper airway of children with",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    tends to be smaller than that of normal controls. This has been demonstrated by MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/30-32\">",
"     30-32",
"    </a>",
"    ] and pharyngometry (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71656 \" href=\"UTD.htm?19/39/20086\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61028 graphicRef55752 \" href=\"UTD.htm?28/13/28888\">",
"     figure 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/33\">",
"     33",
"    </a>",
"    ]. Dynamic MRI studies of the upper airway during tidal breathing under light sedation have demonstrated that the cross sectional area of the upper airways of children with OSA are significantly smaller at all levels, from the epiglottis to the nasopharynx, compared with normal controls; these differences are also seen dynamically when the inspiration of a normal control is compared with that of a child with OSA (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77414 \" href=\"UTD.htm?20/48/21257\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/32\">",
"     32",
"    </a>",
"    ]. Note that the airway of the normal control is:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Larger at all pharyngeal levels",
"     </li>",
"     <li>",
"      The lateral dimension is consistently larger than the AP dimension",
"     </li>",
"     <li>",
"      There is very little change in the size and shape of the airway between inspiration and expiration",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, in children with OSA the airway is:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Smaller at all levels",
"     </li>",
"     <li>",
"      The AP dimension is consistently larger than the lateral dimension",
"     </li>",
"     <li>",
"      There is a substantial change in the size of the airway between inspiration and expiration, which is most apparent in the nasopharynx.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although children with",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    have anatomically smaller upper airways than normals, they do not usually exhibit any upper airway obstruction during wakefulness because of neuromuscular compensation mediated by the pharyngeal dilators, particularly the genioglossus during wakefulness. However, upper airway obstruction occurs if this compensatory activation is eliminated, as occurs during sleep or during anesthesia with muscular paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18246036\">",
"    <span class=\"h2\">",
"     Patterns of OSA/OHV in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep related breathing disorders in children are most often characterized by prolonged obstructive hypoventilation during sleep, rather than by discrete obstructive apneas [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/13,34\">",
"     13,34",
"    </a>",
"    ]. (see",
"    <a class=\"local\" href=\"#H18246274\">",
"     'Balance of forces model of upper airway obstruction'",
"    </a>",
"    above). Sleep architecture often is preserved; there may be little sleep fragmentation, and sleep stage distribution may appear normal. The polysomnogram often displays phasic augmentation of chin and intercostal electromyographic (EMG) activity during NREM sleep, as well as paradoxical chest and abdominal movements.",
"   </p>",
"   <p>",
"    The hypoventilation typically worsens during REM sleep because lung volumes are lower, intercostal muscles do not substantially contribute to inspiratory effort, and the pharyngeal dilators are less effective as compared with NREM sleep. This often leads to an overnight oximetry tracing in which:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      REM periods are often associated with hypoventilation and significant oxygen desaturations",
"     </li>",
"     <li>",
"      NREM stage N3 (slow-wave sleep) is relatively protected without desaturations",
"     </li>",
"     <li>",
"      NREM stage N2 shows modest desaturations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These clinical findings can be understood in terms of how a child compensates for increased resistive loads. At sleep onset, there is decreased tone of the pharyngeal dilators, leading to a decrease in size of the airway. This in turn causes an increase in upper airway resistance, resulting in a decrease in intraluminal pressures in the pharynx. The decreased airflow, increased negative pressure, and increased CO2 stimulate the pharyngeal mechanoreceptors to augment pharyngeal dilator contractions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/13\">",
"     13",
"    </a>",
"    ]. In a child without sleep related breathing disorders, this response maintains airway patency.",
"   </p>",
"   <p>",
"    In children with sleep related breathing disorders, this response does not completely relieve the upper airway obstruction, and hypoventilation ensues, with a rise in PCO2",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a decrease in arterial oxygen saturation. This further stimulates the pharyngeal dilators and the respiratory pump muscles. In many children with OSA, this response usually is sufficient to maintain a partially open pharyngeal airway for long periods of sleep without experiencing discrete obstructive apneic events. By contrast, adults with OSA are more likely to have acute obstructive apneic events, leading to arousal, perhaps because the pharyngeal dilators are less effective",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the pharynx is more collapsible as compared with children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18246211\">",
"    <span class=\"h2\">",
"     Arousal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arousal is the ultimate defense against obstructive apnea, since it leads to a change from the sleeping to the waking state, which in turn results in the opening of the pharyngeal airway and relief of the obstruction. Children use this strategy much less often than adults. Several studies have demonstrated that the majority of obstructive apneas in children during both REM and NREM sleep are terminated without a cortical EEG arousal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. However, many of these events are associated with a subcortical arousal as manifest by a movement and a change in the pulse transit time [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/36\">",
"     36",
"    </a>",
"    ]. The significance of these subcortical arousals is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PREDISPOSING FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic factors anywhere along the upper airway can decrease airway size or stability, and may therefore contribute to the development of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef52116 \" href=\"UTD.htm?0/44/716\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Enlarged tonsils and adenoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common and often the only obvious factor limiting airway size and leading to",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    in children is enlarged tonsils (palatine and lingual) and adenoids. The smallest cross-sectional area of the pharyngeal airway in children is the retropalatal area where the tonsils and adenoids overlap (",
"    <a class=\"graphic graphic_figure graphicRef61028 \" href=\"UTD.htm?21/49/22288\">",
"     figure 3A",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/30,35\">",
"     30,35",
"    </a>",
"    ]. However, adenotonsillar size alone cannot explain the presence of",
"    <span class=\"nowrap\">",
"     OSA/OHV,",
"    </span>",
"    since the majority of children with grossly enlarged tonsils and adenoids do not have",
"    <span class=\"nowrap\">",
"     OSA/OHV,",
"    </span>",
"    and the tonsils of children with",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    are not larger than those of children without",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/37\">",
"     37",
"    </a>",
"    ]. Factors relevant to decisions about whether to perform adenotonsillectomy are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/22/35178?source=see_link\">",
"     \"Tonsillectomy and adenoidectomy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of children with",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    and adenotonsillar hypertrophy improve after a tonsillectomy and adenoidectomy (T&amp;A), but about 10 percent do not improve after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/38\">",
"     38",
"    </a>",
"    ], presumably because in their case a substantial part of the",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    was caused by craniofacial or neuromuscular factors or pharyngeal instability, not simply enlarged tonsils and adenoids [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/38\">",
"     38",
"    </a>",
"    ]. In other children, the",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    initially improves, but later recurs, secondary to adenoidal tissue regrowth, and will resolve after a second surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is a common factor contributing to the OSA in adults, probably by decreasing the size",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increasing the collapsibility of the pharyngeal airway. Although obesity is not as common a cause of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    in children as it is in adults, the prevalence of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    in obese children is higher than in non-obese children, and this is particularly true for adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/39-43\">",
"     39-43",
"    </a>",
"    ]. Because the prevalence and severity of obesity in children is increasing, obesity is likely to become an increasingly important cause of pediatric sleep related breathing disorders in the future.",
"   </p>",
"   <p>",
"    Obesity contributes to airway narrowing in several ways, including fatty infiltration of areas surrounding the airway, tongue, or fat pads lateral to the airway. In many cases, obesity and adenotonsillar hypertrophy combine to cause OSA in an individual patient, and children with obesity are more likely than lean patients to have residual OSA after adenotonsillectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40217?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of obstructive sleep apnea in children\", section on 'Adenotonsillectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both obesity and OSA are inflammatory conditions with additive effects on comorbidities that are mediated by inflammatory processes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/29\">",
"     29",
"    </a>",
"    ]. These comorbidities include",
"    <span class=\"nowrap\">",
"     atherogenesis/cardiovascular",
"    </span>",
"    disease and associated lipid abnormalities, insulin resistance, and fatty liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. The processes seem to be mediated at least in part by increased production of leptin, interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-&alpha;), which are independently induced by obesity and OSA [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/29\">",
"     29",
"    </a>",
"    ]. &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Mucopolysaccharidoses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with any of the mucopolysaccharidoses and mucolipidoses who have significant infiltration and accumulation of macromolecules in the tissues of their upper airway are more likely to have",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=see_link\">",
"     \"Clinical features and diagnosis of the mucopolysaccharidoses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Craniofacial anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with craniofacial anomalies, the characteristics most commonly associated with",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Midfacial hypoplasia",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Retro/micrognathia",
"      </span>",
"     </li>",
"     <li>",
"      An acutely angled skull base",
"     </li>",
"     <li>",
"      Narrow maxillary arch",
"     </li>",
"     <li>",
"      Nasoseptal obstruction",
"     </li>",
"     <li>",
"      Macroglossia &nbsp;",
"     </li>",
"     <li>",
"      Other soft tissue abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These anomalies lead to a decrease in the size of the nasopharynx, oropharynx, or hypopharynx, and can predispose the pharynx to collapse during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/49\">",
"     49",
"    </a>",
"    ]. In some syndromes associated with sleep related breathing disorders, the obstruction can be attributed to specific anatomical sites (",
"    <a class=\"graphic graphic_table graphicRef82466 \" href=\"UTD.htm?24/19/24895\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The role of subtle craniofacial factors in the absence of obvious anomalies is less clear. In one study, the mandibular dimensions of children with a sleep related breathing disorder but without obvious craniofacial abnormalities were no different than in children without a sleep related breathing disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/50\">",
"     50",
"    </a>",
"    ]. However, a narrow maxillary arch has been associated with OSA in children, and orthodontic correction with rapid maxillary expansion has resulted in resolution of the sleep related breathing disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/51\">",
"     51",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Neuromuscular factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuromuscular factors affect the size, shape, compliance, and coordination of the pharyngeal airway, which can have an important effect on the development of sleep related breathing disorders. Neuromuscular control of the upper airway is mediated by local mechanoreceptor reflexes and by central drive, coordinated through the respiratory control center in the medulla.",
"   </p>",
"   <p>",
"    The most common clinical neuromuscular problems contributing to",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    are alterations in muscle tone (either hypotonia or hypertonia). However, the precise mechanism by which changes in tone affect the pharyngeal airway has not yet been elucidated. Chronic changes in muscle tone may have prominent effects on growth and development of the facial skeleton, and thereby affect upper airway patency.",
"   </p>",
"   <p>",
"    Impairment of the coordination and synchronization of the respiratory pump muscles with the pharyngeal dilator muscles may also be a cause of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    in children. This occurs during hiccups [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/52\">",
"     52",
"    </a>",
"    ] and when children with congenital alveolar hypoventilation are provided with diaphragmatic pacers during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/53\">",
"     53",
"    </a>",
"    ]. In both cases, the inspiratory pump functions independently of the pharyngeal dilators, resulting in upper airway obstruction. This illustrates the importance of synchronization of the pharyngeal dilators with the muscles of inspiration.",
"   </p>",
"   <p>",
"    Dysfunction of the central nervous system may play a role in the development of central sleep apnea (CSA) if the respiratory control center of the medulla is affected, or",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    if the dysfunction leads to neuromuscular dysfunction. As examples, either CSA or OSA may result from compression of the brainstem as seen in children with Arnold Chiari malformation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/54,55\">",
"     54,55",
"    </a>",
"    ] or dysfunction of the brainstem as seen in children with bulbar palsy or brainstem tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/56\">",
"     56",
"    </a>",
"    ]. The airway obstruction may be caused by peripheral neuromuscular dysfunction, vocal cord paralysis, or may be directly caused by the central nervous system dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Combined anatomic and neuromuscular factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic and neuromuscular factors often combine to cause a sleep related breathing disorder, but the relative contribution of each can be hard to predict. Both factors are often seen together in children with craniofacial syndromes, making them at especially high risk for the development of a sleep related breathing disorder.",
"   </p>",
"   <p>",
"    The most common example is found in children with trisomy 21 (Down syndrome), which is characterized by midfacial hypoplasia, a high-arched palate, macroglossia, cranial base anomalies, and hypotonia. In one report, 81 percent of children with trisomy 21 had OSA or OHV; this study used a daytime nap study, which may have underestimated the true incidence of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/36/9801/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18245841\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In human",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    animal studies, alcohol,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/26/5542?source=see_link\">",
"     chloral hydrate",
"    </a>",
"    , benzodiazepines, and general anesthetics have all been shown to selectively decrease the activity of the pharyngeal dilators to a greater extent than they affect the diaphragm. This imbalance could lead to an increased tendency of the upper airway to collapse during inspiration. Case reports describe individuals who suffered acute and sometimes fatal worsening of their OSA after treatment with these agents.",
"   </p>",
"   <p>",
"    Narcotic analgesics are powerful respiratory depressants, leading to a marked decrease in hypoxic and hypercarbic ventilatory drive and increased arousal threshold. Together, these factors can be a dangerous combination in a child with a sleep related breathing disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of genetics in the development of",
"    <span class=\"nowrap\">",
"     OSA/OHV",
"    </span>",
"    in children is intriguing but not well understood. Familial aggregation of OSA has been noted in studies of adults and children, in both obese and non-obese populations. Obesity, craniofacial morphology, and ventilatory control all are highly heritable traits and are important in the pathophysiology of sleep related breathing disorders. However, the genetic determinants of sleep related breathing disorders have not yet been delineated in either adults or children. This is an area of active research, and it is likely the genetic factors for OSA will be much better characterized in the next few years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/13/6359?source=see_link&amp;anchor=H9969828#H9969828\">",
"     \"Overview of obstructive sleep apnea in adults\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18245528\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An obstructive sleep related breathing disorder (or sleep-disordered breathing) is characterized by discrete apneas, hypopneas, and respiratory effort-related arousals or by more continuous reductions in gas exchange (hypoventilation). These conditions are caused by upper airway obstruction that occurs exclusively during sleep. Sleep related breathing disorders in children occur along a spectrum of severity. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sleep is categorized into rapid eye movement (REM) and non-REM sleep. REM sleep is associated with low muscle tone and in most patients, increased vulnerability to OSA. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sleep stages'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with a sleep related breathing disorder, the increase in upper airway resistance during sleep is exaggerated. This can lead to markedly increased work of breathing, snoring, obstructive sleep apnea (OSA),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      obstructive hypoventilation (OHV). Immediate consequences can include sleep disruption, hypoxia, and hypercarbia. (See",
"      <a class=\"local\" href=\"#H18246274\">",
"       'Balance of forces model of upper airway obstruction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Obstructive sleep apnea and obstructive hypoventilation'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      The various factors that can limit the size of the upper airway are cumulative. In many children with sleep related breathing disorders, multiple factors contribute to the problem and must be addressed for successful treatment. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Predisposing factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common factor that restricts airway size and contributes to",
"      <span class=\"nowrap\">",
"       OSA/OHV",
"      </span>",
"      in children is enlarged tonsils (palatine and lingual) and adenoids. However, the majority of children with grossly enlarged tonsils and adenoids do not have",
"      <span class=\"nowrap\">",
"       OSA/OHV,",
"      </span>",
"      making it clear that adenotonsillar size alone cannot explain the presence of a sleep related breathing disorder in children. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Enlarged tonsils and adenoids'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Obesity provides an increasingly common contribution to",
"      <span class=\"nowrap\">",
"       OSA/OHV",
"      </span>",
"      in adults and children, probably because obesity decreases the size",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increases the collapsibility of the pharyngeal airway. In many cases, both obesity and adenotonsillar hypertrophy contribute to OSA in an individual patient. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Obesity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other factors contributing to",
"      <span class=\"nowrap\">",
"       OSA/OHV",
"      </span>",
"      in some individuals include mucopolysaccharidoses, craniofacial anomalies, neuromuscular factors, drugs that relax pharyngeal dilators or decrease respiratory drive, or genetic factors. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Predisposing factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Genetics'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8814761\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Mark Mahowald, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM Manual for the Scoring of Sleep and Associated Events. American Academy of Sleep Medicine. West Chester, IL, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/2\">",
"      Hudgel DW, Martin RJ, Johnson B, Hill P. Mechanics of the respiratory system and breathing pattern during sleep in normal humans. J Appl Physiol 1984; 56:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/3\">",
"      Lopes JM, Tabachnik E, Muller NL, et al. Total airway resistance and respiratory muscle activity during sleep. J Appl Physiol 1983; 54:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/4\">",
"      Marcus CL, Omlin KJ, Basinki DJ, et al. Normal polysomnographic values for children and adolescents. Am Rev Respir Dis 1992; 146:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/5\">",
"      Traeger N, Schultz B, Pollock AN, et al. Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 2005; 40:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/6\">",
"      Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006; 117:741.",
"     </a>",
"    </li>",
"    <li>",
"     van Lunteren E. Upper airway effects on breathing. In: The Lung, Crysta R, West J (Eds), Raven Press, New York 1991. p.1632.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/8\">",
"      van Lunteren E, Strohl KP. The muscles of the upper airways. Clin Chest Med 1986; 7:171.",
"     </a>",
"    </li>",
"    <li>",
"     van Lunteren E, Strohl KP. Striated muscles of the upper airways. In: Respiratory Function of the Upper Airway, Mathew OP, Sant Ambrogio G (Eds), Marcel Dekker, New York 1988. p.87.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/10\">",
"      Wiegand L, Zwillich CW, Wiegand D, White DP. Changes in upper airway muscle activation and ventilation during phasic REM sleep in normal men. J Appl Physiol 1991; 71:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/11\">",
"      Roberts JL, Reed WR, Mathew OP, Thach BT. Control of respiratory activity of the genioglossus muscle in micrognathic infants. J Appl Physiol 1986; 61:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/12\">",
"      Jeffries B, Brouillette RT, Hunt CE. Electromyographic study of some accessory muscles of respiration in children with obstructive sleep apnea. Am Rev Respir Dis 1984; 129:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/13\">",
"      Katz ES, White DP. Genioglossus activity during sleep in normal control subjects and children with obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/14\">",
"      Katz ES, Marcus CL, White DP. Influence of airway pressure on genioglossus activity during sleep in normal children. Am J Respir Crit Care Med 2006; 173:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/15\">",
"      Kuna ST, Smickley JS, Insalaco G. Posterior cricoarytenoid muscle activity during wakefulness and sleep in normal adults. J Appl Physiol 1990; 68:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/16\">",
"      Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on tensor palatini EMG and upper airway resistance in normal men. J Appl Physiol 1991; 70:2574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/17\">",
"      Suratt PM, McTier R, Wilhoit SC. Alae nasi electromyographic activity and timing in obstructive sleep apnea. J Appl Physiol 1985; 58:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/18\">",
"      Skatrud JB, Dempsey JA, Badr S, Begle RL. Effect of airway impedance on CO2 retention and respiratory muscle activity during NREM sleep. J Appl Physiol 1988; 65:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/19\">",
"      Isoni S, Feroah TR, Hajduk EA, et al. Anatomy of the pharyngeal airway in sleep apneics: separating anatomic factors from neuromuscular factors. Sleep 1993; 16:S80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/20\">",
"      Sant'Ambrogio G, Mathew OP. Laryngeal receptors and their reflex responses. Clin Chest Med 1986; 7:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/21\">",
"      Thach BT, Schefft GL, Pickens DL, Menon AP. Influence of upper airway negative pressure reflex on response to airway occlusion in sleeping infants. J Appl Physiol 1989; 67:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/22\">",
"      White DP. Sleep-related breathing disorder.2. Pathophysiology of obstructive sleep apnoea. Thorax 1995; 50:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/23\">",
"      Marcus CL, Fernandes Do Prado LB, Lutz J, et al. Developmental changes in upper airway dynamics. J Appl Physiol 2004; 97:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/24\">",
"      DeWeese EL, Sullivan TY. Effects of upper airway anesthesia on pharyngeal patency during sleep. J Appl Physiol 1988; 64:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/25\">",
"      Gozal D, Burnside MM. Increased upper airway collapsibility in children with obstructive sleep apnea during wakefulness. Am J Respir Crit Care Med 2004; 169:163.",
"     </a>",
"    </li>",
"    <li>",
"     Thach B. Neuromuscular control of the upper airway. In: Respiratory Control Disorders in Infants and Children, Beckerman RC, Brouillette RT, Hunt CE (Eds), Williams and Wilkins, Baltimore 1992. p.47.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/27\">",
"      Marcus CL. Sleep-disordered breathing in children. Am J Respir Crit Care Med 2001; 164:16.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Sleep Medicine. International classification of sleep disorders: Diagnostic and coding manual, 2, American Academy of Sleep Medicine, Westchester, IL 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/29\">",
"      Bhattacharjee R, Kim J, Kheirandish-Gozal L, Gozal D. Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol 2011; 46:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/30\">",
"      Arens R, McDonough JM, Corbin AM, et al. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2003; 167:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/31\">",
"      Arens R, McDonough JM, Costarino AT, et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2001; 164:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/32\">",
"      Arens R, Sin S, McDonough JM, et al. Changes in upper airway size during tidal breathing in children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2005; 171:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/33\">",
"      Monahan KJ, Larkin EK, Rosen CL, et al. Utility of noninvasive pharyngometry in epidemiologic studies of childhood sleep-disordered breathing. Am J Respir Crit Care Med 2002; 165:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/34\">",
"      McNamara F, Issa FG, Sullivan CE. Arousal pattern following central and obstructive breathing abnormalities in infants and children. J Appl Physiol 1996; 81:2651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/35\">",
"      Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 2004; 27:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/36\">",
"      Katz ES, Lutz J, Black C, Marcus CL. Pulse transit time as a measure of arousal and respiratory effort in children with sleep-disordered breathing. Pediatr Res 2003; 53:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/37\">",
"      Brodsky L, Moore L, Stanievich JF. A comparison of tonsillar size and oropharyngeal dimensions in children with obstructive adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 1987; 13:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/38\">",
"      Tal A, Bar A, Leiberman A, Tarasiuk A. Sleep characteristics following adenotonsillectomy in children with obstructive sleep apnea syndrome. Chest 2003; 124:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/39\">",
"      Silvestri JM, Weese-Mayer DE, Bass MT, et al. Polysomnography in obese children with a history of sleep-associated breathing disorders. Pediatr Pulmonol 1993; 16:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/40\">",
"      Marcus CL, Curtis S, Koerner CB, et al. Evaluation of pulmonary function and polysomnography in obese children and adolescents. Pediatr Pulmonol 1996; 21:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/41\">",
"      Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child 2007; 92:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/42\">",
"      Bixler EO, Vgontzas AN, Lin HM, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009; 32:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/43\">",
"      Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med 2009; 5:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/44\">",
"      Kheirandish-Gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 2008; 133:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/45\">",
"      Redline S, Storfer-Isser A, Rosen CL, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med 2007; 176:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/46\">",
"      Tauman R, O'Brien LM, Ivanenko A, Gozal D. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 2005; 116:e66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/47\">",
"      Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008; 177:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/48\">",
"      Shapiro J, Strome M, Crocker AC. Airway obstruction and sleep apnea in Hurler and Hunter syndromes. Ann Otol Rhinol Laryngol 1985; 94:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/49\">",
"      Sher AE. Obstructive sleep apnea syndrome: a complex disorder of the upper airway. Otolaryngol Clin North Am 1990; 23:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/50\">",
"      Schiffman PH, Rubin NK, Dominguez T, et al. Mandibular dimensions in children with obstructive sleep apnea syndrome. Sleep 2004; 27:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/51\">",
"      Villa MP, Malagola C, Pagani J, et al. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med 2007; 8:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/52\">",
"      Brouillette RT, Thach BT, Abu-Osba YK, Wilson SL. Hiccups in infants: characteristics and effects on ventilation. J Pediatr 1980; 96:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/53\">",
"      Weese-Mayer DE, Hunt CE, Brouillette RT, Silvestri JM. Diaphragm pacing in infants and children. J Pediatr 1992; 120:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/54\">",
"      Gozal D, Arens R, Omlin KJ, et al. Peripheral chemoreceptor function in children with myelomeningocele and Arnold-Chiari malformation type 2. Chest 1995; 108:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/55\">",
"      Murray C, Seton C, Prelog K, Fitzgerald DA. Arnold Chiari type 1 malformation presenting with sleep disordered breathing in well children. Arch Dis Child 2006; 91:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/56\">",
"      Rosen GM, Bendel AE, Neglia JP, et al. Sleep in children with neoplasms of the central nervous system: case review of 14 children. Pediatrics 2003; 112:e46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/36/9801/abstract/57\">",
"      Marcus CL, Keens TG, Bautista DB, et al. Obstructive sleep apnea in children with Down syndrome. Pediatrics 1991; 88:132.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6347 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.65.66-BC5B390E05-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9801=[""].join("\n");
var outline_f9_36_9801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18245528\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SLEEP STAGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHANGES IN RESPIRATORY PHYSIOLOGY DURING SLEEP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15459797\">",
"      Increased upper airway resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15459804\">",
"      Decreased central respiratory drive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5500564\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18246274\">",
"      BALANCE OF FORCES MODEL OF UPPER AIRWAY OBSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OBSTRUCTIVE SLEEP APNEA AND OBSTRUCTIVE HYPOVENTILATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Airway collapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18246036\">",
"      Patterns of OSA/OHV in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18246211\">",
"      Arousal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PREDISPOSING FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Enlarged tonsils and adenoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Craniofacial anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Neuromuscular factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Combined anatomic and neuromuscular factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18245841\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18245528\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8814761\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6347\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6347|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/62/35813\" title=\"diagnostic image 1\">",
"      MRI imaging to measure the airway and related structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/39/20086\" title=\"diagnostic image 2\">",
"      MRI of the airway in a child with OSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/48/21257\" title=\"diagnostic image 3\">",
"      Upper airway size during tidal breathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6347|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/20/36173\" title=\"figure 1\">",
"      Starling resistor model",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/14/5358\" title=\"figure 2\">",
"      Partial airway collapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/49/22288\" title=\"figure 3A\">",
"      Upper airway size analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/11/13494\" title=\"figure 3B\">",
"      Shape analysis-AP LAT dimension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6347|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/40/39564\" title=\"table 1\">",
"      Polysomnographic values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/44/716\" title=\"table 2\">",
"      Airway obstruction children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/19/24895\" title=\"table 3\">",
"      Syndromes associated with OSA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=related_link\">",
"      Clinical features and diagnosis of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=related_link\">",
"      Control of ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40217?source=related_link\">",
"      Management of obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/13/6359?source=related_link\">",
"      Overview of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/53/11092?source=related_link\">",
"      Sleep physiology in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15286?source=related_link\">",
"      Sleep related breathing disorders in adults: Definitions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9109?source=related_link\">",
"      Stages and architecture of normal sleep",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/22/35178?source=related_link\">",
"      Tonsillectomy and adenoidectomy in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_36_9802="Male infants UTI";
var content_f9_36_9802=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59396%7EPEDS%2F74329%7EPEDS%2F75971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59396%7EPEDS%2F74329%7EPEDS%2F75971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for febrile male infants aged 3 to 24 months suspected of having a UTI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 642px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UTI: urinary tract infection; LR: likelihood ratio.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shaikh N, Morone NE, Lopez L, et al. Does this child have a urinary tract infection? JAMA 2008; 298:2895. Copyright &copy; 2008 American Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for febrile female infants aged 3 to 24 months suspected of having a UTI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 589px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UTI: urinary tract infection; LR: likelihood ratio.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shaikh N, Morone NE, Lopez L, et al. Does this child have a urinary tract infection? JAMA 2008; 298:2895. Copyright &copy; 2008 American Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for verbal children older than 24 months with urinary or abdominal symptoms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 564px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UTI: urinary tract infection; LR: likelihood ratio.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shaikh N, Morone NE, Lopez L, et al. Does this child have a urinary tract infection? JAMA 2008; 298:2895. Copyright &copy; 2008 American Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9802=[""].join("\n");
var outline_f9_36_9802=null;
var title_f9_36_9803="Applications of PET";
var content_f9_36_9803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F77628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F77628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical applications of peritoneal equilibration test",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Peritoneal membrane transport classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Predict dialysis dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Choose peritoneal dialysis regimen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monitor peritoneal membrane function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnose acute membrane injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnose causes of inadequate ultrafiltration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnose causes of inadequate solute clearance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estimate D/P ratio of a solute at a particular time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnose early ultrafiltration failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assess influence of systemic disease on peritoneal membrane function",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     D/P ratio: dialysate to plasma ratio.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9803=[""].join("\n");
var outline_f9_36_9803=null;
var title_f9_36_9804="Physical effects of altitude";
var content_f9_36_9804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical effects of change in altitude",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Altitude, ft",
"       </td>",
"       <td class=\"subtitle1\">",
"        Barometric pressure, mmHG",
"       </td>",
"       <td class=\"subtitle1\">",
"        Atmospheric P02, mmHG",
"       </td>",
"       <td class=\"subtitle1\">",
"        PI02, mmHG",
"       </td>",
"       <td class=\"subtitle1\">",
"        PA02, mmHG",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pa02, mmHG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        760",
"       </td>",
"       <td>",
"        159",
"       </td>",
"       <td>",
"        149",
"       </td>",
"       <td>",
"        103",
"       </td>",
"       <td>",
"        98",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        707",
"       </td>",
"       <td>",
"        148",
"       </td>",
"       <td>",
"        138",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4000",
"       </td>",
"       <td>",
"        656",
"       </td>",
"       <td>",
"        137",
"       </td>",
"       <td>",
"        128",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5000",
"       </td>",
"       <td>",
"        632",
"       </td>",
"       <td>",
"        132",
"       </td>",
"       <td>",
"        122",
"       </td>",
"       <td>",
"        81",
"       </td>",
"       <td>",
"        66",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6000",
"       </td>",
"       <td>",
"        609",
"       </td>",
"       <td>",
"        127",
"       </td>",
"       <td>",
"        117",
"       </td>",
"       <td>",
"        77",
"       </td>",
"       <td>",
"        64",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8000",
"       </td>",
"       <td>",
"        564",
"       </td>",
"       <td>",
"        118",
"       </td>",
"       <td>",
"        108",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10000",
"       </td>",
"       <td>",
"        523",
"       </td>",
"       <td>",
"        109",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        53",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PI02: partial pressure of inspired oxygen; PA02: partial pressure of alveolar oxygen; Pa02: partial pressure of oxygen in arterial blood 8000 feet represents the maximum allowable altitude in commercial aircraft.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Gong, H. Exposure to moderate altitude and cardiorespiratory diseases. Cardiologica 1995; 40:477.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9804=[""].join("\n");
var outline_f9_36_9804=null;
var title_f9_36_9805="Differential dx lab values";
var content_f9_36_9805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequency and severity of laboratory findings among imitators of preeclampsia-eclampsia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Laboratory findings",
"       </td>",
"       <td class=\"subtitle1\">",
"        HELLP syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        AFLP",
"       </td>",
"       <td class=\"subtitle1\">",
"        TTP",
"       </td>",
"       <td class=\"subtitle1\">",
"        HUS",
"       </td>",
"       <td class=\"subtitle1\">",
"        Exacerbation of SLE",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia (less than 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        )",
"       </td>",
"       <td>",
"        More than 20,000",
"       </td>",
"       <td>",
"        More than 50,000",
"       </td>",
"       <td>",
"        20,000 or less",
"       </td>",
"       <td>",
"        More than 20,000",
"       </td>",
"       <td>",
"        More than 20,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemolysis (percent)",
"       </td>",
"       <td>",
"        50-100",
"       </td>",
"       <td>",
"        15-20",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        14-23 with APA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia (percent)",
"       </td>",
"       <td>",
"        Less than 50",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        14-23 with APA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        DIC (percent)",
"       </td>",
"       <td>",
"        Less than 20",
"       </td>",
"       <td>",
"        50-100",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoglycemia (percent)",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        50-100",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VW factor multimers (percent)",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        80-90",
"       </td>",
"       <td>",
"        80",
"       </td>",
"       <td>",
"        Less than 10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ADAMTS13 less than 5 percent (percent)",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        33-100",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impaired renal function (percent)",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        90-100",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        40-80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LDH (IU/L)",
"       </td>",
"       <td>",
"        600 or more",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        More than 1000",
"       </td>",
"       <td>",
"        More than 1000",
"       </td>",
"       <td>",
"        With APA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated ammonia (percent)",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated bilirubin (percent)",
"       </td>",
"       <td>",
"        50-60",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        Less than 10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated transaminases (percent)",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        Usually mild*",
"       </td>",
"       <td>",
"        Usually mild*",
"       </td>",
"       <td>",
"        With APA",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HELLP: hemolysis, elevated liver enzymes, low platelets; AFLP: acute fatty liver of pregnancy; TTP: thrombotic thrombocytopenic purpura; HUS: hemolytic uremic syndrome; SLE: systemic lupus erythematosus; APA: antiphospholipid antibodies with or without catastrophic antiphospholipid syndrome; DIC; disseminated intravascular coagulopathy: VW: von Willebrand; ADAMTS: von Willebrand factor-cleaving metalloprotease; LDH: lactic dehydrogenase; NR: values are not available.",
"     <br>",
"      * Levels less than 100 IU/L.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol 2007; 109:956. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9805=[""].join("\n");
var outline_f9_36_9805=null;
var title_f9_36_9806="Dose and admin of LAI antipsychotic for schizophrenia";
var content_f9_36_9806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F59201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F59201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dosage and administration of long-acting injectable antipsychotics for schizophrenia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fluphenazine decanoate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Haloperidol decanoate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Risperidone microspheres",
"       </td>",
"       <td class=\"subtitle1\">",
"        Paliperidone palmitate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Olanzapine pamoate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Flupentixol decanoate*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Zuclopenthixol decanoate*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pipotiazine palmitate*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Generation",
"       </td>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        Second",
"       </td>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        First",
"       </td>",
"       <td>",
"        First",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Injection Interval",
"       </td>",
"       <td>",
"        2 to 4 weeks",
"       </td>",
"       <td>",
"        4 weeks",
"       </td>",
"       <td>",
"        2 weeks",
"       </td>",
"       <td>",
"        4 weeks",
"       </td>",
"       <td>",
"        2 to 4 weeks",
"       </td>",
"       <td>",
"        2 to 4 weeks",
"       </td>",
"       <td>",
"        2 to 4 weeks",
"       </td>",
"       <td>",
"        3 to 4 weeks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Available dosage strengths",
"       </td>",
"       <td>",
"        <p>",
"         25 mg/mL",
"        </p>",
"        <p>",
"         (variable dose)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         50 mg/mL",
"        </p>",
"        <p>",
"         100 mg/mL",
"        </p>",
"        <p>",
"         (variable dose)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         12.5 mg",
"        </p>",
"        <p>",
"         25 mg",
"        </p>",
"        <p>",
"         37.5 mg",
"        </p>",
"        <p>",
"         50 mg",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         39 mg",
"        </p>",
"        <p>",
"         78 mg",
"        </p>",
"        <p>",
"         117 mg",
"        </p>",
"        <p>",
"         156 mg",
"        </p>",
"        <p>",
"         234 mg",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         210 mg",
"        </p>",
"        <p>",
"         300 mg",
"        </p>",
"        <p>",
"         405 mg",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         20 mg/mL",
"        </p>",
"        <p>",
"         100 mg/mL",
"        </p>",
"        <p>",
"         (variable dose)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         200 mg/mL",
"        </p>",
"        <p>",
"         (variable dose)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         25 mg/mL",
"        </p>",
"        <p>",
"         50 mg/mL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Dose range (adult)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        12.5 to 100 mg",
"       </td>",
"       <td>",
"        20 to 450 mg",
"       </td>",
"       <td>",
"        12.5 to 50 mg",
"       </td>",
"       <td>",
"        39 to 234 mg",
"       </td>",
"       <td>",
"        150 to 405 mg",
"       </td>",
"       <td>",
"        10 to 50 mg",
"       </td>",
"       <td>",
"        100 to 400 mg",
"       </td>",
"       <td>",
"        75 to 200 mg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Maximum recommended dose",
"       </td>",
"       <td>",
"        100 mg every 2 weeks",
"       </td>",
"       <td>",
"        450 mg every 4 weeks",
"       </td>",
"       <td>",
"        50 mg every 2 weeks",
"       </td>",
"       <td>",
"        234 mg every 4 weeks",
"       </td>",
"       <td>",
"        300 mg every 2 weeks or 405 mg every 4 weeks",
"       </td>",
"       <td>",
"        100 mg every 2 weeks",
"       </td>",
"       <td>",
"        600 mg every 2 weeks",
"       </td>",
"       <td>",
"        250 mg every 3 weeks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Conversion from oral tablets",
"       </td>",
"       <td>",
"        1 mg of oral daily &asymp; 1.25 mg LAI every 3 weeks",
"       </td>",
"       <td>",
"        Initiate LAI at 10 to 20 times daily oral dose, up to 100 mg. If initial conversion requires &gt;100 mg, follow by balance in 3 to 7 days. Then administer at 4 week intervals.",
"       </td>",
"       <td>",
"        Initiate LAI at 25 mg every 2 weeks. For first 3 weeks overlap with full-dose oral treatment.",
"       </td>",
"       <td>",
"        Conversion from oral extended release: if stable on oral 12 mg daily, then 234 mg LAI; if 6 mg oral daily, then 117 mg LAI; if 3 mg oral daily, then 39 to 78 mg LAI",
"       </td>",
"       <td>",
"        <p>",
"         If stable on oral 10 mg daily, then 210 mg LAI every 2 weeks or 405 mg LAI every 4 weeks for first 8 weeks, then 150 mg IM LAI every 2 weeks or 300 mg every 4 weeks",
"        </p>",
"        <p>",
"         If stable on oral 15 mg daily, then 300 mg LAI every 2 weeks for first 8 weeks, then 210 mg LAI every 2 weeks or 405 mg LAI every 4 weeks",
"        </p>",
"        <p>",
"         If stable on oral 20 mg daily then 300 mg LAI every 2 weeks",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Initiate LAI at 4 times daily oral dose every two weeks or 8 times daily oral dose every 4 weeks. For first week, overlap with oral treatment.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         If stable on oral dose up to 20 mg daily then 100 mg LAI every 2 weeks",
"        </p>",
"        <p>",
"         If stable on 25 to 40 mg oral daily, then 200 mg LAI every 2 weeks",
"        </p>",
"        <p>",
"         If stable on 50 to 75 mg oral daily then 300 mg LAI every 2 weeks",
"        </p>",
"        <p>",
"         If stable on more than 75 mg daily then 400 mg LAI every 2 weeks",
"        </p>",
"       </td>",
"       <td>",
"        Discontinue oral treatment. Initiate at 50 to 100 mg LAI every 3 weeks. Individualize dose and interval in 25 mg increments based on response no more frequently than every 2 to 3 weeks.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Injection site",
"       </td>",
"       <td>",
"        Deltoid or gluteal",
"       </td>",
"       <td>",
"        Deltoid or gluteal",
"       </td>",
"       <td>",
"        Deltoid or gluteal",
"       </td>",
"       <td>",
"        Deltoid or gluteal",
"       </td>",
"       <td>",
"        Gluteal only",
"       </td>",
"       <td>",
"        Gluteal or lateral thigh",
"       </td>",
"       <td>",
"        Gluteal or lateral thigh",
"       </td>",
"       <td>",
"        Gluteal",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Injection technique",
"       </td>",
"       <td>",
"        Z-Track",
"       </td>",
"       <td>",
"        Z-Track",
"       </td>",
"       <td>",
"        Standard",
"       </td>",
"       <td>",
"        Standard",
"       </td>",
"       <td>",
"        Standard",
"       </td>",
"       <td>",
"        Z-Track",
"       </td>",
"       <td>",
"        Z-Track",
"       </td>",
"       <td>",
"        Z-Track",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Solubilization and vehicle",
"       </td>",
"       <td>",
"        Ester in sesame seed oil",
"       </td>",
"       <td>",
"        Ester in sesame seed oil",
"       </td>",
"       <td>",
"        Microsphere matrix in aqueous suspension",
"       </td>",
"       <td>",
"        Nanoparticles in aqueous suspension",
"       </td>",
"       <td>",
"        Nanoparticles in aqueous suspension",
"       </td>",
"       <td>",
"        Ester in medium chain triglycerides or coconut oil",
"       </td>",
"       <td>",
"        Ester in low viscosity vegetable oil",
"       </td>",
"       <td>",
"        Ester in sesame seed oil",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Long-acting preparations are administered by deep INTRAMUSCULAR administration only and NEVER given intravenously. Subcutaneous administration is not recommended due to variable absorption and increased risk of local site reaction. Details shown are specific to the preparations and forms available in US, unless otherwise noted. Dosing, administration and other details listed in licensed product information may differ for other forms and by country. Consult official product information for detail.",
"    <div class=\"footnotes\">",
"     LAI: intramuscular long-acting injectable (also known as \"depot\" injection).",
"     <br/>",
"     * Not available in US.  Product details shown from Canada product monograph available at: file://webprod3.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp  accessed on March 6, 2012.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Significant dosage reduction required for older or debilitated adults, patients with low cardiac output or hepatic or renal insufficiency. Certain products are not recommended in renal insufficiency. For additional information, see Lexi-Comp drug reference included with UpToDate.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9806=[""].join("\n");
var outline_f9_36_9806=null;
var title_f9_36_9807="Chest x-ray - Tuberculosis and HIV";
var content_f9_36_9807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest x-ray - Tuberculosis and HIV",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph showing asymmetric hilar and mediastinal adenopathy and non-confluent opacification left mid and lower zones. Typical appearance of tuberculosis in patients with CD4 counts &lt;200 cells/microL.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gary Maartens, MBChB, MMed.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_36_9807=[""].join("\n");
var outline_f9_36_9807=null;
